EurekaMag PDF full texts Chapter 57,982

Jing, Y.-Y.; Liu, W.-T.; Guo, S.-W.; Ye, F.; Fan, Q.-M.; Yu, G.-F.; Yu, D.-D.; Gao, L.; Sun, K.; Han, Z.-P.; Li, R.; Yang, Y.; Zhao, Q.-D.; Wu, M.-C.; Wang, H.-Y.; Wei, L.-X. 2015: Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk. Oncotarget 6(40): 42952-42962

Li, X.; Zhong, X.; Chen, Z.-H.; Xing, Y.-F.; Wu, D.-H.; Chen, J.; Ma, X.-K.; Lin, Q.; Wen, J.-Y.; Wei, L.; Wang, T.-T.; Ruan, D.-Y.; Lin, Z.-X.; Wu, X.-Y.; Dong, M. 2014: Hepatitis B virus DNA negativity acts as a favorable prognostic factor in hepatocellular carcinoma patients. Asian Pacific Journal of Cancer Prevention: Apjcp 15(22): 9635-9641

Almeida, R.W.d.; Espírito-Santo, M.P.; Sousa, P.S.F.; Almeida, A.J.d.; Lampe, E.; Lewis-Ximenez, L.L. 2015: Hepatitis B virus DNA stability in plasma samples under short-term storage at 42°C. Brazilian Journal of Medical and Biological Research 48(6): 553-556

Ansari, N.; Makvandi, M.; Samarbaf-Zadeh, A.R. 2015: Hepatitis B virus Genotyping Among Patients with Cirrhosis. Jundishapur Journal of Microbiology 8(3): E14571

Yen, T.T.-C.; Yang, A.; Chiu, W.-T.; Li, T.-N.; Wang, L.-H.; Wu, Y.-H.; Wang, H.-C.; Chen, L.; Wang, W.-C.; Huang, W.; Chang, C.-W.; Chang, M.D.-T.; Shen, M.-R.; Su, I.-J.; Wang, L.H.-C. 2016: Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instability. Oncotarget 7(17): 23346-23360

Xu, Z.; Zhai, L.; Yi, T.; Gao, H.; Fan, F.; Li, Y.; Wang, Y.; Li, N.; Xing, X.; Su, N.; Wu, F.; Chang, L.; Chen, X.; Dai, E.; Zhao, C.; Yang, X.; Cui, C.; Xu, P. 2016: Hepatitis B virus X induces inflammation and cancer in mice liver through dysregulation of cytoskeletal remodeling and lipid metabolism. Oncotarget 7(43): 70559-70574

Bak, Y.; Shin, H.-j.; Bak, I.s.; Yoon, D.-y.; Yu, D.-Y. 2015: Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway. Biochemical and Biophysical Research Communications 466(4): 676-681

Gao, J.; Xiong, Y.; Wang, Y.; Wang, Y.; Zheng, G.; Xu, H. 2016: Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma. International Journal of Oncology 48(1): 329-337

Kim, S.; Lee, H.-S.; Ji, J.-H.; Cho, M.-Y.; Yoo, Y.-S.; Park, Y.-Y.; Cha, H.-J.; Lee, Y.; Kim, Y.; Cho, H. 2015: Hepatitis B virus X protein activates the ATM-Chk2 pathway and delays cell cycle progression. Journal of General Virology 96(8): 2242-2251

Liu, Y.; Xu, Y.; Ma, H.; Wang, B.; Xu, L.; Zhang, H.; Song, X.; Gao, L.; Liang, X.; Ma, C. 2016: Hepatitis B virus X protein amplifies TGF-β promotion on HCC motility through down-regulating PPM1a. Oncotarget 7(22): 33125-33135

Xiong, L.; Liu, Y.; Xiong, Q. 2015: Hepatitis B virus X protein and methylation of the E-cadherin promoter in hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 23(7): 543-546

Zhang, M.; Gu, J.; Zhang, C. 2016: Hepatitis B virus X protein binding to hepsin promotes C3 production by inducing IL-6 secretion from hepatocytes. Oncotarget 7(7): 7780-7800

Mitra, B.; Guo, H. 2016: Hepatitis B virus X protein crosses out Smc5/6 complex to maintain covalently closed circular DNA transcription. Hepatology 64(6): 2246-2249

Tsunematsu, S.; Suda, G.; Yamasaki, K.; Kimura, M.; Izumi, T.; Umemura, M.; Ito, J.; Sato, F.; Nakai, M.; Sho, T.; Morikawa, K.; Ogawa, K.; Tanaka, Y.; Watashi, K.; Wakita, T.; Sakamoto, N. 2017: Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A. Journal of Medical Virology 89(2): 267-275

Fu, S.; Zhou, R.-R.; Li, N.; Huang, Y.; Fan, X.-G. 2016: Hepatitis B virus X protein in liver tumor microenvironment. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 2016

Chen, W.-n.; Liu, L.-l.; Jiao, B.-y.; Lin, W.-s.; Lin, X.-j.; Lin, X. 2015: Hepatitis B virus X protein increases the IL-1β-induced NF-κB activation via interaction with evolutionarily conserved signaling intermediate in Toll pathways (ECSIT). Virus Research 195: 236-245

Shin Kim, S.; Yeom, S.; Kwak, J.; Ahn, H.-J.; Lib Jang, K. 2016: Hepatitis B virus X protein induces epithelial-mesenchymal transition by repressing E-cadherin expression via upregulation of E12/E47. Journal of General Virology 97(1): 134-143

Zhu, M.; Guo, J.; Li, W.; Lu, Y.; Fu, S.; Xie, X.; Xia, H.; Dong, X.; Chen, Y.; Quan, M.; Zheng, S.; Xie, K.; Li, M. 2015: Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells. Oncotarget 6(14): 12196-12208

Wang, D.-Y.; Zou, L.-P.; Liu, X.-J.; Zhu, H.-G.; Zhu, R. 2015: Hepatitis B virus X protein induces the histone H3 lysine 9 trimethylation on the promoter of p16 gene in hepatocarcinogenesis. Experimental and Molecular Pathology 99(3): 399-408

Wang, D.-Y.; An, S.-H.; Liu, L.; Bai, S.-S.; Wu, K.-X.; Zhu, R.; Wang, Z.-J. 2016: Hepatitis B virus X protein influences enrichment profiles of H3K9me3 on promoter regions in human hepatoma cell lines. Oncotarget 7(51): 84883-84892

Bandopadhyay, M.; Sarkar, N.; Datta, S.; Das, D.; Pal, A.; Panigrahi, R.; Banerjee, A.; Panda, C.K.; Das, C.; Chakrabarti, S.; Chakravarty, R. 2016: Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis. Infectious Agents and Cancer 11: 40

Wu, Y.; Zhang, J.; Zhang, H.; Zhai, Y. 2016: Hepatitis B virus X protein mediates yes-associated protein 1 upregulation in hepatocellular carcinoma. Oncology Letters 12(3): 1971-1974

Cui, H.; Li, Q.-L.; Chen, J.; Na, Q.; Liu, C.-X. 2015: Hepatitis B virus X protein modifies invasion, proliferation and the inflammatory response in an HTR-8/SVneo cell model. Oncology Reports 34(4): 2090-2098

Kong, F.; Hu, W.; Zhou, K.; Wei, X.; Kou, Y.; You, H.; Zheng, K.; Tang, R. 2016: Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells. Journal of Experimental and Clinical Cancer Research: Cr 35(1): 172

Li, M.; Hu, L.; Zhu, F.; Zhou, Z.; Tian, J.; Ai, J. 2016: Hepatitis B virus X protein promotes renal epithelial-mesenchymal transition in human renal proximal tubule epithelial cells through the activation of NF-κB. International Journal of Molecular Medicine 38(2): 513-520

Cao, K.; Gong, H.; Qiu, Z.; Wen, Q.; Zhang, B.; Tang, T.; Zhou, X.; Cao, T.; Wang, B.; Shi, H.; Wang, R. 2016: Hepatitis B virus X protein reduces the stability of Nrdp1 to up-regulate ErbB3 in hepatocellular carcinoma cells. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(8): 10375-10382

Feng, G.; Li, J.; Zheng, M.; Yang, Z.; Liu, Y.; Zhang, S.; Ye, L.; Zhang, W.; Zhang, X. 2016: Hepatitis B virus X protein up-regulates C4b-binding protein α through activating transcription factor Sp1 in protection of hepatoma cells from complement attack. Oncotarget 7(19): 28013-28026

Fu, X.; Song, X.; Li, Y.; Tan, D.; Liu, G. 2016: Hepatitis B virus X protein upregulates DNA methyltransferase 3A/3B and enhances SOCS-1CpG island methylation. Molecular Medicine Reports 13(1): 301-308

Tu, J.; Zhang, T.; Cheng, J.; Zeng, Z.Z.; Lu, F.M.; Chen, X.M. 2016: Hepatitis B virus X protein-regulated expression of Plk1. Zhonghua Gan Zang Bing Za Zhi 24(1): 46-50

Rivière, L.; Gérossier, L.; Hantz, O.; Neuveut, C. 2016: Hepatitis B virus and chromatin remodeling: HBx counteracts SETDB1/HP1/H3K9me3 transcriptional silencing. Medecine Sciences: M/S 32(5): 455-458

Malhotra, R.; Soin, D.; Grover, P.; Galhotra, S.; Khutan, H.; Kaur, N. 2016: Hepatitis B virus and hepatitis C virus co-infection in hemodialysis patients: A retrospective study from a tertiary care hospital of North India. Journal of Natural Science Biology and Medicine 7(1): 72-74

Dong, Y.; Qiu, C.; Xia, X.; Wang, J.; Zhang, H.; Zhang, X.; Xu, J. 2015: Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study. Archives of Virology 160(4): 929-936

Coppola, N.; De Pascalis, S.; Onorato, L.; Calò, F.; Sagnelli, C.; Sagnelli, E. 2016: Hepatitis B virus and hepatitis C virus infection in healthcare workers. World Journal of Hepatology 8(5): 273-281

Wang, Z.; Sheng, Y.-Y.; Dong, Q.-Z.; Qin, L.-X. 2016: Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: a meta-analysis. World Journal of Gastroenterology 22(10): 3038-3051

Lamontagne, J.; Steel, L.F.; Bouchard, M.J. 2015: Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. World Journal of Gastroenterology 21(24): 7375-7399

Yang, Y.; Han, Q.; Zhang, C.; Xiao, M.; Zhang, J. 2016: Hepatitis B virus antigens impair NK cell function. International Immunopharmacology 38: 291-297

Chan, V.; Lai, C.L.; Chan, K.M.; Yuen, M.F. 2014: Hepatitis B virus array for genotyping and mutation detection. Hong Kong Medical Journal 20(Suppl 6): 25-27

Koumbi, L.; Pollicino, T.; Raimondo, G.; Stampoulis, D.; Khakoo, S.; Karayiannis, P. 2016: Hepatitis B virus basal core promoter mutations show lower replication fitness associated with cccDNA acetylation status. Virus Research 220: 150-160

Zhong, Y.W.; Di, F.L.; Liu, C.; Zhang, X.C.; Bi, J.F.; Li, Y.L.; Wu, S.Q.; Dong, H.; Liu, L.M.; He, J.; Shi, Y.M.; Zhang, H.F.; Zhang, M. 2016: Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 22(4): 379.e1-379.e8

Zampino, R.; Boemio, A.; Sagnelli, C.; Alessio, L.; Adinolfi, L.E.; Sagnelli, E.; Coppola, N. 2015: Hepatitis B virus burden in developing countries. World Journal of Gastroenterology 21(42): 11941-11953

Visentini, M.; Pascolini, S.; Mitrevski, M.; Marrapodi, R.; Del Padre, M.; Todi, L.; Camponeschi, A.; Axiotis, E.; Carlesimo, M.; De Santis, A.; Fiorilli, M.; Casato, M. 2016: Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody. Clinical and Experimental Rheumatology 34(3 Suppl 97: S28-S32

Ene, L.; Duiculescu, D.; Tardei, G.; Ruta, S.; Smith, D.M.; Mehta, S.; Letendre, S.; Achim, C.L. 2015: Hepatitis B virus compartmentalization in the cerebrospinal fluid of HIV-infected patients. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 21(4): 387.E5-8

Jiang, P.; Du, W.; Xiong, Y.; Lv, Y.; Feng, J.; Zhu, S.; Xue, X.; Chen, S.; Zhang, L. 2015: Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection. Oncotarget 6(41): 43281-43292

Constantinescu, I.; Dinu, A.-A.; Boscaiu, V.; Niculescu, M. 2014: Hepatitis B virus core promoter mutations in patients with chronic hepatitis B and hepatocellular carcinoma in bucharest, romania. Hepatitis Monthly 14(10): E22072

Liu, W.; Lin, Y-Ting.; Yan, X-Li.; Ding, Y-Lan.; Wu, Y-Li.; Chen, W-Nan.; Lin, X. 2015: Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 29(3): 1113-1123

Jia, B.; Guo, M.; Li, G.; Yu, D.; Zhang, X.; Lan, K.; Deng, Q. 2015: Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7. Journal of Virology 89(4): 2041-2051

Zhou, T.; Jin, M.; Ding, Y.; Zhang, Y.; Sun, Y.; Huang, S.; Xie, Q.; Xu, C.; Cai, W. 2016: Hepatitis B virus dampens autophagy maturation via negative regulation of Rab7 expression. Bioscience Trends 10(4): 244-250

Kanda, T.; Nakamoto, S.; Sasaki, R.; Wu, S. 2015: Hepatitis B virus e antigen plays an important role in the treatment for chronic hepatitis B. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 531-534

Zhang, X.; Zhang, R.; Yang, H.; Xiang, Q.; Jiang, Q.; He, Q.; Zhang, T.; Chen, C.; Zhu, H.; Wang, Q.; Ning, Q.; Li, Y.; Lei, P.; Shen, G. 2016: Hepatitis B virus enhances cisplatin-induced hepatotoxicity via a mechanism involving suppression of glucose-regulated protein of 78 Kda. Chemico-Biological Interactions 254: 45-53

MacLachlan, J.H.; Cowie, B.C. 2015: Hepatitis B virus epidemiology. Cold Spring Harbor Perspectives in Medicine 5(5): A021410

Zhang, A.-Y.; Lai, C.-L.; Poon, R.T.-P.; Huang, F.-Y.; Seto, W.-K.; Fung, J.; Wong, D.K.-H.; Yuen, M.-F. 2016: Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 31(9): 1638-1645

Lu, G.; Villa, J.A.; Donlin, M.J.; Edwards, T.C.; Cheng, X.; Heier, R.F.; Meyers, M.J.; Tavis, J.E. 2016: Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors. Antiviral Research 135: 24-30

Cai, Q.; Zhu, H.; Zhang, Y.; Li, X.; Zhang, Z. 2016: Hepatitis B virus genotype A: design of reference sequences for sub-genotypes. Virus Genes 52(3): 325-333

Yang, G.; Han, M.; Chen, F.; Xu, Y.; Chen, E.; Wang, X.; Liu, Y.; Sun, J.; Hou, J.; Ning, Q.; Wang, Z. 2014: Hepatitis B virus genotype B and mutations in basal core promoter and pre-core/core genes associated with acute-on-chronic liver failure: a multicenter cross-sectional study in China. Hepatology International 8(4): 508-516

Sayan, M.; Sanlıdağ, T.; Akçalı, S.; Arıkan, A.şe. 2014: Hepatitis B virus genotype e infection in Turkey: the detection of the first case. Mikrobiyoloji Bulteni 48(4): 683-688

Vratnica, Z.; Zehender, G.; Ebranati, E.; Sorrentino, C.; Lai, A.; Vujošević, D.; Veo, C.; Lo Presti, A.; Cella, E.; Giovanetti, M.; Laušević, D.; Galli, M.; Ciccozzi, M.; Mugoša, B. 2015: Hepatitis B virus genotype and subgenotype prevalence and distribution in Montenegro. Journal of Medical Virology 87(5): 807-813

González López Ledesma, M.ía.M.; Mojsiejczuk, L.N.; Rodrigo, B.én.; Sevic, I.; Mammana, L.; Galdame, O.; Gadano, A.; Fainboim, H.; Campos, R.; Flichman, D. 2015: Hepatitis B virus genotype distribution and genotype-specific BCP/preCore substitutions in acute and chronic infections in Argentina. Plos one 10(3): E0121436

Zirabamuzale, J.T.; Opio, C.K.; Bwanga, F.; Seremba, E.; Apica, B.S.; Colebunders, R.; Ocama, P. 2016: Hepatitis B virus genotypes a and D in Uganda. Journal of Virus Eradication 2(1): 19-21

Ntagirabiri, R.én.; Munezero, B.; Nahimana, C.; Ndabaneze, E. 2016: Hepatitis B virus genotypes and evolutionary markers in chronic HBsAG patients in Bujumbura. Pan African Medical Journal 23: 95

Li, H.-M.; Wang, J.-Q.; Wang, R.; Zhao, Q.; Li, L.; Zhang, J.-P.; Shen, T. 2015: Hepatitis B virus genotypes and genome characteristics in China. World Journal of Gastroenterology 21(21): 6684-6697

Mello, Fávia.Miryan.Martins.Almeida.de.; Kuniyoshi, A.Satie.Oba.; Lopes, Aé.Fanhani.; Gomes-Gouvêa, M.Soares.; Bertolini, D.Armando. 2014: Hepatitis B virus genotypes and mutations in the basal core promoter and pre-core/core in chronically infected patients in southern Brazil: a cross-sectional study of HBV genotypes and mutations in chronic carriers. Revista da Sociedade Brasileira de Medicina Tropical 47(6): 701-708

Lin, C.-L.; Kao, J.-H. 2015: Hepatitis B virus genotypes and variants. Cold Spring Harbor Perspectives in Medicine 5(5): A021436

Liu, Z.; Song, C.; Wen, J.; Xu, L.; Liu, Y.; Zhu, J.; Zhu, L.; Hu, Z.; Ma, H.; Liu, L. 2016: Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma. Oncotarget 7(28): 44076-44083

Tian, Q.; Jia, J. 2016: Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia. Hepatology International 10(6): 854-860

Asaad, A.M.; Al-Ayed, M.S.Z.; Aleraky, M.; Qureshi, M.A. 2015: Hepatitis B virus genotyping in chronic hepatitis B patients in southwestern Saudi Arabia. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 19(5): 525-528

Bai, L.; Zhang, W.; Tan, L.; Yang, H.; Ge, M.; Zhu, C.; Zhang, R.; Cao, Y.; Chen, J.; Luo, Z.; Ho, W.; Liu, F.; Wu, K.; Wu, J. 2015: Hepatitis B virus hijacks CTHRC1 to evade host immunity and maintain replication. Journal of Molecular Cell Biology 7(6): 543-556

Hadžić, N.; Bansal, S. 2016: Hepatitis B virus in children: more therapeutic options-but unknown and known unknowns still present. Hepatology 63(2): 360-362

Ricardo-Lax, I.; Ramanan, V.; Michailidis, E.; Shamia, T.; Reuven, N.; Rice, C.M.; Shlomai, A.; Shaul, Y. 2015: Hepatitis B virus induces RNR-R2 expression via DNA damage response activation. Journal of Hepatology 63(4): 789-796

Hu, J.-L.; Liu, L.-P.; Yang, S.-L.; Fang, X.; Wen, L.; Ren, Q.-G.; Yu, C. 2016: Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein. Oncology Reports 35(3): 1443-1448

Moraes, T.Cinquini.; Fiaccadori, Fíola.Souza.; Souza, M.; Almeida, Tâmera.Nunes.Vieira.; Cunha, M.dos.Passos.; Castro, Ítalo.de.Araújo.; Cardoso, D.das.Dôres.de.Paula. 2015: Hepatitis B virus infection among institutionalized mentally ill patients in Brazil. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 19(6): 643-647

Tohme, R.A.; Andre-Alboth, J.; Tejada-Strop, A.; Shi, R.; Boncy, J.; François, J.; Domercant, J.Wysler.; Griswold, M.; Hyppolite, E.; Adrien, P.; Kamili, S. 2016: Hepatitis B virus infection among pregnant women in Haiti: A cross-sectional serosurvey. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 76: 66-71

Shen, Y.-Y.; Hou, W.; Yang, Z.-Q.; Xiao, W. 2015: Hepatitis B virus infection and genotype in asymptomatic people from 10 ethnic groups in Yunnan, China. World Journal of Gastroenterology 21(44): 12586-12592

Kumada, T.; Toyoda, H.; Tada, T. 2015: Hepatitis B virus infection and its prevention. Nihon Rinsho. Japanese Journal of Clinical Medicine 73 Suppl. 9: 565-569

Fiorino, S.; de Biase, D.; Fornelli, A.; Masetti, M.; Cuppini, A.; Bondi, A.; Tallini, G.; Jovine, E.; Pession, A. 2015: Hepatitis B virus infection and pancreatic neuroendocrine tumor: a case report. Pancreas 44(2): 341-342

Sai, L.-T.; Yao, Y.-Y.; Guan, Y.-Y.; Shao, L.-H.; Ma, R.-P.; Ma, L.-X. 2016: Hepatitis B virus infection and replication in a new cell culture system established by fusing HepG2 cells with primary human hepatocytes. Journal of Microbiology Immunology and Infection 49(4): 471-476

Wijarnpreecha, K.; Thongprayoon, C.; Panjawatanan, P.; Ungprasert, P. 2016: Hepatitis B virus infection and risk of coronary artery disease: a meta-analysis. Annals of Translational Medicine 4(21): 423

Wijarnpreecha, K.; Thongprayoon, C.; Panjawatanan, P.; Manatsathit, W.; Ungprasert, P. 2016: Hepatitis B virus infection and risk of gallstones: a systematic review and meta-analysis. European Journal of Gastroenterology and Hepatology 28(12): 1437-1442

Ye, Y.-F.; Xiang, Y.-Q.; Fang, F.; Gao, R.; Zhang, L.-F.; Xie, S.-H.; Liu, Z.; Du, J.-L.; Chen, S.-H.; Hong, M.-H.; Qian, C.-N.; Ye, W.; Zeng, Y.-X.; Liu, Q.; Cao, S.-M. 2015: Hepatitis B virus infection and risk of nasopharyngeal carcinoma in southern China. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 24(11): 1766-1773

Su, F.-H.; Chang, S.-N.; Sung, F.-C.; Su, C.-T.; Shieh, Y.-H.; Lin, C.-C.; Yeh, C.-C. 2014: Hepatitis B virus infection and the risk of male infertility: a population-based analysis. Fertility and Sterility 102(6): 1677-1684

Yan, L-Bo.; Rao, H-Ying.; Ma, Y-Ji.; Bai, L.; Chen, E-Qiang.; Du, L-Yao.; Yang, R-Feng.; Wei, L.; Tang, H. 2016: Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study. Bmj Open 6(10): E012016

Chotun, N.; Nel, E.; Cotton, M.F.; Preiser, W.; Andersson, M.I. 2015: Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa. Vaccine 33(36): 4618-4622

Yano, Y.; Utsumi, T.; Lusida, M.I.; Hayashi, Y. 2015: Hepatitis B virus infection in Indonesia. World Journal of Gastroenterology 21(38): 10714-10720

Pisano, M.ía.B.én.; Blanco, S.án.; Carrizo, H.; Ré, V.E.; Gallego, S. 2016: Hepatitis B virus infection in blood donors in Argentina: prevalence of infection, genotype distribution and frequency of occult HBV infection. Archives of Virology 161(10): 2813-2817

Komatsu, H.; Inui, A. 2015: Hepatitis B virus infection in children. Expert Review of AntI-Infective Therapy 13(4): 427-450

Gunardi, H.; Iskandar, M.Y.; Turyadi; Ie, S.I.; Dwipoerwantoro, P.G.; Gani, R.A.; Muljono, D.H. 2017: Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission. Hepatology International 11(1): 96-104

Katayama, K.; Sato, T.; Do, S.H.; Yamada, H.; Tabuchi, A.; Komiya, Y.; Matsuo, J.; Nakashima, A.; Ohisa, M.; Akita, T.; Yorioka, N.; Miyakawa, Y.; Yoshizawa, H.; Tanaka, J. 2015: Hepatitis B virus infection in hemodialysis patients in Japan: Prevalence, incidence and occult hepatitis B virus infection. Hepatology Research: the Official Journal of the Japan Society of Hepatology 45(12): 1211-1219

Li, H.; Yang, F.; Gao, B.; Yu, Z.; Liu, X.; Xie, F.; Zhang, J. 2015: Hepatitis B virus infection in hepatocellular carcinoma tissues upregulates expression of DNA methyltransferases. International Journal of Clinical and Experimental Medicine 8(3): 4175-4185

Coppola, N.; Alessio, L.; Pisaturo, M.; Macera, M.; Sagnelli, C.; Zampino, R.; Sagnelli, E. 2015: Hepatitis B virus infection in immigrant populations. World journal of hepatology 7(30): 2955-2961

Teshale, E.H.; Kamili, S.; Drobeniuc, J.; Denniston, M.; Bakamutamaho, B.; Downing, R. 2015: Hepatitis B virus infection in northern Uganda: Impact of pentavalent hepatitis B vaccination. Vaccine 33(46): 6161-6163

Mansouri, N.; Movafagh, A.; Sayad, A.; Ghafouri-Fard, S.; Darvish, H.; Zare-Abdollahi, D.; Emamalizadeh, B.; Shahvaisizadeh, F.; Ghaedi, H.; Bastami, M.; Kayyal, M.; Hashemi, M.; Heidari, M.; Nejatizadeh, A.; Zamani, M. 2014: Hepatitis B virus infection in patients with blood disorders: a concise review in pediatric study. Iranian Journal of Pediatric Hematology and Oncology 4(4): 178-187

Amponsah-Dacosta, E.; Lebelo, R.L.; Rakgole, J.N.; Selabe, S.G.; Gededzha, M.P.; Mayaphi, S.H.; Powell, E.A.; Blackard, J.T.; Mphahlele, M.J. 2015: Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 63: 12-17

Qian, H-Gang.; Hao, C-Yi. 2014: Hepatitis B virus infection is an independent factor influencing the occurrence of liver metastasis in colorectal cancer: a retrospective analysis of 1413 cases. Hepato-Gastroenterology 61(135): 1908-1914

Zhang, J.; Shen, Y.; Cai, H.; Liu, Y.-M.; Qin, G. 2015: Hepatitis B virus infection status and risk of type 2 diabetes mellitus: a meta-analysis. Hepatology Research: the Official Journal of the Japan Society of Hepatology 45(11): 1100-1109

Lee, B.S.; Park, E.-C.; Park, S.W.; Nam, C.M.; Roh, J. 2015: Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea. World Journal of Gastroenterology 21(2): 502-510

Tanaka, J. 2015: Hepatitis B virus infection, its burden and countermeasures from the epidemiological point of view. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 321-329

Noordeen, F. 2015: Hepatitis B virus infection: An insight into infection outcomes and recent treatment options. Virusdisease 26(1-2): 1-8

Zhu, C.; Gao, G.; Song, H.; Xu, F.; Wu, K.; Liu, X. 2016: Hepatitis B virus inhibits apolipoprotein A5 expression through its core gene. Lipids in Health and Disease 15(1): 178

Barthel, S.R.; Medvedev, R.; Heinrich, T.; Büchner, S.M.; Kettern, N.; Hildt, E. 2016: Hepatitis B virus inhibits insulin receptor signaling and impairs liver regeneration via intracellular retention of the insulin receptor. Cellular and Molecular Life Sciences: Cmls 73(21): 4121-4140

Araujo, N.M. 2015: Hepatitis B virus intergenotypic recombinants worldwide: An overview. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 36: 500-510

Tao, L.-Y.; He, X.-D.; Xiu, D.-R. 2016: Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma. Clinics and Research in Hepatology and Gastroenterology 40(6): 682-687

Churin, Y.; Roderfeld, M.; Roeb, E. 2015: Hepatitis B virus large surface protein: function and fame. Hepatobiliary Surgery and Nutrition 4(1): 1-10

Deng, M.; Hou, J.; Hu, J.; Wang, S.; Chen, M.; Chen, L.; Ju, Y.; Li, C.; Meng, S. 2016: Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma. Cancer Letters 383(1): 62-72

Nozaki, A.; Chuma, M. 2015: Hepatitis B virus management to prevent reactivation. Nihon Rinsho. Japanese Journal of Clinical Medicine 73 Suppl. 9: 443-447

Zhou, H-ying.; Luo, Y.; Chen, W-dong.; Gong, G-zhong. 2015: Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta-regression analysis. Journal of Gastroenterology and Hepatology 30(6): 977-983

Song, C.; Liu, Y.; Xu, L.; Wen, J.; Jiang, D.; Chen, J.; Zhai, X.; Hu, Z.; Liu, L.; Liu, J. 2016: Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinoma. Cancer Medicine 5(7): 1687-1693

Lim, C.Shen.; Brown, C.M. 2016: Hepatitis B virus nuclear export elements: RNA stem-loop α and β, key parts of the HBV post-transcriptional regulatory element. Rna Biology 13(9): 743-747

Muhamad, A.; Ho, K.L.; Rahman, M.B.A.; Tejo, B.A.; Uhrín, D.ša.; Tan, W.S. 2015: Hepatitis B virus peptide inhibitors: solution structures and interactions with the viral capsid. Organic and Biomolecular Chemistry 13(28): 7780-7789

Liu, Y.; Li, J.; Chen, J.; Li, Y.; Wang, W.; Du, X.; Song, W.; Zhang, W.; Lin, L.; Yuan, Z. 2015: Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways. Journal of Virology 89(4): 2287-2300

Hsieh, Y.-H.; Chang, Y.-Y.; Su, I.-J.; Yen, C.-J.; Liu, Y.-R.; Liu, R.-J.; Hsieh, W.-C.; Tsai, H.-W.; Wang, L.H.-C.; Huang, W. 2015: Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis. Journal of Pathology 236(3): 337-347

Lee, S.-A.; Kim, K.-J.; Kim, H.; Choi, W.-H.; Won, Y.-S.; Kim, B.-J. 2015: Hepatitis B virus preS1 deletion is related to viral replication increase and disease progression. World Journal of Gastroenterology 21(16): 5039-5048

Yang, H.; Fu, Q.; Liu, C.; Li, T.; Wang, Y.; Zhang, H.; Lu, X.; Sang, X.; Zhong, S.; Huang, J.; Mao, Y. 2015: Hepatitis B virus promotes autophagic degradation but not replication in autophagosome. Bioscience Trends 9(2): 111-116

Buti, M.; Tabernero, D.; Mas, A.; Homs, M.; Prieto, M.; Rodríguez-Frías, F.; Casafont, F.; Casillas, R.; González, A.; Miras, M.; Herrero, J.I.; Castells, L.; Esteban, R. 2015: Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin. Transplant Infectious Disease: An Official Journal of the Transplantation Society 17(2): 208-220

Juan Juan, A.; Caballero de García, N.; Masnou Ridaura, H.; Sala Llinas, M.; Morillas, M.R.; Planas Vila, R. 2017: Hepatitis B virus reactivation after cessation of prophylaxis with entecavir in a patient with Burkitt type acute lymphoblastic leukaemia treated with rituximab. Gastroenterologia y Hepatologia 40(7): 470-471

Wahle, R.C.; Perez, R.M.; Pereira, P.íc.F.; Oliveira, E.M.G.; Emori, C.T.; Uehara, S.N.d.O.; Silva, I.S.d.S.; Silva, A.ôn.E.B.; Ferraz, M.L.G. 2015: Hepatitis B virus reactivation after treatment for hepatitis C in hemodialysis patients with HBV/HCV coinfection. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 19(5): 533-537

Liu, W.P.; Wang, X.P.; Zheng, W.; Ping, L.Y.; Zhang, C.; Wang, G.Q.; Song, Y.Q.; Zhu, J. 2016: Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma. Leukemia and Lymphoma 57(6): 1355-1362

Chen, K.-L.; Chen, J.; Rao, H.-L.; Guo, Y.; Huang, H.-Q.; Zhang, L.; Shao, J.-Y.; Lin, T.-Y.; Jiang, W.-Q.; Zou, D.-H.; Hu, L.-Y.; Wirian, M.L.; Cai, Q.-Q. 2015: Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival. Chinese Journal of Cancer 34(5): 225-234

Yang, Y.; Du, Y.; Luo, W.-X.; Li, C.; Chen, Y.; Cheng, K.; Ding, J.; Zhou, Y.; Ge, J.; Yang, X.; Liu, J.-Y. 2015: Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy. Cancer ChemoTherapy and Pharmacology 75(4): 783-790

Mori, S.; Fujiyama, S. 2015: Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations. World Journal of Gastroenterology 21(36): 10274-10289

Kim, E.; Yune, S.; Ha, J.M.; Lee, W.J.; Hwang, J.-w.; Paik, Y.-H.; Gwak, G.Y.; Choi, M.S.; Lee, J.H.; Koh, K.C.; Paik, S.W.; Yoo, B.C. 2014: Hepatitis B virus reactivation during anti-cancer chemotherapy in patients with past hepatitis B virus infection. Hepato-Gastroenterology 61(134): 1704-1711

Seto, W.-K. 2015: Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification. World Journal of Hepatology 7(6): 825-830

Colson, P.; Borentain, P.; Coso, D.; Motte, A.; Aurran-Schleinitz, T.; Charbonnier, A.; Stoppa, A.M.; Chabannon, C.; Serrero, M.él.; Bertrand, J.; Barlesi, F.; Serratrice, J.; Portal, I.; Botta-Fridlund, D.; Tamalet, C.; Gerolami, R.é 2015: Hepatitis B virus reactivation in HBsAg-negative patients is associated with emergence of viral strains with mutated HBsAg and reverse transcriptase. Virology 484: 354-363

Voican, C.S.; Mir, O.; Loulergue, P.; Dhooge, M.; Brezault, C.; Dréanic, J.; Chaussade, S.; Pol, S.; Coriat, R. 2016: Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment. Annals of Oncology: Official Journal of the European Society for Medical Oncology 27(12): 2172-2184

Malahleha, M.; Ahmed, K.; Deese, J.; Nanda, K.; van Damme, L.; De Baetselier, I.; Burnett, R.J. 2015: Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report. Journal of Medical Case Reports 9: 207

Tsutsumi, Y.; Yamamoto, Y.; Ito, S.; Ohigashi, H.; Shiratori, S.; Naruse, H.; Teshima, T. 2015: Hepatitis B virus reactivation with a rituximab-containing regimen. World Journal of Hepatology 7(21): 2344-2351

Verrier, E.R.; Colpitts, C.C.; Sureau, C.; Baumert, T.F. 2016: Hepatitis B virus receptors and molecular drug targets. Hepatology International 10(4): 567-573

Liu, N.; Jiao, T.; Huang, Y.; Liu, W.; Li, Z.; Ye, X. 2015: Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway. Journal of Virology 89(5): 2739-2749

Mazzaro, C.; Dal Maso, L.; Urraro, T.; Mauro, E.; Castelnovo, L.; Casarin, P.; Monti, G.; Gattei, V.; Zignego, A.L.; Pozzato, G. 2016: Hepatitis B virus related cryoglobulinemic vasculitis: a multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 48(7): 780-784

Yan, Q.; Lan, Y.-H.; Huang, Y.-X.; Fan, R.-S.; Liu, L.; Song, S.-P.; Li, Y.-G. 2016: Hepatitis B virus replication is upregulated in proliferated peripheral blood lymphocytes. Molecular Medicine Reports 13(4): 3581-3587

Jones, L.R.; Sede, M.; Manrique, J.M.; Quarleri, J. 2016: Hepatitis B virus resistance substitutions: long-term analysis by next-generation sequencing. Archives of Virology 161(10): 2885-2891

Clark, D.N.; Hu, J. 2015: Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development. Antiviral Research 123: 132-137

Hammond, S.P.; Swaminathan, S.; Bensinger, W.I.; Baden, L.R. 2014: Hepatitis B virus screening and potential reactivation in patients undergoing treatment for cancer. Journal of the National Comprehensive Cancer Network: Jnccn 12(12): 1655-1657

Wong, W.W.L.; Hicks, L.K.; Tu, H.-A.; Pritchard, K.I.; Krahn, M.D.; Feld, J.J.; Chan, K.K. 2015: Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis. Breast Cancer Research and Treatment 151(3): 639-652

Webale, M.K.; Kilongosi, M.W.; Budambula, V.; Lihana, R.; Musumba, F.O.; Nyamache, A.K.; Budambula, N.L.M.; Ahmed, A.A.; Ouma, C.; Were, T. 2015: Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya. Bmc Infectious Diseases 15: 299

Bookstaver, P.Brandon.; Foster, J.L.; Lu, Z.Kevin.; Mann, J.R.; Ambrose, C.; Grant, A.; Burgess, S. 2016: Hepatitis B virus seroconversion rates among health sciences students in the southeastern United States. Journal of American College Health: J of Ach 64(1): 69-73

Hooja, S.; Singhal, A.; Bachhiwal, R.; Yadav, R.; Vyas, N. 2015: Hepatitis B virus seroprevalence and its correlation with CD4 cells and liver enzymes among human immunodeficiency virus positive individuals at a tertiary care hospital in North-West India. International Journal of Applied and Basic Medical Research 5(1): 36-40

Hanaoka, M.; Hisano, M.; Hama, I.; Tsukamoto, K.; Ito, R.; Ito, Y.; Sago, H.; Matsui, A.; Yamaguchi, K. 2016: Hepatitis B virus surface antibody titers in babies administered hepatitis B immune globulin both intravenously and intramuscularly after birth. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 29(12): 1945-1948

Wang, H.; Wu, D.; Wang, X.; Chen, G.; Zhang, Y.; Yan, W.; Luo, X.; Han, M.; Ning, Q. 2016: Hepatitis B virus surface protein-induced hPIAS1 transcription requires TAL1, E47, MYOG, NFI, and MAPK signal pathways. Biological Chemistry 397(11): 1173-1185

Manzoor, S.; Saalim, M.; Imran, M.; Resham, S.; Ashraf, J. 2015: Hepatitis B virus therapy: What's the future holding for us?. World Journal of Gastroenterology 21(44): 12558-12575

Hu, S.; Jiang, L-Bin.; Zou, X-Jing.; Yi, W.; Tian, D-Ying. 2016: Hepatitis B virus upregulates host expression of α-1,2-mannosidases via the PPARα pathway. World journal of gastroenterology 22(43): 9534-9543

Zhu, C-Liang.; Cheng, D-Zhi.; Liu, F.; Yan, X-Hong.; Wu, K-Lang.; Wang, F-Bing.; Liu, X-Hui. 2015: Hepatitis B virus upregulates the expression of kinesin family member 4A. Molecular Medicine Reports 12(3): 3503-3507

Mormile, R. 2016: Hepatitis B virus vaccination failure in celiac disease and type 1 diabetes: what is the truth?. International Journal of Colorectal Disease 31(5): 1049

Yanase, M.; Murata, K.; Mikami, S.; Nozaki, Y.; Masaki, N.; Mizokami, M. 2016: Hepatitis B virus vaccination-related seroprevalence among health-care personnel in a Japanese tertiary medical center. Hepatology Research: the Official Journal of the Japan Society of Hepatology 46(13): 1330-1337

Zhang, Y.; Liu, H.; Yi, R.; Yan, T.; He, Y.; Zhao, Y.; Liu, J. 2016: Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression. Journal of Experimental and Clinical Cancer Research: Cr 35(1): 87

Coppola, N.; Alessio, L.; Gualdieri, L.; Pisaturo, M.; Sagnelli, C.; Caprio, N.; Maffei, R.; Starace, M.; Angelillo, I.Francesco.; Pasquale, G.; Sagnelli, E. 2015: Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 20(35): 30009

Grenha, V.; Parada, B.; Ferreira, C.; Figueiredo, A.; Macário, F.; Alves, R.; Coelho, H.; Sepúlveda, L.; Freire, M.J.; Retroz, E.; Mota, A. 2015: Hepatitis B virus, hepatitis C virus, and kidney transplant acute rejection and survival. Transplantation Proceedings 47(4): 942-945

Eberle, J. 2016: Hepatitis B virus--diagnostic update. MMW Fortschritte der Medizin 158(6): 60-63

Deng, L.; Song, Y.; Young, K.H.; Hu, S.; Ding, N.; Song, W.; Li, X.; Shi, Y.; Huang, H.; Liu, W.; Zheng, W.; Wang, X.; Xie, Y.; Lin, N.; Tu, M.; Ping, L.; Ying, Z.; Zhang, C.; Sun, Y.; Zhu, J. 2015: Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin. Oncotarget 6(28): 25061-25073

Liang, H.-W.; Wang, N.; Wang, Y.; Wang, F.; Fu, Z.; Yan, X.; Zhu, H.; Diao, W.; Ding, Y.; Chen, X.; Zhang, C.-Y.; Zen, K. 2016: Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. Journal of Hepatology 64(2): 278-291

Yoo, J.-J.; Lee, J.-H.; Yoon, J.-H.; Lee, M.; Lee, D.H.; Cho, Y.; Jang, E.S.; Cho, E.J.; Yu, S.J.; Kim, Y.J.; Lee, H.-S. 2015: Hepatitis B virus-related glomerulonephritis: not a predominant cause of proteinuria in korean patients with chronic hepatitis B. Gastroenterology Research and Practice 2015: 126532

Shin, G-Choul.; Kang, H.Seok.; Lee, A.Ram.; Kim, K-Hwan. 2016: Hepatitis B virus-triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response. Autophagy 12(12): 2451-2466

Lin, C.-L.; Yang, H.-C.; Kao, J.-H. 2016: Hepatitis B virus: new therapeutic perspectives. Liver International: Official Journal of the International Association for the Study of the Liver 36(Suppl 1): 85-92

Samal, J.; Kandpal, M.; Vivekanandan, P. 2015: Hepatitis B "e" antigen-mediated inhibition of HBV replication fitness and transcription efficiency in vitro. Virology 484: 234-240

Mehdi, S.R.; Al Ajlan, A.R. 2006: Hepatitis B&C virus infection in cases of Non-Hodgkin's lymphoma in Saudi Arabia. Turkish Journal of Haematology: Official Journal of Turkish Society of Haematology 23(4): 200-204

Dionne-Odom, J.; Mbah, R.; Rembert, N.J.; Tancho, S.; Halle-Ekane, G.E.; Enah, C.; Welty, T.K.; Tih, P.M.; Tita, A.T.N. 2016: Hepatitis B, HIV, and Syphilis Seroprevalence in Pregnant Women and Blood Donors in Cameroon. Infectious Diseases in Obstetrics and Gynecology 2016: 4359401

Kerubo, G.; Khamadi, S.; Okoth, V.; Madise, N.; Ezeh, A.; Ziraba, A.; Abdalla, Z.; Mwau, M. 2015: Hepatitis B, Hepatitis C and HIV-1 Coinfection in two Informal Urban Settlements in Nairobi, Kenya. Plos one 10(6): E0129247

Tigen, E.Tukenmez.; Doğru, A.; Karadağ, F.Yılmaz. 2015: Hepatitis B, Hepatitis C and human immunodeficiency virus prevalences among first time blood donors in Istanbul, Turkey, 2004-2011. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis 53(2): 176-179

Yildiz, S.M.; Candevir, A.; Kibar, F.; Karaboga, G.; Turhan, F.T.; Kis, C.; Dincer, S.; Guvenc, B. 2015: Hepatitis B, Hepatitis C, Human immunodeficiency virus and syphilis frequency among blood donors: a single center study. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 53(3): 308-314

Halle, M.-P.; Choukem, S.-P.; Kaze, F.F.; Ashuntantang, G.; Tchamago, V.; Mboue-Djieka, Y.; Temfack, E.; Luma, H.N. 2016: Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon. Iranian Journal of Kidney Diseases 10(5): 304-309

Arora, S.; Malik, A.; Kumar, D.; Sodhi, N. 2016: Hepatitis B, interferon, and acne fulminans in a young girl. Indian Dermatology Online Journal 7(2): 93-95

Öcal, S.; Korkmaz, M.; Harmancı, Öz.ür.; Ensaroğlu, F.; Akdur, A.ın.; Selçuk, H.; Moray, G.ök.; Haberal, M. 2015: Hepatitis B- and hepatitis D-virus-related liver transplant: single-center data. Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation 13(Suppl 1): 133-138

Hajarizadeh, B.; Richmond, J.; Ngo, N.; Lucke, J.; Wallace, J. 2016: Hepatitis B-Related Concerns and Anxieties Among people with Chronic Hepatitis B in Australia. Hepatitis Monthly 16(6): E35566

Yu, L.; Wang, J.; Zhu, D.; Leng, A.; Wangen, K.R. 2016: Hepatitis B-related knowledge and vaccination in association with discrimination against Hepatitis B in rural China. Human Vaccines and Immunotherapeutics 12(1): 70-76

Gupta, A.; Punatar, S.; Gawande, J.; Bagal, B.; Mathew, L.; Bhat, V.; Kannan, S.; Khattry, N. 2016: Hepatitis B-related serological events in hematopoietic stem cell transplant patients and efficacy of lamivudine prophylaxis against reactivation. Hematological Oncology 34(3): 140-146

Lok, A.Suk-Fong. 2016: Hepatitis B: 50 years after the discovery of Australia antigen. Journal of viral hepatitis 23(1): 5-14

Frew, G.; McGeorge, E.; Grant, S.; de Wildt, G. 2017: Hepatitis B: A cross-sectional survey of knowledge, attitudes and practices amongst backpackers in Thailand. Travel Medicine and Infectious Disease 15: 57-62

Chang, B.W.; Kaung, A.; Robbins, L.; Tran, T.T. 2015: Hepatitis B: Working Towards a Cure. Current Gastroenterology Reports 17(9): 35

Krishnamoorthy, T.L.; Mutimer, D. 2015: Hepatitis B: encouraging the use of interferon. Current Opinion in Infectious Diseases 28(6): 557-562

Morikawa, K.; Shimazaki, T.; Takeda, R.; Izumi, T.; Umumura, M.; Sakamoto, N. 2016: Hepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protection. Annals of Translational Medicine 4(18): 337

Liu, S.-H.K.; Seto, W.-K.; Lai, C.-L.; Yuen, M.-F. 2016: Hepatitis B: treatment choice and monitoring for response and resistance. Expert Review of Gastroenterology and Hepatology 10(6): 697-707

Webster, D.P.; Klenerman, P.; Dusheiko, G.M. 2015: Hepatitis C. Lancet 385(9973): 1124-1135

Roberts, K.; Macleod, J.; Metcalfe, C.; Simon, J.; Horwood, J.; Hollingworth, W.; Marlowe, S.; Gordon, F.H.; Muir, P.; Coleman, B.; Vickerman, P.; Harrison, G.I.; Waldron, C.-A.; Irving, W.; Hickman, M. 2016: Hepatitis C - Assessment to Treatment Trial (HepCATT) in primary care: study protocol for a cluster randomised controlled trial. Trials 17: 366

Forton, D.M. 2016: Hepatitis C - the brain strain. Liver International: Official Journal of the International Association for the Study of the Liver 36(10): 1415-1417

Tasleem, S.; Sood, G.K. 2015: Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy. Journal of Clinical and Translational Hepatology 3(2): 134-139

Reynolds, A. 2016: Hepatitis C at Croi. Positively Aware: the Monthly Journal of the Test Positive Aware Network 28(3): 25-27

Freiman, J.M.; Tran, T.M.; Schumacher, S.G.; White, L.F.; Ongarello, S.; Cohn, J.; Easterbrook, P.J.; Linas, B.P.; Denkinger, C.M. 2016: Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: a Systematic Review and Meta-analysis. Annals of Internal Medicine 165(5): 345-355

Kuniholm, M.H.; Leach, T.; Lunievicz, J.; Olivo, N.í; Anastos, K.; Vazquez, Y.; Brennan-Ing, M.; Karpiak, S.E.; Alao, O.; Nash, D.; Ernst, J. 2015: Hepatitis C Direct Acting Antiviral Therapies in a new York City HIV/AIDS Special Needs Plan: Uptake and Barriers. Aids Patient Care and Stds 29(12): 643-645

Chhatwal, J.; Wang, X.; Ayer, T.; Kabiri, M.; Chung, R.T.; Hur, C.; Donohue, J.M.; Roberts, M.S.; Kanwal, F. 2016: Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals. Hepatology 64(5): 1442-1450

Pawlotsky, J.-M. 2016: Hepatitis C Drugs: Is Next Generation the Last Generation?. Gastroenterology 151(4): 587-590

Souii, A.; Elargoubi, A.; Fallecker, C.; Mastouri, M.; Drouet, E. 2016: Hepatitis C Genotype Prevalence in Monastir Region, Tunisia: Correlation between 5' Untranslated Region (5'UTR), Non-structural 5B (NS5B), and Core Sequences in HCV Subtyping. Current Microbiology 73(3): 324-334

Cummins, C.A.; Erlyana, E.; Fisher, D.G.; Reynolds, G.L. 2015: Hepatitis C Infection Among Hispanics in California. Journal of Addictive Diseases 34(4): 263-273

Alaei, A.; Alaei, K.; Waye, K.; Tracy, M.; Nalbandyan, M.; Mutlu, E.; Cetin, M.K. 2017: Hepatitis C infection and other drug-related harms among inpatients who injected drugs in Turkey. Journal of Viral Hepatitis 24(6): 496-505

Youssef, R.; Abu-Zeid, O.; Sayed, K.; Osman, S.; Omran, D.; El Shafei, A.; Ghaith, D. 2015: Hepatitis C Infection in Egyptian Psoriatic Patients: Prevalence and Correlation with Severity of Disease. Iranian Journal of Public Health 44(9): 1294-1295

Saab, S.; Rheem, J.; Sundaram, V. 2015: Hepatitis C Infection in the Elderly. Digestive Diseases and Sciences 60(11): 3170-3180

Yu, C.; Gifford, A.L.; Christiansen, C.L.; Drainoni, M-Lynn. 2016: Hepatitis C Is Poorly Associated With Drug Use in Cambodian Americans in Lowell, Massachusetts. Open Forum Infectious Diseases 3(2): Ofw099

Wenzler, E.; Dickson, W.; Vibhakar, S.; Adeyemi, O.M.; Danziger, L.H. 2015: Hepatitis C Management and the Infectious Diseases Pharmacist. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 61(7): 1201-1202

Chastain, C.A.; Beekmann, S.E.; Wallender, E.K.; Hulgan, T.; Stapleton, J.T.; Polgreen, P.M. 2015: Hepatitis C Management and the Infectious Diseases Physician: a Survey of Current and Anticipated Practice Patterns. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 61(5): 792-794

Gentry, J.; Blosser, S.; Backfish, K.; Cross, M.; Cruz, M.; Hartle, E.; Vecchio, E.; Chapman, E.; Conrad, C.; Duwve, J.; Galang, R.; Hillman, D.; Khudyakov, Y.; Peters, P.J.; Pontones, P.; Roseberry, J.; Sandoval, M.; Switzer, W.; Lovchik, J.; Liu, L. 2016: Hepatitis C Nucleic Acid Amplification Testing (NAAT) for Acute Case Detection: A Historical Protocol Repurposed to Combat a Current Outbreak. Open Forum Infectious Diseases 2(Suppl 1)

Zucker, D.M.; Shanmugam, A. 2016: Hepatitis C Point-of-Care Testing in Vulnerable Populations: a Human Factors Study. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 39(6): 472-477

Simoncini, G.M.; Jessop, A.B. 2017: Hepatitis C Post-Exposure Prophylaxis for Healthcare Personnel: Policy Analysis Among Philadelphia's Large Teaching Institutions. Infection Control and Hospital Epidemiology 38(2): 246-248

Kakati, B.; Seetharam, A. 2014: Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and Management. Journal of Clinical and Translational Hepatology 2(3): 189-196

Trager, E.; Khalili, M.; Masson, C.L.; Vittinghoff, E.; Creasman, J.; Mangurian, C. 2016: Hepatitis C Screening Rate Among Underserved Adults with Serious Mental Illness Receiving Care in California Community Mental Health Centers. American Journal of Public Health 106(4): 740-742

Wurcel, A.G.; Chen, D.D.; Fitzpatrick, R.E.; Grasberger, P.E.; Kirshner, C.H.; Anderson, J.E.; Chui, K.K.H.; Knox, T.A. 2016: Hepatitis C Screening in people with Human Immunodeficiency Virus: Lessons Learned from Syphilis Screening. Open Forum Infectious Diseases 3(1): Ofv215

Akiyama, M.J.; Kaba, F.; Rosner, Z.; Alper, H.; Holzman, R.S.; MacDonald, R. 2016: Hepatitis C Screening of the "Birth Cohort" (Born 1945-1965) and Younger Inmates of New York City Jails. American journal of public health 106(7): 1276-1277

Ghazaryan, L.; Smith, L.; Parker, M.; Flanigan, C.; Pulver, W.; Sullivan, T.; Carrascal, A. 2016: Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in new York State in 2006. Maternal and Child Health Journal 20(3): 550-555

Moezzi, M.; Imani, R.; Karimi, A.; Pourheidar, B. 2015: Hepatitis C Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province of Iran in 2013. Journal of Clinical and Diagnostic Research: Jcdr 9(10): Lc13-Lc17

Isnard Bagnis, C.; Cacoub, P. 2016: Hepatitis C Therapy in Renal Patients: Who, How, When?. Infectious Diseases and Therapy 5(3): 313-327

Aghemo, A.; Buti, M. 2016: Hepatitis C Therapy: Game Over!. Gastroenterology 151(5): 795-798

Poordad, F. 2015: Hepatitis C Therapy: Simple for the Patient, not so Simple for the Clinician. Clinics in Liver Disease 19(4): Ix

Jayasekera, C.R.; Arora, S.; Ahmed, A. 2016: Hepatitis C Treatment Delivery Mandates Optimizing Available Health Care Human Resources: a Case for Task Shifting. JAMA 315(18): 1947-1948

Hynicka, L.M.; Heil, E.L. 2016: Hepatitis C Treatment Exposed or Experienced?. Annals of PharmacoTherapy 50(4): 328

Midgard, H.åv.; Bramness, J.ør.G.; Skurtveit, S.; Haukeland, J.W.; Dalgard, O. 2016: Hepatitis C Treatment Uptake among Patients who have Received Opioid Substitution Treatment: a Population-Based Study. Plos one 11(11): E0166451

Gentil, M.A.; González-Corvillo, C.; Perelló, M.; Zarraga, S.; Jiménez-Martín, C.; Lauzurica, L.R.; Alonso, A.; Franco, A.; Hernández-Marrero, D.; Sánchez-Fructuoso, A. 2016: Hepatitis C Treatment with Direct-Acting Antivirals in Kidney Transplant: Preliminary Results from a Multicenter Study. Transplantation Proceedings 48(9): 2944-2946

Lagasca, A.M.; Kan, V.L. 2015: Hepatitis C Treatment at a Veterans Affairs Medical Center After the Availability of Direct-Acting Agents: Things Are Looking up. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 61(8): 1347-1349

Vargas, H.E. 2016: Hepatitis C Treatment in 2016: Reasons to be an OPTIMIST. Hepatology 64(2): 330-332

Chasser, Y.; Kim, A.Y.; Freudenreich, O. 2017: Hepatitis C Treatment: Clinical Issues for Psychiatrists in the Post-Interferon Era. Psychosomatics 58(1): 1-10

El-Guindi, M.A. 2016: Hepatitis C Viral Infection in Children: Updated Review. Pediatric Gastroenterology Hepatology and Nutrition 19(2): 83-95

Esmat, G.Eldeen.; Al Akel, W.; Abdel Aziz, R.Ahmed.; Al Sayed Taha, A.; Sabry, D.; Rashed, L.A.; Mostafa, A.; El Kazaz, A.Y.; Ahmed, S.H. 2016: Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 36(3): 149-158

Falk, G.W. 2015: Hepatitis C Virus. Gastroenterology Clinics of North America 44(4): Xiii

Kim, A. 2016: Hepatitis C Virus. Annals of Internal Medicine 165(5): Itc33-Itc48

Onyekwere, C.Asabamaka.; O Ogbera, A.; Olusola Dada, A.; O Adeleye, O.; O Dosunmu, A.; Akinbami, A.A.; Osikomaiya, B.; Hameed, O. 2016: Hepatitis C Virus (HCV) Prevalence in Special Populations and Associated Risk Factors: A Report From a Tertiary Hospital. Hepatitis monthly 16(5): e35532

Jhaveri, R.; Hashem, M.; El-Kamary, S.S.; Saleh, D.'a.A.; Sharaf, S.A.; El-Mougy, F.; Abdelsalam, L.; Ehab, M.; El-Ghazaly, H. 2015: Hepatitis C Virus (HCV) Vertical Transmission in 12-Month-Old Infants Born to HCV-Infected Women and Assessment of Maternal Risk Factors. Open Forum Infectious Diseases 2(2): Ofv089

Stindt, S.; Cebula, P.; Albrecht, U.; Keitel, V.; Schulte am Esch, J.; Knoefel, W.T.; Bartenschlager, R.; Häussinger, D.; Bode, J.G. 2016: Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family. Plos one 11(2): E0148711

White, D.A.E.; Anderson, E.S.; Pfeil, S.K.; Trivedi, T.K. 2016: Hepatitis C Virus Antibody Testing: Result Availability at Time of Discharge for Emergency Department Patients. Journal of Acquired Immune Deficiency Syndromes 71(3): E82-E84

El-Maadawy, E.A.; Talaat, R.M.; Sadek, R.F.; El-Sherbini, S.M.; Abdel-Bary, N.; Abdel-Aziz, A.A. 2016: Hepatitis C Virus Associations with Non Hodgkin's Lymphoma: Insights on Inflammation/Angiogenesis and CD Markers. Asian Pacific journal of cancer prevention: APJCP 17(9): 4415-4420

Clerc, O.; Darling, K.; Calmy, A.; Dubois-Arber, F.ço.; Cavassini, M. 2016: Hepatitis C Virus Awareness Among Men who have Sex with Men in Southwest Switzerland. Sexually Transmitted Diseases 43(1): 44-48

Nguyen, L.T.; Dunford, L.; Freitas, I.; Holder, P.; Nguyen, L.A.; O'Gorman, J.; Connell, J.; Carr, M.; Hall, W.; De Gascun, C. 2015: Hepatitis C Virus Core Mutations Associated with False-Negative Serological Results for Genotype 3a Core Antigen. Journal of Clinical Microbiology 53(8): 2697-2700

Kim, G-Woo.; Lee, S-Hoon.; Cho, H.; Kim, M.; Shin, E-Cheol.; Oh, J-Won. 2016: Hepatitis C Virus Core Protein Promotes miR-122 Destabilization by Inhibiting GLD-2. Plos Pathogens 12(7): E1005714

Cheroni, C.; Donnici, L.; Aghemo, A.; Balistreri, F.; Bianco, A.; Zanoni, V.; Pagani, M.; Soffredini, R.; D'Ambrosio, R.; Rumi, M.Grazia.; Colombo, M.; Abrignani, S.; Neddermann, P.; De Francesco, R. 2015: Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity. Plos one 10(9): E0138546

Hill, L. 2015: Hepatitis C Virus Direct-Acting Antiviral Drug Interactions and use in Renal and Hepatic Impairment. Topics in Antiviral Medicine 23(2): 92-96

Combellick, J.; Smith, D.J.; Jordan, A.E.; Hagan, H. 2015: Hepatitis C Virus Disease Progression in people who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis. Jmir Research Protocols 4(2): E68

Read, S.A.; Tay, E.S.; Shahidi, M.; O'Connor, K.S.; Booth, D.R.; George, J.; Douglas, M.W. 2015: Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response. Plos one 10(8): E0136227

Beaumont, E.; Roch, E.; Chopin, L.; Roingeard, P. 2016: Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties. Plos one 11(3): E0151626

Hammerstad, S.S.; Stefan, M.; Blackard, J.; Owen, R.P.; Lee, H.J.; Concepcion, E.; Yi, Z.; Zhang, W.; Tomer, Y. 2017: Hepatitis C Virus E2 Protein Induces Upregulation of IL-8 Pathways and Production of Heat Shock Proteins in Human Thyroid Cells. Journal of Clinical Endocrinology and Metabolism 102(2): 689-697

Falson, P.; Bartosch, B.; Alsaleh, K.; Tews, B.A.; Loquet, A.; Ciczora, Y.; Riva, L.; Montigny, C.éd.; Montpellier, C.; Duverlie, G.; Pécheur, E.-I.; le Maire, M.; Cosset, F.ço.-L.ïc.; Dubuisson, J.; Penin, F.ço. 2015: Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion. Journal of Virology 89(20): 10333-10346

Chaabna, K.; Kouyoumjian, S.P.; Abu-Raddad, L.J. 2016: Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis. Plos one 11(2): E0149966

Biegel, J.M.; Pager, C.T. 2016: Hepatitis C Virus Exploitation of Processing Bodies. Journal of Virology 90(10): 4860-4863

Park, S.Bum.; Seronello, S.; Mayer, W.; Ojcius, D.M. 2016: Hepatitis C Virus Frameshift/Alternate Reading Frame Protein Suppresses Interferon Responses Mediated by Pattern Recognition Receptor Retinoic-Acid-Inducible Gene-I. Plos one 11(7): E0158419

Serre, Séphanie.B.N.; Jensen, S.B.; Ghanem, L.; Humes, D.G.; Ramirez, S.; Li, Y-Ping.; Krarup, H.; Bukh, J.; Gottwein, J.M. 2016: Hepatitis C Virus Genotype 1 to 6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness, and Resistance Patterns in the Context of the Infectious Viral Life Cycle. Antimicrobial Agents and ChemoTherapy 60(6): 3563-3578

Yang, R.; Yang, X.; Xiu, B.; Rao, H.; Fei, R.; Guan, W.; Liu, Y.; Wang, Q.; Feng, X.; Zhang, H.; Wei, L. 2017: Hepatitis C Virus Genotype Analyses in Chronic Hepatitis C Patients and Individuals with Spontaneous Virus Clearance Using a Newly Developed Serotyping Assay. Journal of Clinical Laboratory Analysis 31(1)

Xie, Y.; Garza, G.; Dong, J. 2016: Hepatitis C Virus Genotype and Subtype Distribution in Patient Specimens Tested at the University of Texas Medical Branch, Galveston, Between January 2011 and November 2014. Laboratory medicine 47(2): 112-118

Chen, W.; Li, X.-M.; Li, A.-L.; Yang, G.; Hu, H.-N. 2016: Hepatitis C Virus Increases Free Fatty Acids Absorption and Promotes its Replication Via Down-Regulating GADD45α Expression. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 22: 2347-2356

Branche, E.; Conzelmann, S.ép.; Parisot, C.; Bedert, L.; Lévy, P.L.; Bartosch, B.; Clément, S.; Negro, F. 2016: Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein. Plos one 11(1): E0146000

Wang, C.-C.; Chang, C.-T.; Lin, C.-L.; Lin, I.-C.; Kao, C.-H. 2015: Hepatitis C Virus Infection Associated with an Increased Risk of Deep Vein Thrombosis: a Population-Based Cohort Study. Medicine 94(38): E1585

Fabrizi, F.; Verdesca, S.; Messa, P.; Martin, P. 2015: Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: a Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 60(12): 3801-3813

Dash, S.; Chava, S.; Aydin, Y.; Chandra, P.K.; Ferraris, P.; Chen, W.; Balart, L.A.; Wu, T.; Garry, R.F. 2016: Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response. Viruses 8(5)

Petta, S.; Maida, M.; Macaluso, F.S.; Barbara, M.; Licata, A.; Craxì, A.; Cammà, C. 2016: Hepatitis C Virus Infection Is Associated with Increased Cardiovascular Mortality: a Meta-Analysis of Observational Studies. Gastroenterology 150(1): 145-155.E4; Quiz E15-16

Wu, P.-H.; Lin, Y.-T.; Hsieh, K.-P.; Chuang, H.-Y.; Sheu, C.-C. 2015: Hepatitis C Virus Infection Is Associated with an Increased Risk of Active Tuberculosis Disease: a Nationwide Population-Based Study. Medicine 94(33): E1328

Zhang, F.-M.; Chen, L.-H.; Chen, H.-T.; Shan, G.-D.; Hu, F.-L.; Yang, M.; Chen, W.-G.; Xu, G.-Q. 2016: Hepatitis C Virus Infection Is Positively Associated with Gallstones in Liver Cirrhosis. Digestion 93(3): 221-228

Cook, N.; Turse, E.P.; Garcia, A.S.; Hardigan, P.; Amofah, S.A. 2016: Hepatitis C Virus Infection Screening Within Community Health Centers. Journal of the American Osteopathic Association 116(1): 6-11

Giuffrida, M.A.; Brown, D.Cimino.; Ellenberg, S.S.; Farrar, J.T. 2018: Development and psychometric testing of the Canine Owner-Reported Quality of Life questionnaire, an instrument designed to measure quality of life in dogs with cancer. Journal of the American Veterinary Medical Association 252(9): 1073-1083

Cacoub, P.; Commarmond, C.é; Sadoun, D.; Desbois, A.C. 2017: Hepatitis C Virus Infection and Rheumatic Diseases: the Impact of Direct-Acting Antiviral Agents. Rheumatic Diseases Clinics of North America 43(1): 123-132

Ladino, M.; Pedraza, F.; Roth, D. 2016: Hepatitis C Virus Infection in Chronic Kidney Disease. Journal of the American Society of Nephrology: Jasn 27(8): 2238-2246

Chopra, G.S.; Gupta, R.M.; Gedela, S.R.; Varma, P.P.; Rai, R.; Nema, S.K. 2005: Hepatitis C Virus Infection in Haemodialysis Patients: "Wolf in Sheep's Clothing". Medical Journal Armed Forces India 61(3): 241-244

Afzal, M.S.; Ahmad, T.; Ahmed, H. 2015: Hepatitis C Virus Infection in Iran; Viral Spread Routes in General Population and Safety Measures. Hepatitis Monthly 15(10): E17343

Kyvernitakis, A.; Mahale, P.; Popat, U.R.; Jiang, Y.; Hosry, J.; Champlin, R.E.; Torres, H.A. 2016: Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 22(4): 717-722

Arora, A.; Bansal, N.; Sharma, P.; Singla, V.; Gupta, V.; Tyagi, P.; Malik, M.; Kumar, A. 2016: Hepatitis C Virus Infection in Patients with End-Stage Renal Disease: a Study from a Tertiary Care Centre in India. Journal of Clinical and Experimental Hepatology 6(1): 21-25

Coyle, J.R.; Goerge, E.; Kacynski, K.; Rodgers, R.; Raines, P.; Vail, L.S.; Lowhim, S. 2016: Hepatitis C Virus Infections Associated with Unsafe Injection Practices at a Pain Management Clinic, Michigan, 2014-2015. Pain Medicine (): -

Bayer, K.; Banning, C.; Bruss, V.; Wiltzer-Bach, L.; Schindler, M. 2016: Hepatitis C Virus Is Released via a Noncanonical Secretory Route. Journal of Virology 90(23): 10558-10573

Rajalakshmy, A.R.; Malathi, J.; Madhavan, H.N. 2015: Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll like Receptor Ligand Treatment Furnished Immune Tolerance. Plos one 10(5): E0125419

Yi, G.; Wen, Y.; Shu, C.; Han, Q.; Konan, K.V.; Li, P.; Kao, C.C. 2016: Hepatitis C Virus NS4B can Suppress STING Accumulation to Evade Innate Immune Responses. Journal of Virology 90(1): 254-265

Smirnova, O.A.; Ivanova, O.N.; Bartosch, B.; Valuev-Elliston, V.T.; Mukhtarov, F.; Kochetkov, S.N.; Ivanov, A.V. 2016: Hepatitis C Virus NS5A Protein Triggers Oxidative Stress by Inducing NADPH Oxidases 1 and 4 and Cytochrome P450 2E1. Oxidative Medicine and Cellular Longevity 2016: 8341937

Bansal, R.; Frelin, L.; Brenndörfer, E.Daniel.; Storm, G.; Prakash, J.; Sällberg, M. 2015: Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo. Plos one 10(6): E0128466

Huynh, V.T.T.; Lim, Y.-S.; Tran, S.C.; Pham, T.M.; Nguyen, L.N.; Hwang, S.B. 2016: Hepatitis C Virus Nonstructural 5A Protein Interacts with Abelson Interactor 1 and Modulates Epidermal Growth Factor-mediated MEK/ERK Signaling Pathway. Journal of Biological Chemistry 291(43): 22607-22617

Jiang, X.; Kanda, T.; Wu, S.; Nakamoto, S.; Nakamura, M.; Sasaki, R.; Haga, Y.; Wakita, T.; Shirasawa, H.; Yokosuka, O. 2015: Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation. Plos one 10(7): E0131973

Weber, D.J.; Rutala, W.A.; Fried, M.W. 2016: Hepatitis C Virus Outbreaks in Hemodialysis Centers: a Continuing Problem. Infection Control and Hospital Epidemiology 37(2): 140-142

Yamauchi, S.; Takeuchi, K.; Chihara, K.; Sun, X.; Honjoh, C.; Yoshiki, H.; Hotta, H.; Sada, K. 2015: Hepatitis C Virus Particle Assembly Involves Phosphorylation of NS5A by the c-Abl Tyrosine Kinase. Journal of Biological Chemistry 290(36): 21857-21864

Naggie, S.; Holland, D.P.; Sulkowski, M.S.; Thomas, D.L. 2017: Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a thing. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 64(1): 92-99

Han, Y.; Niu, J.; Wang, D.; Li, Y. 2016: Hepatitis C Virus Protein Interaction Network Analysis Based on Hepatocellular Carcinoma. Plos one 11(4): E0153882

Barouch-Bentov, R.; Neveu, G.; Xiao, F.; Beer, M.; Bekerman, E.; Schor, S.; Campbell, J.; Boonyaratanakornkit, J.; Lindenbach, B.; Lu, A.; Jacob, Y.; Einav, S. 2016: Hepatitis C Virus Proteins Interact with the Endosomal Sorting Complex Required for Transport (ESCRT) Machinery via Ubiquitination To Facilitate Viral Envelopment. mBio 7(6)

Harrington, P.R.; Deming, D.J.; Komatsu, T.E.; Naeger, L.K. 2015: Hepatitis C Virus RNA Levels During Interferon-Free Combination Direct-Acting Antiviral Treatment in Registrational Trials. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 61(4): 666-667

Gambato, M.; Pérez-Del-Pulgar, S.ía.; Hedskog, C.; Svarovskia, E.S.; Brainard, D.; Denning, J.; Curry, M.P.; Charlton, M.; Caro-Pérez, N.; Londoño, M.C.; Koutsoudakis, G.; Forns, X. 2016: Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated with an Interferon-Free Regimen. Gastroenterology 151(4): 633-636.E3

Chen, L.; Li, W.; Zhang, K.; Zhang, R.; Lu, T.; Hao, M.; Jia, T.; Sun, Y.; Lin, G.; Wang, L.; Li, J. 2016: Hepatitis C Virus RNA Real-Time Quantitative RT-PCR Method Based on a new Primer Design Strategy. Journal of Molecular Diagnostics: Jmd 18(1): 84-91

Valero, M.ía.L.; Sabariegos, R.; Cimas, F.J.; Perales, C.; Domingo, E.; Sánchez-Prieto, R.; Mas, A. 2016: Hepatitis C Virus RNA-Dependent RNA Polymerase Interacts with the Akt/PKB Kinase and Induces its Subcellular Relocalization. Antimicrobial Agents and ChemoTherapy 60(6): 3540-3550

Sacks-Davis, R.; Grebely, J.; Dore, G.J.; Osburn, W.; Cox, A.L.; Rice, T.M.; Spelman, T.; Bruneau, J.; Prins, M.; Kim, A.Y.; McGovern, B.H.; Shoukry, N.H.; Schinkel, J.; Allen, T.M.; Morris, M.; Hajarizadeh, B.; Maher, L.; Lloyd, A.R.; Page, K.; Hellard, M.; Page, K.; Bruneau, J.; Cox, A.L.; Dore, G.J.; Grebely, J.; Hellard, M.; Lauer, G.; Kim, A.Y.; Lloyd, A.R.; Maher, L.; McGovern, B.H.; Prins, M.; Shoukry, N.H.; Morris, M.; Hahn, J.; Rice, T.M.; Alavi, M.; Bouchard, R.; Evans, J.; Grady, B.; Aneja, J.; Sacks-Davis, R.; Teutsch, S.; White, B.; Wells, B.; Zang, G.; Applegate, T.; Matthews, G.; Yeung, B.; Grady, B.; van de Laar, T.; Aneja, J.; Erin Prince, L.; Roy, E.; Zang, G.; Bates, A.; Enriquez, J.; Chow, S.; Park, J.; McCredie, L.; Teu 2015: Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study. Journal of Infectious Diseases 212(9): 1407-1419

Izquierdo, L.; Oliveira, C.; Fournier, C.; Descamps, V.ér.; Morel, V.; Dubuisson, J.; Brochot, E.; Francois, C.; Castelain, S.; Duverlie, G.; Helle, F. 2016: Hepatitis C Virus Resistance to Carbohydrate-Binding Agents. Plos one 11(2): E0149064

Pawlotsky, J.-M. 2016: Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens. Gastroenterology 151(1): 70-86

White, D.A.E.; Anderson, E.S.; Pfeil, S.K.; Deering, L.J.; Todorovic, T.; Trivedi, T.K. 2016: Hepatitis C Virus Screening and Emergency Department Length of Stay. Plos one 11(10): E0164831

Prasad, M.R. 2016: Hepatitis C Virus Screening in Pregnancy: Is it time to Change our Practice?. Obstetrics and Gynecology 128(2): 229-230

Galbraith, J.W. 2016: Hepatitis C Virus Screening: An Important Public Health Opportunity for United States Emergency Departments. Annals of Emergency Medicine 67(1): 129-130

Villareal, V.A.; Fu, D.; Costello, D.A.; Xie, X.S.; Yang, P.L. 2016: Hepatitis C Virus Selectively Alters the Intracellular Localization of Desmosterol. Acs Chemical Biology 11(7): 1827-1833

Giugliano, S.; Petroff, M.G.; Warren, B.D.; Jasti, S.; Linscheid, C.; Ward, A.; Kramer, A.; Dobrinskikh, E.; Sheiko, M.A.; Gale, M.; Golden-Mason, L.; Winn, V.D.; Rosen, H.R. 2015: Hepatitis C Virus Sensing by Human Trophoblasts Induces Innate Immune Responses and Recruitment of Maternal NK Cells: Potential Implications for Limiting Vertical Transmission. Journal of Immunology 195(8): 3737-3747

Dondog, B.; Schnitzler, P.; Michael, K.M.; Clifford, G.; Franceschi, S.; Pawlita, M.; Waterboer, T. 2015: Hepatitis C Virus Seroprevalence in Mongolian Women Assessed by a Novel Multiplex Antibody Detection Assay. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 24(9): 1360-1365

Pfaender, S.; Grabski, E.; Detje, C.N.; Riebesehl, N.; Lienenklaus, S.; Steinmann, E.; Kalinke, U.; Pietschmann, T. 2016: Hepatitis C Virus Stimulates Murine CD8α-Like Dendritic Cells to Produce Type i Interferon in a TRIF-Dependent Manner. Plos Pathogens 12(7): E1005736

Nawaz-Tipu, H. 2015: Hepatitis C Virus Subtype 3a Envelope Protein 1 Binding with Human Leukocyte Antigen Class i Types of Pakistani Population: Candidate Epitopes for Synthetic Peptide Vaccine. Iranian Journal of Allergy Asthma and Immunology 14(5): 526-534

Jiao, Y.; Zhang, X.; Wang, C.; Li, L.; Liu, J.; Bar, K.J.; Wei, H.; Hu, Y.; Huang, P.; Zeng, Z.; Jiang, S.; Du, J.; Shao, Y.; Metzger, D.; Li, S.; Ma, L. 2016: Hepatitis C Virus Subtype and Evolution Characteristic Among Drug Users, Men who have Sex with Men, and the General Population in Beijing, China. Medicine 95(6): E2688

Schoenbachler, B.T.; Smith, B.D.; Seña, A.C.; Hilton, A.; Bachman, S.; Lunda, M.; Spaulding, A.C. 2016: Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012-2014. Public Health Reports 131 Suppl. 2: 98-104

Carey, K.J.; Huang, W.; Linas, B.P.; Tsui, J.I. 2016: Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders. Journal of Substance Abuse Treatment 66: 54-59

Chu, C.E.; Wu, F.; He, X.; Zhou, K.; Cheng, Y.; Cai, W.; Geng, E.; Volberding, P.; Tucker, J.D. 2016: Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected people who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion. Open Forum Infectious Diseases 3(2): Ofw065

Stanciu, C.; Trifan, A. 2015: Hepatitis C Virus Treatment Revolution: Eastern European Story. Hepatitis Monthly 15(7): E28969

McCance-Katz, E.F.; Valdiserri, R.O. 2015: Hepatitis C Virus Treatment and Injection Drug Users: it Is time to Separate Fact from Fiction. Annals of Internal Medicine 163(3): 224-225

McCance-Katz, E.F.; Valdiserri, R.O. 2016: Hepatitis C Virus Treatment and Persons who Inject Drugs. Annals of Internal Medicine 164(3): 203-204

Muir, A.J.; Naggie, S. 2015: Hepatitis C Virus Treatment: Is it Possible to Cure all Hepatitis C Virus Patients?. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 13(12): 2166-2172

Kim, S.; Han, K.-H.; Ahn, S.H. 2016: Hepatitis C Virus and Antiviral Drug Resistance. Gut and Liver 10(6): 890-895

Herold, S.; Freudenreich, O. 2016: Hepatitis C Virus and Schizophrenia: Expanding the Role of the Community Psychiatrist. Psychosomatics 57(6): 634-637

Granot, E.; Sokal, E.M. 2015: Hepatitis C Virus in Children: Deferring Treatment in Expectation of Direct-Acting Antiviral Agents. Israel Medical Association Journal: Imaj 17(11): 707-711

Suarez Benjumea, A.; Gonzalez-Corvillo, C.; Sousa, J.M.; Bernal Blanco, G.; Suñer Poblet, M.; Perez Valdivia, M.A.; Gonzalez Roncero, F.M.; Acevedo, P.; Gentil Govantez, M.A. 2016: Hepatitis C Virus in Kidney Transplant Recipients: a Problem on the Path to Eradication. Transplantation Proceedings 48(9): 2938-2940

Daw, M.A.; El-Bouzedi, A.; Ahmed, M.O.; Dau, A.A.; Agnan, M.M. 2016: Hepatitis C Virus in North Africa: An Emerging Threat. Thescientificworldjournal 2016: 7370524

Gheith, O.; Halim, M.A.; Othman, N.; Al-Otaibi, T.; Nair, P.; Nampoory, N. 2017: Hepatitis C Virus in the Renal Transplant Population: An Update With Focus on the New Era of Antiviral Regimens. Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation 15(1): 10-20

Laufer, C.B.; Carroll, M.B. 2015: Hepatitis C Virus in the US Military Retiree Population: to Screen, or not to Screen?. Journal of Clinical Medicine Research 7(10): 757-761

Artenie, A.Adelina.; Roy, Élise.; Zang, G.; Jutras-Aswad, D.; Bamvita, J-Marie.; Puzhko, S.; Daniel, M.; Bruneau, J. 2015: Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention. International Journal on Drug Policy 26(10): 970-975

Waruingi, W.; Mhanna, M.J.; Kumar, D.; Abughali, N. 2015: Hepatitis C Virus universal screening versus risk based selective screening during pregnancy. Journal of Neonatal-Perinatal Medicine 8(4): 371-378

Kralj, D.; Virović Jukić, L.; Stojsavljević, S.; Duvnjak, M.; Smolić, M.; Čurčić, I.B.ć 2016: Hepatitis C Virus, Insulin Resistance, and Steatosis. Journal of Clinical and Translational Hepatology 4(1): 66-75

Bartenschlager, R.F.W.; Rice, C.M.; Sofia, M.J. 2016: Hepatitis C Virus-From Discovery to Cure: The 2016 Lasker-DeBakey Clinical Medical Research Award. JAMA 316(12): 1254-1255

Lee, E.M.; Alsagheir, A.; Wu, X.; Hammack, C.; McLauchlan, J.; Watanabe, N.; Wakita, T.; Kneteman, N.M.; Douglas, D.N.; Tang, H. 2016: Hepatitis C Virus-Induced Degradation of Cell Death-Inducing DFFA-Like Effector B Leads to Hepatic Lipid Dysregulation. Journal of Virology 90(8): 4174-4185

Goh, C.C.; Roggerson, K.M.; Lee, H-Chon.; Golden-Mason, L.; Rosen, H.R.; Hahn, Y.S. 2016: Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1. Journal of Immunology 196(5): 2283-2292

Pham, T.M.; Tran, S.C.; Lim, Y.-S.; Hwang, S.B. 2017: Hepatitis C Virus-Induced Rab32 Aggregation and its Implications for Virion Assembly. Journal of Virology 91(3)

Bandiera, S.; Pernot, S.; El Saghire, H.; Durand, S.C.; Thumann, C.; Crouchet, E.; Ye, T.; Fofana, I.; Oudot, M.A.; Barths, J.; Schuster, C.; Pessaux, P.; Heim, M.H.; Baumert, T.F.; Zeisel, M.B. 2016: Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis. Journal of Virology 90(14): 6387-6400

Gokhale, N.S.; Vazquez, C.; Horner, S.M. 2014: Hepatitis C Virus. Strategies to Evade Antiviral Responses. Future Virology 9(12): 1061-1075

Dultz, G.; Zeuzem, S. 2015: Hepatitis C Virus: a European Perspective. Gastroenterology Clinics of North America 44(4): 807-824

Asselah, T.; Bourlière, M. 2015: Hepatitis C Virus: Current and Evolving Treatments for Genotype 4. Gastroenterology Clinics of North America 44(4): 859-870

Liang, T.J. 2016: Hepatitis C Virus: from Obscurity to the Lasker. Gastroenterology 151(6): 1052-1053

Westermann, C.; Dulon, M.; Wendeler, D.; Nienhaus, A. 2016: Hepatitis C among healthcare personnel: secondary data analyses of costs and trends for hepatitis C infections with occupational causes. Journal of Occupational Medicine and Toxicology 11: 52

Kargar Kheirabad, A.; Bahri, F.; Kargar, M.; Ghasemzadeh, I. 2016: Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran. Hepatitis Monthly 16(10): E40375

Sims, O.T.; Womack, B.G. 2015: Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings. Social Work in Public Health 30(4): 325-335

Graham, C.S. 2015: Hepatitis C and HIV co-infection: closing the gaps. JAMA 313(12): 1217-1218

Berbesi-Fernández, D.; Segura-Cardona, Án.; Montoya-Vélez, L.; Castaño-Perez, G.A. 2015: Hepatitis C and HIV in injecting drug users in Armenia, Colombia. Adicciones 27(4): 246-252

Todd, C.S.; Nasir, A.; Stanekzai, M.Raza.; Fiekert, K.; Sipsma, H.L.; Vlahov, D.; Strathdee, S.A. 2015: Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan. Harm Reduction Journal 12: 22

Klinge, M.J.; Borhani, A.A.; Malik, S.M. 2016: Hepatitis C and Numerous Disappearing Hepatic Nodules: No-dule C It, No-dule Don't. Gastroenterology 151(1): 37-39

De Carli, J.ão.P.; Linden, M.S.S.; da Silva, S.O.; Trentin, M.S.; Matos, F.d.S.; Paranhos, L.R. 2016: Hepatitis C and Oral Lichen Planus: Evaluation of their Correlation and Risk Factors in a Longitudinal Clinical Study. Journal of Contemporary Dental Practice 17(1): 27-31

Mack, H.; Paylor, I. 2016: Hepatitis C and Social Work. British Journal of Social Work 46(4): 1115-1130

Galati, G.; Rampa, L.; Vespasiani-Gentilucci, U.; Marino, M.; Pisani, F.; Cota, C.; Guidi, A.; Picardi, A. 2016: Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy. World Journal of Hepatology 8(29): 1244-1250

Scotto, G.; Armignacco, O.; Starnini, G.; Francavilla, R.; Foti, G.; Portelli, V.; Mazzeo, M.; Minerva, N.; Carretta, V.; Lo Muzio, L.; Fazio, V. 2016: Hepatitis C and immigration: a multicentre study. Le Infezioni in Medicina 24(3): 210-216

Knobler, H.; Malnick, S. 2016: Hepatitis C and insulin action: An intimate relationship. World Journal of Hepatology 8(2): 131-138

Azmi, A.N.; Tan, S.-S.; Mohamed, R. 2015: Hepatitis C and kidney disease: An overview and approach to management. World Journal of Hepatology 7(1): 78-92

Ferraz, R.V.; Pereira, N.R.; Carvalho, C.áu.; Sarmento, A.ón. 2015: Hepatitis C and leptospirosis: simultaneous acute infections or recurrence of occult hepatitis C. BMJ Case Reports

Kim, W.S.; Lee, S.S.; Lee, C.M.; Kim, H.J.; Ha, C.Y.; Kim, H.J.; Kim, T.H.; Jung, W.T.; Lee, O.J.; Hong, J.W.; You, H.S.; Cho, H.C. 2016: Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury. Bmc Infectious Diseases 16: 50

Olubamwo, O.O.; Aregbesola, A.O.; Miettola, J.; Kauhanen, J.; Tuomainen, T.-P. 2016: Hepatitis C and risk of coronary atherosclerosis - a systematic review. Public Health 138: 12-25

Page, E.E.; Nelson, M. 2016: Hepatitis C and sex. Clinical Medicine 16(2): 189-192

Shafran, S.D. 2015: Hepatitis C and the sex trade. Canadian Journal of Gastroenterology and Hepatology 29(8): 405-406

Olubamwo, O.O.; Onyeka, I.N.; Miettola, J.; Kauhanen, J.; Tuomainen, T.-P. 2016: Hepatitis C as a risk factor for carotid atherosclerosis - a systematic review. Clinical Physiology and Functional Imaging 36(4): 249-260

Muga, R.; Zuluaga, P.; Sanvisens, A.; Rivas, I.; Fuster, D.; Bolao, F.; Tor, J. 2015: Hepatitis C associated to substance abuse: ever closer to a treatment without Interferon. Adicciones 27(2): 141-149

Khullar, V.; Firpi, R.J. 2015: Hepatitis C cirrhosis: new perspectives for diagnosis and treatment. World Journal of Hepatology 7(14): 1843-1855

Soriano, V.; Labarga, P.; Fernandez-Montero, J.é V.; de Mendoza, C.; Esposito, I.; Benítez-Gutiérrez, L.; Barreiro, P. 2016: Hepatitis C cure with antiviral therapy--benefits beyond the liver. Antiviral Therapy 21(1): 1-8

Saxena, V.; Terrault, N.A. 2015: Hepatitis C direct antiviral drugs and hepatic decompensation in patients with advanced cirrhosis: culprit or innocent bystander?. Digestive Diseases and Sciences 60(4): 806-809

Bennett, H.; Gordon, J.; Jones, B.; Ward, T.; Webster, S.; Kalsekar, A.; Yuan, Y.; Brenner, M.; McEwan, P. 2017: Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapies. European Journal of Health Economics: Hepac: Health Economics in Prevention and Care 18(8): 1001-1011

Kamal-Yanni, M. 2015: Hepatitis C drug affordability. Lancet. Global Health 3(2): E73-E74

McCarthy, M. 2015: Hepatitis C drug maker puts profit ahead of patients, US Senate report charges. Bmj 351: H6573

Muñoz-Gámez, J.é A.; Salmerón, J.; Ruiz-Extremera, Án. 2016: Hepatitis C during pregnancy, vertical transmission and new treatment possibilities. Medicina Clinica 147(11): 499-505

Hellard, M.; Sacks-Davis, R.; Doyle, J. 2016: Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks. Journal of Epidemiology and Community Health 70(12): 1151-1154

Bateman-Steel, C.R.; Smedley, E.J.; Kong, M.; Ferson, M.J. 2015: Hepatitis C enhanced surveillance: results from a southeastern Sydney pilot program. Public Health Research and Practice 25(2): E2521520

Waheed, Y. 2015: Hepatitis C eradication: a long way to go. World Journal of Gastroenterology 21(43): 12510-12512

Cosar, A.M.; Durand, C.M.; Cameron, A.M.; Gurakar, A. 2016: Hepatitis C following liver transplantation: current approach and future research opportunities. Current Opinion in Infectious Diseases 29(4): 346-352

Sabourin, G. 2015: Hepatitis C genotype 1. Harvoni and Holkira Pak reimbursed?. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 12(5): 60

Pérez-Parente, D.; Suárez-Ordóñez, S.; Suárez-Santamaría, M.; Morano-Amado, L.E. 2015: Hepatitis C genotype 1b and 4 cured after telaprevir-based therapy. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 107(4): 251

Kattakuzhy, S.; Levy, R.; Rosenthal, E.; Tang, L.; Wilson, E.; Kottilil, S. 2016: Hepatitis C genotype 3 disease. Hepatology International 10(6): 861-870

Abdel-Ghaffar, T.Y.; Sira, M.M.; El Naghi, S. 2015: Hepatitis C genotype 4: the past, present, and future. World Journal of Hepatology 7(28): 2792-2810

Halfon, P.; Mohamed, S.; Penaranda, G.; Khiri, H.èn.; Chiche, L.; Nicolas, C.; Abergel, A. 2016: Hepatitis C genotype 4R resistance-associated polymorphisms: the achilles heel of the nonstructural 5A inhibitors?. Hepatology 64(2): 697-698

Prabdial-Sing, N.; Chirwa, T.; Thaver, J.; Smuts, H.; Vermeulen, M.; Suchard, M.; Puren, A.J. 2016: Hepatitis C genotype distribution in patient and blood donor samples in South Africa for the period 2008-2012. Journal of Viral Hepatitis 23(11): 881-888

Alavian, S.M. 2015: Hepatitis C genotypes distribution in intravenous drug users in tehran. Jundishapur Journal of Microbiology 8(3): E17134

Chung, R.T.; Davis, G.L.; Jensen, D.M.; Masur, H.; Saag, M.S.; Thomas, D.L.; Aronsohn, A.I.; Charlton, M.R.; Feld, J.J.; Fontana, R.J.; Ghany, M.G.; Godofsky, E.W.; Graham, C.S.; Kim, A.Y.; Kiser, J.J.; Kottilil, S.; Marks, K.M.; Martin, P.; Mitruka, K.; Morgan, T.R.; Naggie, S.; Raymond, D.; Reau, N.S.; Schooley, R.T.; Sherman, K.E.; Sulkowski, M.S.; Vargas, H.E.; Ward, J.W.; Wyles, D.L. 2015: Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 62(3): 932-954

Planas, R. 2014: Hepatitis C in 2014: responses to frequent questions in daily clinical practice. Gastroenterologia y Hepatologia 37 Suppl. 1: 1-2

Beebe, A.; Quattlebaum, T.; Gicquelais, R.E.; Zohoori, N.; Haselow, D.T.; Smith, N.H.; Patil, N. 2015: Hepatitis C in Arkansas: updates on epidemiology, testing and treatment. Journal of the Arkansas Medical Society 111(12): 248-251

Mina, M.Mokhlis.; Herawati, L.; Butler, T.; Lloyd, A. 2016: Hepatitis C in Australian prisons: a national needs assessment. International Journal of Prisoner Health 12(1): 3-16

Indolfi, G.; Bartolini, E.; Serranti, D.; Azzari, C.; Resti, M. 2015: Hepatitis C in Children Co-infected with Human Immunodeficiency Virus. Journal of Pediatric Gastroenterology and Nutrition 61(4): 393-399

Azevedo, T.C.L.; Zwahlen, M.; Rauch, A.; Egger, M.; Wandeler, G. 2016: Hepatitis C in HIV-infected individuals: a systematic review and meta-analysis of estimated prevalence in Africa. Journal of the International Aids Society 19(1): 20711

Habib, S.; Malik, S.; Fu, B.; Chang, J.; Nalesnik, M.; Humar, A.; Shaikh, O.S. 2015: Hepatitis C in Liver Allograft Recipients: Utility of One-Year Post-Transplantation Biopsy as an Indicator of Antiviral Therapy. Gastroenterology Research 8(6): 281-290

Rhea, S.; Fleischauer, A.; Foust, E.; Davies, M. 2016: Hepatitis C in North Carolina: Two Epidemics With One Public Health Response. North Carolina Medical Journal 77(3): 190-192

Hüsing, A.; Kabar, I.; Schmidt, H.H.; Heinzow, H.S. 2015: Hepatitis C in Special Patient Cohorts: new Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine. International Journal of Molecular Sciences 16(8): 18033-18053

Darke, J.; Cresswell, T.; McPherson, S.; Hamoodi, A. 2015: Hepatitis C in a prison in the North East of England: what is the economic impact of the universal offer of testing and emergent medications?. Journal of Public Health (): -

Baker, R.D.; Baker, S.S. 2015: Hepatitis C in children in times of change. Current Opinion in Pediatrics 27(5): 614-618

Marinaki, S.; Boletis, J.N.; Sakellariou, S.; Delladetsima, I.K. 2015: Hepatitis C in hemodialysis patients. World Journal of Hepatology 7(3): 548-558

Karageorgopoulos, D.E.; Allen, J.; Bhagani, S. 2015: Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?. World Journal of Hepatology 7(15): 1936-1952

Foley, Véronique.; Petit, Gève.; Giraud, M-José.; Boisvert, K.; Rietmann, Mèle.; Brousselle, A. 2016: Hepatitis C in Intravenous Drug Users: Study of Obstacles and Facilitators to Access to Health Care and Services. Sante Publique 28(3): 363-374

Alonso, M.; Gutzman, A.; Mazin, R.; Pinzon, C.E.; Reveiz, L.; Ghidinelli, M. 2015: Hepatitis C in key populations in Latin America and the Caribbean: systematic review and meta-analysis. International Journal of Public Health 60(7): 789-798

Belga, S.; Doucette, K.E. 2016: Hepatitis C in non-hepatic solid organ transplant candidates and recipients: a new horizon. World Journal of Gastroenterology 22(4): 1650-1663

Crisan, D.; Radu, C.; Suciu, A.; Leach, N.; Stefanescu, H.; Avram, L.; Crisan, N.; Grigorescu, M. 2017: Hepatitis C in nonobese nondiabetic patients: Insulin resistance and the metabolic syndrome make a difference. Journal of Viral Hepatitis 24(1): 86-87

Layden, J.E.; Phillips, R.; Opare-Sem, O.; Akere, A.; Salako, B.L.; Nelson, K.; Dugas, L.; Luke, A.; Tayo, B.O.; Cooper, R.S. 2014: Hepatitis C in sub-saharan Africa: urgent need for attention. Open Forum Infectious Diseases 1(2): Ofu065

Mukomolov, S.; Trifonova, G.; Levakova, I.; Bolsun, D.; Krivanogova, E. 2016: Hepatitis C in the Russian Federation: challenges and future directions. Hepatic Medicine: Evidence and Research 8: 51-60

Kieran, J.Ann.; Norris, S.; O'Leary, A.; Walsh, C.; Merriman, R.; Houlihan, D.; McCormick, P.Aiden.; McKiernan, S.; Bergin, C.; Barry, M. 2015: Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study. Bmc Infectious Diseases 15: 471

Cherchiglia, M.L.; Giordano, L.F.áv.C.; Machado, E.L.; Gomes, I.C.; Carmo, R.A.; Acúrcio, F.d.A.; Andrade, E.I.G.; Queiroz, O.V.; Ferreira, C.S. 2016: Hepatitis C incidence in hemodialysis patients in Brazil from 2000 to 2003. Cadernos de Saude Publica 32(8): E00167914

Anonymous 2007: Hepatitis C increases risk of non-Hodgkin's lymphoma. Nursing Standard 1987) 21(44): 16-17

Vigani, A.G. 2013: Hepatitis C infection and chronic renal diseases. Hepatology International 7(1): 16-27

Wijarnpreecha, K.; Thongprayoon, C.; Sanguankeo, A.; Upala, S.; Ungprasert, P.; Cheungpasitporn, W. 2017: Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 41(1): 39-45

Khoury, T.; Chen, S.; Adar, T.; Jacob, E.O.; Mizrahi, M. 2014: Hepatitis C infection and lymphoproliferative disease: accidental comorbidities?. World Journal of Gastroenterology 20(43): 16197-16202

Wijarnpreecha, K.; Nissaisorakarn, P.; Sornprom, S.; Thongprayoon, C.; Thamcharoen, N.; Maneenil, K.; Podboy, A.J.; Cheungpasitporn, W. 2016: Hepatitis C infection and renal cell carcinoma: a systematic review and meta-analysis. World Journal of Gastrointestinal Pathophysiology 7(4): 314-319

Kovari, H.; Rauch, A.; Kouyos, R.; Rougemont, M.; Cavassini, M.; Schmid, P.; Stöckle, M.; Bernasconi, E.; Weber, R.; Ledergerber, B. 2016: Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study. Clinical Infectious Diseases

Rouabhia, S.; Chaabna, K. 2017: Hepatitis C infection in eastern Algeria: Between statistics and reality. Journal of Medical Virology 89(6): 941-942

Ozer Etik, D.; Ocal, S.; Boyacioglu, A.S. 2015: Hepatitis C infection in hemodialysis patients: a review. World Journal of Hepatology 7(6): 885-895

Chen, T.-T.; Chiu, C.-F.; Yang, T.-Y.; Lin, C.-C.; Sargeant, A.M.; Yeh, S.-P.; Liao, Y.-M.; Bai, L.-Y. 2015: Hepatitis C infection is associated with hepatic toxicity but does not compromise the survival of patients with diffuse large B cell lymphoma treated with rituximab-based chemotherapy. Leukemia Research 39(2): 151-156

Younossi, Z.M.; Birerdinc, A.; Henry, L. 2016: Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences. Journal of Hepatology 65(1 Suppl): S109-S119

Diatta, T.; Chavade, D.; Degos, F.ço.; d'Andon, A.; Guillevin, L.ïc. 2016: Hepatitis C infection: Therapeutic strategies. Presse Medicale 45(5): 495-508

Lea, T.; Hopwood, M.; Aggleton, P. 2016: Hepatitis C knowledge among gay and other homosexually active men in Australia. Drug and Alcohol Review 35(4): 477-483

Foschi, A.; Casana, M.; Radice, A.; Ranieri, R.; d'Arminio Monforte, A. 2016: Hepatitis C management in prisons: An insight into daily clinical practice in three major Italian correctional houses. Hepatology 64(5): 1821-1822

Chun, K.; Afshar, M.; Audish, D.; Kabigting, F.; Paik, A.; Gallo, R.; Hata, T. 2017: Hepatitis C may enhance key amplifiers of psoriasis. Journal of the European Academy of Dermatology and Venereology: Jeadv 31(4): 672-678

Burns, J. 2014: High-cost drugs. Where's the ROI?. Managed Care 23(12): 20-23

Anonymous 2005: Hepatitis C nightmare. Nursing Standard 1987) 20(5): 26-27

Stępień, Młgorzata.; Rosińska, M. 2015: Hepatitis C oubreaks in Poland in 2003-2013. Medical procedures as a dominant route of HCV transmission. Przeglad Epidemiologiczny 69(3): 465-72 585-90

Vladimirsky, S.N.í; Munné, M.S.; Otegui, L.O.; Altabert, N.R.; Soto, S.S.; Brajterman, L.; González, J.E. 2015: Hepatitis C patients' record in the Sentinel Units for viral Hepatitis in Argentina 2007- 2014. Distribution by year of birth. Acta Gastroenterologica Latinoamericana 45(2): 110-116

Bailey, S.; Scalley, B.; Gilles, M. 2015: Hepatitis C polymerase chain reaction testing by GPs. Australian Family Physician 44(1-2): 69-70

Sanai, F.M.; Alghamdi, A.S.; Alghamdi, M.Y. 2015: Hepatitis C position statement: Taking a stand and standing by it. Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association 21(4): 262-263

Gyarmathy, V.A.; Sárosi, P.ét. 2015: Hepatitis C prevalence among people who inject drugs in Hungary. LANCET. Infectious Diseases 15(11): 1261-1262

Midgard, Håvard.; Bjøro, B.; Mæland, A.; Konopski, Z.; Kileng, H.; Damås, J.K.; Paulsen, Jørn.; Heggelund, L.; Sandvei, P.K.; Ringstad, J.O.; Karlsen, L.N.; Stene-Johansen, K.; Pettersson, J.H-O.; Dorenberg, D.H.; Dalgard, O. 2016: Hepatitis C reinfection after sustained virological response. Journal of Hepatology 64(5): 1020-1026

Weir, A.; McLeod, A.; Innes, H.; Valerio, H.; Aspinall, E.J.; Goldberg, D.J.; Barclay, S.T.; Dillon, J.F.; Fox, R.; Fraser, A.; Hayes, P.C.; Kennedy, N.; Mills, P.R.; Stanley, A.J.; Aitken, C.; Gunson, R.; Templeton, K.; Hunt, A.; McIntyre, P.; Hutchinson, S.J. 2016: Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs. Drug and Alcohol Dependence 165: 53-60

Wu, Z.; Matsui, O.; Kitao, A.; Kozaka, K.; Koda, W.; Kobayashi, S.; Ryu, Y.; Minami, T.; Sanada, J.; Gabata, T. 2015: Hepatitis C related chronic liver cirrhosis: feasibility of texture analysis of MR images for classification of fibrosis stage and necroinflammatory activity grade. Plos one 10(3): E0118297

Brener, L.; Murphy, D.A.; Cama, E.J.; Ellard, J. 2015: Hepatitis C risk factors, attitudes and knowledge among HIV-positive, HIV-negative and HIV-untested gay and bisexual men in Australia. Sexual Health 12(5): 411-417

Joshi, S.N. 2014: Hepatitis C screening. Ochsner Journal 14(4): 664-668

Corona-Lau, C.; Muñoz, L.; Wolpert, E.; Aguilar, L.M.; Dehesa, M.; Gutiérrez, C.ón.; Kershenobich, D. 2015: Hepatitis C screening in the general population. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 67(2): 104-108

Ward, C.J.; Lee, V. 2015: Hepatitis C screening of men who have sex with men. Bmj 350: H642

Zhou, W.; Wang, X.; Zhou, S.; Xie, N.; Liu, P.; Luo, L.; Peng, J.; Liu, M.; Desrosiers, A.; Schottenfeld, R.; Chawarski, M.C. 2015: Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China. Addiction 110(5): 796-802

Boesecke, C.; Grint, D.; Soriano, V.; Lundgren, J.D.; d'Arminio Monforte, A.; Mitsura, V.M.; Chentsova, N.; Hadziosmanovic, V.; Kirk, O.; Mocroft, A.; Peters, L.; Rockstroh, J.ür.K.; Losso, M.; Kundro, M.; Vetter, N.; Zangerle, R.; Karpov, I.; Vassilenko, A.; Mitsura, V.M.; Suetnov, O.; Clumeck, N.; De Wit, S.; Delforge, M.; Florence, E.; Vandekerckhove, L.; Hadziosmanovic, V.; Kostov, K.; Begovac, J.; Machala, L.; Jilich, D.; Sedlacek, D.; Nielsen, J.; Kronborg, G.; Benfield, T.; Larsen, M.; Gerstoft, J.; Katzenstein, T.; Hansen, A.-B.E.; Skinhøj, P.; Pedersen, C.; Ostergaard, L.; Dragsted, U.B.; Nielsen, L.N.; Zilmer, K.; Smidt, J.; Ristola, M.; Katlama, C.; Viard, J.-P.; Girard, P.-M.; Vanhems, P.; Pradier, C.; Dabis, F.; Neau, D. 2015: Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?. Liver International: Official Journal of the International Association for the Study of the Liver 35(11): 2384-2391

Shopnick, R.I.; Bolivar, E.; Brettler, D.B. 1996: Hepatitis C seropositivity in HIV-negative children with severe haemophilia. Haemophilia: the Official Journal of the World Federation of Hemophilia 2(2): 100-103

Rao, V.B.; Johari, N.; du Cros, P.; Messina, J.; Ford, N.; Cooke, G.S. 2015: Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. LANCET. Infectious Diseases 15(7): 819-824

Alonso López, S.; Agudo Fernández, S.; García Del Val, A.; Martínez Abad, M.; López Hermosa Seseña, P.; Izquierdo, M.ía.J.ús.; Núñez, I.; Berbel León, S.; Visedo Campillo, L.; Guisado Pérez, C.; Sánchez Lozano, S.; Mariño Pfeiffer, I.; García Bermúdez, L.; Sánchez Jiménez, F.J.; López Vega, E.; Zambrano Álvarez, J.ús.; Castro Pastor, M.L.; Montes Ramírez, G.; Murillo, C.; Villafranca Ortega, N.; Ayuso Hernández, I.; Espejo, M.ía.; Lasala López, P.; Rodríguez Caravaca, G.; Carrascosa Aguilar, B.; Gutiérrez García, M.ía.L.; Fernández Rodríguez, C. 2016: Hepatitis C seroprevalence in an at-risk population in the southwest Madrid region of Spain. Gastroenterologia y Hepatologia 39(10): 656-662

Kueht, M.; Bebko, S.; Helmick, R.; Awad, S. 2016: Hepatitis C status and infectious complications in the surgical intensive care unit: a retrospective analysis of 1,941 consecutive patients. American Journal of Surgery 211(6): 1064-1070

Prussing, C.; Bornschlegel, K.; Balter, S. 2015: Hepatitis C surveillance among youth and young adults in New York City, 2009-2013. Journal of urban health: bulletin of the New York Academy of Medicine 92(2): 387-399

Ross, D.B.; Belperio, P.S.; Chartier, M.; Backus, L.I. 2017: Hepatitis C testing in U.S. veterans born 1945-1965: An update. Journal of hepatology 66(1): 237-238

Frimpong, J.A.; D'Aunno, T. 2016: Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services. Substance Abuse Treatment Prevention and Policy 11: 13

Jiao, Y.-m.; Weng, W.-j.; Gao, Q.-s.; Zhu, W.-j.; Cai, W.-p.; Li, L.-h.; Li, H.-j.; Gao, Y.-q.; Wu, H. 2015: Hepatitis C therapy with interferon-α and ribavirin reduces the CD4 cell count and the total, 2LTR circular and integrated HIV-1 DNA in HIV/HCV co-infected patients. Antiviral Research 118: 118-122

Au, T.H.; Destache, C.J.; Vivekanandan, R. 2015: Hepatitis C therapy: Looking toward interferon-sparing regimens. Journal of the American Pharmacists Association: Japha 55(2): E72

Hellard, M.; McBryde, E.; Sacks Davis, R.; Rolls, D.A.; Higgs, P.; Aitken, C.; Thompson, A.; Doyle, J.; Pattison, P.; Robins, G. 2015: Hepatitis C transmission and treatment as prevention - The role of the injecting network. International Journal on Drug Policy 26(10): 958-962

Mehta, G.; Dusheiko, G. 2015: Hepatitis C treatment and quality of life - you can't always get what you want, but you might get what you need. Journal of Hepatology 63(2): 300-302

Dore, G.J. 2016: Hepatitis C treatment as prevention among HIV-infected men who have sex with men: Feasible?. Hepatology 64(6): 1834-1836

Cousien, A.; Tran, V.Chi.; Deuffic-Burban, S.; Jauffret-Roustide, M.; Dhersin, J-Stéphane.; Yazdanpanah, Y. 2016: Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs. Hepatology 63(4): 1090-1101

Isaksen, K.; Aabakken, L.; Grimstad, T.; Karlsen, L.; Sandvei, P.Kristian.; Dalgard, O. 2015: Hepatitis C treatment at three Norwegian hospitals 2000-2011. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 135(22): 2052-2058

Anonymous 2013: Hepatitis C treatment extends life. Harvard men's health watch 17(9): 8

Lu, M.; Li, J.; Rupp, L.B.; Holmberg, S.D.; Moorman, A.C.; Spradling, P.R.; Teshale, E.H.; Zhou, Y.; Boscarino, J.A.; Schmidt, M.A.; Lamerato, L.E.; Trinacty, C.; Trudeau, S.; Gordon, S.C.; Xing, J.; Tong, C.; Nerenz, D.R.; Akkerman, N.; Oja-Tebbe, N.; Zhang, T.; Daar, Z.S.; Smith, R.E.; Parker, J.V.; Donald, J.L.; Keast, E.M. 2016: Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma. Journal of Viral Hepatitis 23(9): 718-729

Mariño, Z.; Londoño, M.-C.; Forns, X. 2015: Hepatitis C treatment for patients post liver transplant. Current Opinion in Organ Transplantation 20(3): 251-258

Sakamoto, M.; Enomoto, N. 2015: Hepatitis C treatment in consideration of the carcinogenic risk and drug-resistant mutations. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 165-170

Verna, E.C.; O'Leary, J.G. 2015: Hepatitis C treatment in patients on the liver transplant waiting list. Current Opinion in Organ Transplantation 20(3): 242-250

Berenguer, M.; Jorquera, F.; Ángel Serra, M.; Sola, R.; Castellano, G. 2014: Hepatitis C treatment in special patient groups. Gastroenterologia y Hepatologia 37(Suppl 1): 23-36

Vespasiani-Gentilucci, U.; Galati, G.; Gallo, P.; De Vincentis, A.; Riva, E.; Picardi, A. 2015: Hepatitis C treatment in the elderly: new possibilities and controversies towards interferon-free regimens. World Journal of Gastroenterology 21(24): 7412-7426

Cotte, L.; Pugliese, P.; Valantin, M.-A.; Cuzin, L.; Billaud, E.; Duvivier, C.; Naqvi, A.; Cheret, A.; Rey, D.; Pradat, P.; Poizot-Martin, I. 2016: Hepatitis C treatment initiation in HIV-HCV coinfected patients. Bmc Infectious Diseases 16: 345

Riedel, D.J.; Taylor, S.; Simango, R.; Kiromera, A.; Sebeza, J.; Baribwira, C.; Musabeyezu, E. 2016: Hepatitis C treatment outcomes using interferon- and ribavirin-based therapy in Kigali, Rwanda. Transactions of the Royal Society of Tropical Medicine and Hygiene 110(8): 495-497

Mravčík, V.; Strada, L.; Reimer, J.; Schulte, B. 2014: Hepatitis C treatment uptake and adherence among injecting drug users in the Czech Republic. Epidemiologie Mikrobiologie Imunologie: Casopis Spolecnosti Pro Epidemiologii a Mikrobiologii Ceske Lekarske Spolecnosti J.E. Purkyne 63(4): 265-269

Young, A.M.; Stephens, D.B.; Khaleel, H.A.; Havens, J.R. 2015: Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment. Contemporary Clinical Trials 41: 9-16

Kelly, D. 2016: Hepatitis C viraemia after apparent spontaneous clearance. Lancet 387(10031): 1968

Indolfi, G.; Mangone, G.; Bartolini, E.; Moriondo, M.; Azzari, C.; Resti, M. 2016: Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child. Lancet 387(10031): 1967-1968

Fülöp, B.; Mihm, U.; Rohde, P.; Buggisch, P.; Schlosser, B.; Biermer, M.; Brodzinski, A.; Fischer, J.; Böhm, S.; van Bömmel, F.; Sarrazin, C.; Berg, T. 2016: Hepatitis C viral dynamics during ribavirin priming differ according to prior treatment response and HCV type. Journal of Viral Hepatitis 23(11): 866-872

Su, T.-H.; Liu, C.-J.; Tseng, T.-C.; Chou, S.-W.; Liu, C.-H.; Yang, H.-C.; Wu, S.-J.; Chen, P.-J.; Chen, D.-S.; Chen, C.-L.; Kao, J.-H. 2016: Hepatitis C viral infection increases the risk of lymphoid-neoplasms: a population-based cohort study. Hepatology 63(3): 721-730

Golden-Mason, L.; Waasdorp Hurtado, C.E.; Cheng, L.; Rosen, H.R. 2015: Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3. Clinical Immunology 158(1): 114-125

Anonymous 2005: Hepatitis C viral load not affected by alcohol intake. Nursing Standard 1987) 20(9): 18-19

Shindoh, J.; Hasegawa, K.; Takemura, N.; Omichi, K.; Ishizawa, T.; Aoki, T.; Sakamoto, Y.; Sugawara, Y.; Kokudo, N. 2014: Hepatitis C viral load predicts tumor recurrence after curative resection of hepatocellular carcinoma regardless of the genotype of hepatitis C virus. Hepatology International 8(1): 112-120

Huang, C.-F.; Yeh, M.-L.; Lee, J.-J.; Chen, M.-C.; Dai, C.-Y.; Huang, J.-F.; Chang, J.-M.; Chen, H.-C.; Hwang, S.-J.; Chuang, W.-L.; Yu, M.-L. 2014: Hepatitis C viremia interferes with serum hepatitis B virus surface antigen and DNA levels in hepatitis B uremics. Hepatology International 8(2): 224-232

Chang, L.-Y.; Li, Y.; Kaplan, D.E. 2017: Hepatitis C viraemia reversibly maintains subset of antigen-specific T-bet+ tissue-like memory B cells. Journal of Viral Hepatitis 24(5): 389-396

Grint, D.; Tedaldi, E.; Peters, L.; Mocroft, A.; Edlin, B.; Gallien, S.; Klinker, H.; Boesecke, C.; Kokordelis, P.; Rockstroh, J.K. 2017: Hepatitis C virus (HCV) RNA profiles among chronic HIV/HCV-coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in nine individuals. HIV Medicine 18(6): 430-434

Smith, D.J.; Combellick, J.; Jordan, A.E.; Hagan, H. 2015: Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): a systematic review and meta-analysis. International Journal on Drug Policy 26(10): 911-921

Wang, M.; Zhang, Y.; Li, Z.; Zhang, H.; Zhang, Z.; Yue, D.; Zhou, R.; Li, X.; Wu, S.; Li, J. 2015: Hepatitis C virus (HCV) genotype 2a has a better virologic response to antiviral therapy than HCV genotype 1b. International Journal of Clinical and Experimental Medicine 8(5): 7446-7456

Petruzziello, A.; Marigliano, S.; Loquercio, G.; Cacciapuoti, C. 2016: Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe. Infectious Agents and Cancer 11: 53

Basu, D.; Sharma, A.K.; Gupta, S.; Nebhinani, N.; Kumar, V. 2015: Hepatitis C virus (HCV) infection and risk factors for HCV positivity in injecting and non-injecting drug users attending a de-addiction centre in northern India. Indian Journal of Medical Research 142(3): 311-316

Mori, N.; Imamura, M.; Takaki, S.; Araki, T.; Hayes, N.C.; Aisaka, Y.; Chayama, K. 2014: Hepatitis C virus (HCV) reactivation caused by steroid therapy for dermatomyositis. Internal Medicine 53(23): 2689-2693

Tagawa, A.; Ogawa, T.; Tetsuka, S.; Otsuka, M.; Hashimoto, R.; Kato, H.; Ando, K.; Tanabe, H. 2016: Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 9: 155-157

Forns, X.; Berg, T. 2016: Hepatitis C virus - a teacher of clinical research, cell biology and immunology. Journal of Hepatology 65(1 Suppl): S1

Mihăilă, R.-G. 2016: Hepatitis C virus - associated B cell non-Hodgkin's lymphoma. World Journal of Gastroenterology 22(27): 6214-6223

Merat, S.J.; Molenkamp, R.; Wagner, K.; Koekkoek, S.M.; van de Berg, D.; Yasuda, E.; Böhne, M.; Claassen, Y.B.; Grady, B.P.; Prins, M.; Bakker, A.Q.; de Jong, M.D.; Spits, H.; Schinkel, J.; Beaumont, T. 2016: Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance. Plos one 11(10): E0165047

Kwak, J.; Tiwari, I.; Jang, K.L. 2017: Hepatitis C virus core activates proteasomal activator 28γ expression via upregulation of p53 levels to control virus propagation. Journal of General Virology 98(1): 56-67

Roopngam, P.; Liu, K.; Mei, L.; Zheng, Y.; Zhu, X.; Tsai, H-I.; Huang, L. 2016: Hepatitis C virus E2 protein encapsulation into poly d, l-lactic- co -glycolide microspheres could induce mice cytotoxic T-cell response. International Journal of Nanomedicine 11: 5361-5370

Kinoshita, C.; Nagano, T.; Seki, N.; Tomita, Y.; Sugita, T.; Aida, Y.; Itagaki, M.; Satoh, K.; Sutoh, S.; Abe, H.; Tsubota, A.; Aizawa, Y. 2016: Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles. World Journal of Gastroenterology 22(29): 6716-6725

Korba, B.; Shetty, K.; Medvedev, A.; Viswanathan, P.; Varghese, R.; Zhou, B.; Roy, R.; Makambi, K.; Ressom, H.; Loffredo, C.A. 2015: Hepatitis C virus Genotype 1a core gene nucleotide patterns associated with hepatocellular carcinoma risk. Journal of General Virology 96(9): 2928-2937

Zhang, J.; Ishigaki, Y.; Takegami, T. 2015: Hepatitis C virus NS3 protein modulates the biological behaviors of malignant hepatocytes by altering the expression of host cell microRNA. Molecular Medicine Reports 12(4): 5109-5115

Ferreira, A.R.; Magalhães, A.C.; Camões, Fátima.; Gouveia, A.; Vieira, M.; Kagan, J.C.; Ribeiro, D. 2016: Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response. Journal of Cellular and Molecular Medicine 20(4): 750-757

McCauley, J.A.; Rudd, M.T. 2016: Hepatitis C virus NS3/4a protease inhibitors. Current Opinion in Pharmacology 30: 84-92

Parvaiz, F.; Manzoor, S.; Iqbal, J.; Sarkar-Dutta, M.; Imran, M.; Waris, G. 2015: Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis. World Journal of Gastroenterology 21(43): 12361-12369

Igloi, Z.; Kazlauskas, A.; Saksela, K.; Macdonald, A.; Mankouri, J.; Harris, M. 2015: Hepatitis C virus NS5A protein blocks epidermal growth factor receptor degradation via a proline motif- dependent interaction. Journal of General Virology 96(8): 2133-2144

Chen, M.; Gan, X.; Yoshino, K.-I.; Kitakawa, M.; Shoji, I.; Deng, L.; Hotta, H. 2016: Hepatitis C virus NS5A protein interacts with lysine methyltransferase SET and MYND domain-containing 3 and induces activator protein 1 activation. Microbiology and Immunology 60(6): 407-417

Ross-Thriepland, D.; Harris, M. 2015: Hepatitis C virus NS5A: enigmatic but still promiscuous 10 years on!. Journal of General Virology 96(Part 4): 727-738

Zhou, P.; Cai, Q.; Chen, Y.C.; Zhang, M.S.; Guan, J.; Li, X.J. 1997: Hepatitis C virus RNA detection in serum and peripheral blood mononuclear cells of patients with hepatitis C. World Journal of Gastroenterology 3(2): 108-110

Luna, J.M.; Scheel, T.K.H.; Danino, T.; Shaw, K.S.; Mele, A.; Fak, J.J.; Nishiuchi, E.; Takacs, C.N.; Catanese, M.T.; de Jong, Y.P.; Jacobson, I.M.; Rice, C.M.; Darnell, R.B. 2015: Hepatitis C virus RNA functionally sequesters miR-122. Cell 160(6): 1099-1110

Cento, V.; Di Paolo, D.; Di Carlo, D.; Micheli, V.; Tontodonati, M.; De Leonardis, F.; Aragri, M.; Antonucci, F.P.; Di Maio, V.C.; Mancon, A.; Lenci, I.; Manunta, A.; Taliani, G.; Di Biagio, A.; Nicolini, L.A.; Nosotti, L.; Sarrecchia, C.; Siciliano, M.; Landonio, S.; Pellicelli, A.; Gasbarrini, A.; Vecchiet, J.; Magni, C.F.; Babudieri, S.; Mura, M.S.; Andreoni, M.; Parruti, G.; Rizzardini, G.; Angelico, M.; Perno, C.F.; Ceccherini-Silberstein, F. 2015: Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 47(2): 157-163

Paul, D.; Madan, V.; Bartenschlager, R. 2014: Hepatitis C virus RNA replication and assembly: living on the fat of the land. Cell Host and Microbe 16(5): 569-579

Kazakov, T.; Yang, F.; Ramanathan, H.N.; Kohlway, A.; Diamond, M.S.; Lindenbach, B.D. 2015: Hepatitis C virus RNA replication depends on specific cis- and trans-acting activities of viral nonstructural proteins. Plos Pathogens 11(4): E1004817

Shlomai, A. 2015: Hepatitis C virus addiction to liver miR-122 takes its Toll on the host. Hepatology 62(5): 1633-1635

Mumtaz, G.R.; Weiss, H.A.; Abu-Raddad, L.J. 2015: Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden?. Journal of the International Aids Society 18: 20582

Yang, D.-R.; Zhu, H.-Z. 2015: Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?. World Journal of Gastroenterology 21(13): 3786-3800

Bassendine, M.F.; Nielsen, S.U.; Bridge, S.H.; Felmlee, D.J.; Sheridan, D.A.; Packard, C.J.; Neely, R.D. 2017: Hepatitis C virus and atherosclerosis: a legacy after virologic cure?. Clinics and Research in Hepatology and Gastroenterology 41(1): 25-30

Böckle, B.C.; Sepp, N.T. 2010: Hepatitis C virus and autoimmunity. Auto- Immunity Highlights 1(1): 23-35

Wang, L.; Ou, J.-h.J. 2015: Hepatitis C virus and autophagy. Biological Chemistry 396(11): 1215-1222

Lee, C.A. 1995: Hepatitis C virus and haemophilia: the natural history of HCV in haemophilic patients. Haemophilia: the Official Journal of the World Federation of Hemophilia 1(Suppl 4): 8-12

Bonamassa, B.; Ciccarese, F.; Antonio, V.D.; Contarini, A.; Palù, G.; Alvisi, G. 2015: Hepatitis C virus and host cell nuclear transport machinery: a clandestine affair. Frontiers in Microbiology 6: 619

Kong, L.; Li, S.; Yu, X.; Fang, X.; Xu, A.; Huang, M.; Wu, X.; Guo, Y.; Guo, F.; Xu, J. 2016: Hepatitis C virus and its protein NS4B activate the cancer-related STAT3 pathway via the endoplasmic reticulum overload response. Archives of Virology 161(8): 2149-2159

Filipe, A.; McLauchlan, J. 2015: Hepatitis C virus and lipid droplets: finding a niche. Trends in Molecular Medicine 21(1): 34-42

Burra, P.; De Martin, E.; Zanetto, A.; Senzolo, M.; Russo, F.P.; Zanus, G.; Fagiuoli, S. 2016: Hepatitis C virus and liver transplantation: where do we stand?. Transplant International: Official Journal of the European Society for Organ Transplantation 29(2): 135-152

Paydas, S. 2015: Hepatitis C virus and lymphoma. Critical Reviews in Oncology/Hematology 93(3): 246-256

Ponzetto, A.; Carloni, G. 2016: Hepatitis C virus and lymphoma. Hepatology 64(5): 1813

Mathew, S.; Faheem, M.; Ibrahim, S.M.; Iqbal, W.; Rauff, B.; Fatima, K.; Qadri, I. 2016: Hepatitis C virus and neurological damage. World Journal of Hepatology 8(12): 545-556

Pozzato, G.; Mazzaro, C.; Dal Maso, L.; Mauro, E.; Zorat, F.; Moratelli, G.; Bulian, P.; Serraino, D.; Gattei, V. 2016: Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options. World Journal of Hepatology 8(2): 107-116

Naderi, M.; Gholipour, N.; Zolfaghari, M.R.; Moradi Binabaj, M.; Yegane Moghadam, A.; Motalleb, G. 2014: Hepatitis C virus and vaccine development. International Journal of Molecular and Cellular Medicine 3(4): 207-215

Aikawa, N.ád.E.; Nascimento, A.P.; Hayata, A.é L.S.; Bonfá, E.; Goldenstein-Schainberg, C.áu. 2016: Hepatitis C virus antibodies in high risk juvenile onset systemic lupus erythematosus. Revista Brasileira de Reumatologia 56(3): 235-239

Smith, B.D.; Yartel, A.K.; Krauskopf, K.; Massoud, O.I.; Brown, K.A.; Fallon, M.B.; Rein, D.B. 2015: Hepatitis C virus antibody positivity and predictors among previously undiagnosed adult primary care outpatients: cross-sectional analysis of a multisite retrospective cohort study. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 60(8): 1145-1152

Takeuchi, L.C.; Pham, T.K.; Katz, A.R. 2015: Hepatitis C virus antibody prevalence, demographics and associated factors among persons screened at Hawai'i community-based health settings, 2010-2013. Hawai'i Journal of Medicine and Public Health: a Journal of Asia Pacific Medicine and Public Health 74(1): 9-15

Ibrahim, I.; Salah, H.; El Sayed, H.; Mansour, H.; Eissa, A.; Wood, J.; Fathi, W.; Tobar, S.; Gur, R.C.; Gur, R.E.; Dickerson, F.; Yolken, R.H.; El Bahaey, W.; Nimgaonkar, V. 2016: Hepatitis C virus antibody titers associated with cognitive dysfunction in an asymptomatic community-based sample. Journal of Clinical and Experimental Neuropsychology 38(8): 861-868

Gill, K.; Ghazinian, H.; Manch, R.; Gish, R. 2016: Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatology International 10(3): 415-423

Tanoglu, A.; Karagoz, E.; Beyazit, Y. 2015: Hepatitis C virus associated hepatocellular carcinoma risk. Asian Pacific Journal of Cancer Prevention: Apjcp 16(6): 2585

Burki, T.K. 2015: Hepatitis C virus associated with high rates of cancer. LANCET. Oncology 16(6): E266

Amako, Y.; Munakata, T.; Kohara, M.; Siddiqui, A.; Peers, C.; Harris, M. 2015: Hepatitis C virus attenuates mitochondrial lipid β-oxidation by downregulating mitochondrial trifunctional-protein expression. Journal of Virology 89(8): 4092-4101

Colpitts, C.C.; Baumert, T.F. 2016: Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals. Hepatology International 10(5): 741-748

Bedimo, R.; Maalouf, N.M.; Lo Re, V. 2016: Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture. Current Opinion in HIV and Aids 11(3): 285-293

Fernández-Montero, J.V.; Barreiro, P.; de Mendoza, C.; Labarga, P.; Soriano, V. 2016: Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients. Journal of Viral Hepatitis 23(1): 47-52

Ploen, D.; Hildt, E. 2015: Hepatitis C virus comes for dinner: how the hepatitis C virus interferes with autophagy. World Journal of Gastroenterology 21(28): 8492-8507

Wang, L.; Lv, H.; Zhang, G. 2017: Hepatitis C virus core antigen assay: an alternative method for hepatitis C diagnosis. Annals of Clinical Biochemistry 54(2): 279-285

Moon, J.; Kaowinn, S.; Cho, I.-R.; Min, D.S.; Myung, H.; Oh, S.; Kaewpiboon, C.; Kraemer, O.H.; Chung, Y.-H. 2016: Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4. Biochemical and Biophysical Research Communications 474(3): 428-434

Li, Z.-Q.; Gu, X.-Y.; Hu, J.-X.; Ping, Y.; Li, H.; Yan, J.-Y.; Li, J.; Sun, R.; Yu, Z.-J.; Zhang, Y. 2016: Hepatitis C virus core protein impairs metabolic disorder of liver cell via HOTAIR-Sirt1 signalling. Bioscience Reports 36(3)

Tiwari, I.; Yoon, M.-H.; Park, B.-J.; Jang, K.L. 2015: Hepatitis C virus core protein induces epithelial-mesenchymal transition in human hepatocytes by upregulating E12/E47 levels. Cancer Letters 362(1): 131-138

Kwak, J.; Shim, J.H.; Tiwari, I.; Jang, K.L. 2016: Hepatitis C virus core protein inhibits E6AP expression via DNA methylation to escape from ubiquitin-dependent proteasomal degradation. Cancer Letters 380(1): 59-68

Mileo, A.M.; Mattarocci, S.; Matarrese, P.; Anticoli, S.; Abbruzzese, C.; Catone, S.; Sacco, R.; Paggi, M.G.; Ruggieri, A. 2015: Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation. Journal of Experimental and Clinical Cancer Research: Cr 34: 140

Seo, Y.L.; Heo, S.; Jang, K.L. 2015: Hepatitis C virus core protein overcomes H2O2-induced apoptosis by downregulating p14 expression via DNA methylation. Journal of General Virology 96(Part 4): 822-832

Zhou, J.-J.; Meng, Z.; Zhou, Y.; Cheng, D.; Ye, H.-L.; Zhou, Q.-B.; Deng, X.-G.; Chen, R.-F. 2016: Hepatitis C virus core protein regulates OCT4 expression and promotes cell cycle progression in hepatocellular carcinoma. Oncology Reports 36(1): 582-588

Hasin, Y.; Shteingart, S.; Dahari, H.; Gafanovich, I.; Floru, S.; Braun, M.; Shlomai, A.; Verstandig, A.; Dery, I.; Uprichard, S.L.; Cotler, S.J.; Lurie, Y. 2016: Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report. World Journal of Hepatology 8(20): 858-862

Li, Q.; Sodroski, C.; Lowey, B.; Schweitzer, C.J.; Cha, H.; Zhang, F.; Liang, T.J. 2016: Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition. Proceedings of the National Academy of Sciences of the United States of America 113(27): 7620-7625

Klepper, A.; Eng, F.J.; Doyle, E.H.; El-Shamy, A.; Rahman, A.H.; Fiel, M.Isabel.; Avino, G.Carrasco.; Lee, M.; Ye, F.; Roayaie, S.; Bansal, M.B.; MacDonald, M.R.; Schiano, T.D.; Branch, A.D. 2017: Hepatitis C virus double-stranded RNA is the predominant form in human liver and in interferon-treated cells. Hepatology 66(2): 357-370

Lontok, E.; Harrington, P.; Howe, A.; Kieffer, T.; Lennerstrand, J.; Lenz, O.; McPhee, F.; Mo, H.; Parkin, N.; Pilot-Matias, T.; Miller, V. 2015: Hepatitis C virus drug resistance-associated substitutions: State of the art summary. Hepatology 62(5): 1623-1632

DebRoy, S.; Hiraga, N.; Imamura, M.; Hayes, C.N.; Akamatsu, S.; Canini, L.; Perelson, A.S.; Pohl, R.T.; Persiani, S.; Uprichard, S.L.; Tateno, C.; Dahari, H.; Chayama, K. 2016: Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy. Journal of Viral Hepatitis 23(9): 708-717

Sakem, B.; Madaliński, K.; Nydegger, U.; Stępień, Młgorzata.; Godzik, P.; Kołakowska, A.; Risch, L.; Risch, M.; Zakrzewska, K.; Rosińska, M. 2016: Hepatitis C virus epidemiology and prevention in Polish and Swiss population - similar and contrasting experiences. Annals of Agricultural and Environmental Medicine: Aaem 23(3): 425-431

Ceccherini Silberstein, F.; Di Maio, V.C.; Aragri, M.; Ciotti, M.; Cento, V.; Perno, C.F. 2016: Hepatitis C virus gene sequencing as a tool for precise genotyping in the era of new direct antiviral agents. Hepatology 63(3): 1058-1059

Echeverría, N.; Moratorio, G.; Cristina, J.; Moreno, P. 2015: Hepatitis C virus genetic variability and evolution. World Journal of Hepatology 7(6): 831-845

Vilchez, R.A. 2015: Hepatitis C virus genotype 1 NS5A variants in Japanese patients. LANCET. Infectious Diseases 15(12): 1378

Ampuero, J.; Reddy, K.R.; Romero-Gomez, M. 2016: Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options. World Journal of Gastroenterology 22(22): 5285-5292

Shalimar 2014: Hepatitis C virus genotype 3: hope for nonresponders and patients with cirrhosis. Journal of Clinical and Experimental Hepatology 4(2): 179-181

Schnell, G.; Tripathi, R.; Beyer, J.; Reisch, T.; Krishnan, P.; Lu, L.; Dekhtyar, T.; Hall, C.; Vilchez, R.A.; Pilot-Matias, T.; Collins, C. 2015: Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir. Antimicrobial Agents and ChemoTherapy 59(11): 6807-6815

Llaneras, J.; Riveiro-Barciela, M.; Buti, M.; Esteban, R. 2017: Hepatitis C virus genotype 4: Genotype 1's little brother. Journal of Viral Hepatitis 24(1): 4-12

Murphy, D.G.; Sablon, E.; Chamberland, J.; Fournier, E.; Dandavino, R.; Tremblay, C.éc.L. 2015: Hepatitis C virus genotype 7, a new genotype originating from central Africa. Journal of Clinical Microbiology 53(3): 967-972

Ju, W.; Yang, S.; Feng, S.; Wang, Q.; Liu, S.; Xing, H.; Xie, W.; Zhu, L.; Cheng, J. 2015: Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6. Virology Journal 12: 109

Oztürk, A.B.; Doğan, U.B.; Oztürk, N.A.ça.; Ozyazici, G.; Demir, M.; Akin, M.S.; Böngöl, A.S. 2014: Hepatitis C virus genotypes in Adana and Antakya regions of Turkey. Turkish Journal of Medical Sciences 44(4): 661-665

Mwangi, J.; Nganga, Z.; Mpoke, S.; Lihana, R.; Kinyua, J.; Lagat, N.; Muriuki, J.; Lel, R.; Kageha, S.; Osman, S.; Ichimura, H. 2016: Hepatitis C virus genotypes in Kenya. Archives of Virology 161(1): 95-101

Win, N.N.; Kanda, T.; Nakamoto, S.; Yokosuka, O.; Shirasawa, H. 2016: Hepatitis C virus genotypes in Myanmar. World Journal of Gastroenterology 22(27): 6095-6099

Jarvis, L.M.; Ludlam, C.A.; Simmonds, P. 1995: Hepatitis C virus genotypes in multi-transfused individuals. Haemophilia: the Official Journal of the World Federation of Hemophilia 1(Suppl 4): 3-7

Adler, N.R.; Biddle, M.; Beswick, L.; Hair, C.; Allen, B.; Graves, S.; Islam, A.; Watson, J.P. 2013: Hepatitis C virus heterogeneity: lipoprotein and immunoglobulin binding and clinical status. Journal of Clinical and Experimental Hepatology 3(4): 362-363

Miller, F.D. 2016: Hepatitis C virus in Arabian Gulf countries: Implications and priorities. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 46: 115

Watt, G.P.; Vatcheva, K.P.; Beretta, L.; Pan, J.J.; Fallon, M.B.; McCormick, J.B.; Fisher-Hoch, S.P. 2016: Hepatitis C virus in Mexican Americans: a population-based study reveals relatively high prevalence and negative association with diabetes. Epidemiology and Infection 144(2): 297-305

Fabrizi, F.; Dixit, V.; Martin, P.; Messa, P. 2016: Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis. Journal of Medical Virology 88(3): 487-497

Kato, N.; Muroyama, R.; Goto, K. 2015: Hepatitis C virus induced hepatocellular carcinoma associated genes. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(2): 333-338

Fralick, M.; Feld, J.J. 2015: Hepatitis C virus infection. Cmaj: Canadian Medical Association Journal 187(15): 1159

Liu, Y.-B.; Xie, J.-Z.; Zhong, C.-J.; Liu, K. 2014: Hepatitis C virus infection among hemodialysis patients in Asia: a meta-analysis. European Review for Medical and Pharmacological Sciences 18(21): 3174-3182

Varma, S.; Kumar, S.; Garg, A.; Malhotra, P.; Das, A.; Sharma, A.; Chawla, Y.K.; Dhiman, R.K. 2011: Hepatitis C virus infection among patients with chronic immune thrombocytopenic purpura in northern India. Journal of Clinical and Experimental Hepatology 1(2): 68-72

Ba-Essa, E.M.; Mobarak, E.I.; Al-Daghri, N.M. 2016: Hepatitis C virus infection among patients with diabetes mellitus in Dammam, Saudi Arabia. Bmc Health Services Research 16: 313

Kopilović, B.; Poljak, M.; Seme, K.; Klavs, I. 2015: Hepatitis C virus infection among pregnant women in Slovenia: study on 31,849 samples obtained in four screening rounds during 1999, 2003, 2009 and 2013. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 20(22): 21144

Cacoub, P.; Desbois, A.C.; Isnard-Bagnis, C.; Rocatello, D.; Ferri, C. 2016: Hepatitis C virus infection and chronic kidney disease: time for reappraisal. Journal of Hepatology 65(1 Suppl): S82-S94

Zeniya, M. 2015: Hepatitis C virus infection and hemodialysis: update 2014. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(2): 304-311

Fernández-Dávila, P.; Folch, C.; Ferrer, L.; Soriano, R.úl.; Diez, M.; Casabona, J. 2015: Hepatitis C virus infection and its relationship to certain sexual practices in men-who-have-sex-with-men in Spain: results from the European MSM internet survey (EMIS). Enfermedades Infecciosas y Microbiologia Clinica 33(5): 303-310

Tsui, J.I.; Lira, M.C.; Cheng, D.M.; Winter, M.R.; Alford, D.P.; Liebschutz, J.M.; Mao, J.; Edwards, R.R.; Samet, J.H. 2015: Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. Drug and Alcohol Dependence 153: 286-292

Zampino, R.; Coppola, N.; Sagnelli, C.; Di Caprio, G.; Sagnelli, E. 2015: Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment. World Journal of Hepatology 7(21): 2323-2330

Okasha, O.; Munier, A.; Delarocque-Astagneau, E.; El Houssinie, M.; Rafik, M.; Bassim, H.; Hamid, M.Abdel.; Mohamed, M.K.; Fontanet, A. 2015: Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt. Eastern Mediterranean Health Journal 21(3): 199-212

Huang, P.; Zhu, L.G.; Zhai, X.J.; Zhu, Y.F.; Yue, M.; Su, J.; Wang, J.; Yang, H.T.; Zhang, Y.; Shen, H.B.; Peng, Z.H.; Yu, R.B. 2015: Hepatitis C virus infection and risk factors in the general population: a large community-based study in eastern China, 2011-2012. Epidemiology and Infection 143(13): 2827-2836

Le Marchand, C.; Bahia, F.; Page, K.; Brites, C. 2015: Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 19(5): 486-491

Li, H.; Hu, B.; Zhou, Z.-Q.; Guan, J.; Zhang, Z.-Y.; Zhou, G.-W. 2015: Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies. World Journal of Surgical Oncology 13: 161

Pastore, F.; Martocchia, A.; Stefanelli, M.; Prunas, P.; Giordano, S.; Toussan, L.; Devito, A.; Falaschi, P. 2016: Hepatitis C virus infection and thyroid autoimmune disorders: a model of interactions between the host and the environment. World Journal of Hepatology 8(2): 83-91

Boyd, J.T.; Wangensteen, K.J.; Krawitt, E.L.; Hamill, R.W.; Kao, C.-H.; Tsai, H.-H. 2016: Hepatitis C virus infection as a risk factor for Parkinson disease: a nationwide cohort study. Neurology 87(3): 342

Cornberg, M.; Wedemeyer, H. 2016: Hepatitis C virus infection from the perspective of heterologous immunity. Current Opinion in Virology 16: 41-48

Ridruejo, E.; Bessone, F.; Daruich, J.R.; Estes, C.; Gadano, A.án.C.; Razavi, H.; Villamil, F.G.; Silva, M.O. 2016: Hepatitis C virus infection in Argentina: Burden of chronic disease. World Journal of Hepatology 8(15): 649-658

Kao, J.-H. 2016: Hepatitis C virus infection in Taiwan: Past, present, and future. Journal of the Formosan Medical Association 115(2): 65-66

Uruha, A.; Noguchi, S.; Hayashi, Y.K.; Tsuburaya, R.S.; Yonekawa, T.; Nonaka, I.; Nishino, I. 2016: Hepatitis C virus infection in inclusion body myositis: a case-control study. Neurology 86(3): 211-217

Aqel, B.A.; Vargas, H.E. 2015: Hepatitis C virus infection in nonliver solid organ transplant candidates and recipients. Current Opinion in Organ Transplantation 20(3): 259-266

Rou, W.S.; Lee, B.S. 2015: Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?. Clinical and Molecular Hepatology 21(2): 122-124

Al Humayed, S.M.; El-Mekki, A.A.; Mahfouz, A.A. 2017: Hepatitis C virus infection in southwestern Saudi Arabia: Are we still in the plateau phase?. Journal of Medical Virology 89(5): 867-871

De Sanctis, V.; Soliman, A.T.; Candini, G.; Elsedfy, H. 2015: Hepatitis C virus infection in thalassemic patients with and without insulin dependent diabetes. Indian Journal of Endocrinology and Metabolism 19(2): 303-304

Allison, W.E.; Chiang, W.; Rubin, A.; O'Donnell, L.; Saldivar, M.A.; Maurantonio, M.; Dela Cruz, J.; Duvidovich, S.; Carmody, E. 2016: Hepatitis C virus infection in the 1945-1965 birth cohort (baby boomers) in a large urban ED. American journal of emergency medicine 34(4): 697-701

Zhou, M.; Li, H.; Ji, Y.; Ma, Y.; Hou, F.; Yuan, P. 2015: Hepatitis C virus infection in the general population: a large community-based study in Mianyang, West China. Bioscience Trends 9(2): 97-103

Giugliano, S.; Kriss, M.; Golden-Mason, L.; Dobrinskikh, E.; Stone, A.E.L.; Soto-Gutierrez, A.; Mitchell, A.; Khetani, S.R.; Yamane, D.; Stoddard, M.; Li, H.; Shaw, G.M.; Edwards, M.G.; Lemon, S.M.; Gale, M.; Shah, V.H.; Rosen, H.R. 2015: Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication. Gastroenterology 148(2): 392-402.E13

Liu, Y.; Chen, L.; Zou, Z.; Zhu, B.; Hu, Z.; Zeng, P.; Wu, L.; Xiong, J. 2016: Hepatitis C virus infection induces elevation of CXCL10 in human brain microvascular endothelial cells. Journal of Medical Virology 88(9): 1596-1603

Pérez-Vilaró, G.; Fernández-Carrillo, C.; Mensa, L.; Miquel, R.; Sanjuan, X.; Forns, X.; Pérez-del-Pulgar, S.ía.; Díez, J. 2015: Hepatitis C virus infection inhibits P-body granule formation in human livers. Journal of Hepatology 62(4): 785-790

Fletcher, N.F.; Humphreys, E.; Jennings, E.; Osburn, W.; Lissauer, S.; Wilson, G.K.; van IJzendoorn, S.C.D.; Baumert, T.F.; Balfe, P.; Afford, S.; McKeating, J.A. 2015: Hepatitis C virus infection of cholangiocarcinoma cell lines. Journal of General Virology 96(Part 6): 1380-1388

Grigorov, B.; Reungoat, E.; Gentil Dit Maurin, A.; Varbanov, M.; Blaising, J.; Michelet, M.; Manuel, R.; Parent, R.; Bartosch, B.; Zoulim, F.; Ruggiero, F.; Pécheur, E.-I. 2017: Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx. Cellular Microbiology 19(5)

Kim, J.H.; Lee, C.H.; Lee, S.-W. 2016: Hepatitis C virus infection stimulates transforming growth factor-β1 expression through up-regulating miR-192. Journal of Microbiology 54(7): 520-526

Lévy, P.L.; Duponchel, S.; Eischeid, H.; Molle, J.; Michelet, M.; Diserens, G.ël.; Vermathen, M.; Vermathen, P.; Dufour, J.-F.; Dienes, H.-P.; Steffen, H.-M.; Odenthal, M.; Zoulim, F.; Bartosch, B. 2017: Hepatitis C virus infection triggers a tumor-like glutamine metabolism. Hepatology 65(3): 789-803

Hsu, Y.-C.; Wu, C.-Y.; Lin, J.-T. 2015: Hepatitis C virus infection, antiviral therapy, and risk of hepatocellular carcinoma. Seminars in Oncology 42(2): 329-338

Tanaka, J.; Aizaki, H.; Uchida, S. 2015: Hepatitis C virus infection, its burden and countermeasures from the epidemiological point of view. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 89-97

Gondeau, C.; Pageaux, G.P.; Larrey, D. 2015: Hepatitis C virus infection: Are there still specific problems with genotype 3?. World Journal of Gastroenterology 21(42): 12101-12113

Wangensteen, K.J.; Krawitt, E.L.; Hamill, R.W.; Boyd, J.T. 2016: Hepatitis C virus infection: a risk factor for Parkinson's disease. Journal of Viral Hepatitis 23(7): 535

Smyth, D.; Webster, D. 2015: Hepatitis C virus infection: accessing drug treatment. Cmaj: Canadian Medical Association Journal 187(15): 1113-1114

Kwon, Y.-C.; Ray, R.B.; Ray, R. 2014: Hepatitis C virus infection: establishment of chronicity and liver disease progression. Excli Journal 13: 977-996

Lapi, F.; Capogrosso Sansone, A.; Mantarro, S.; Simonetti, M.; Tuccori, M.; Blandizzi, C.; Rossi, A.; Corti, G.; Bartoloni, A.; Bellia, A.; Baiocchi, L.; Cricelli, I.; Cricelli, C. 2017: Hepatitis C virus infection: opportunities for an earlier detection in primary care. European Journal of Gastroenterology and Hepatology 29(3): 271-276

Pears, E. 2011: Hepatitis C virus infection: risk factors, diagnosis and management. Nursing Standard 1987) 25(17): 49-56

Alaizari, N.A.; Al-Maweri, S.A.; Al-Shamiri, H.M.; Tarakji, B.; Shugaa-Addin, B. 2016: Hepatitis C virus infections in oral lichen planus: a systematic review and meta-analysis. Australian Dental Journal 61(3): 282-287

Scull, M.A.; Shi, C.; de Jong, Y.P.; Gerold, G.; Ries, M.; von Schaewen, M.; Donovan, B.M.; Labitt, R.N.; Horwitz, J.A.; Gaska, J.M.; Hrebikova, G.; Xiao, J.W.; Flatley, B.; Fung, C.; Chiriboga, L.; Walker, C.M.; Evans, D.T.; Rice, C.M.; Ploss, A. 2015: Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice. Hepatology 62(1): 57-67

Kubota, N.; Nomoto, M.; Hwang, G.-W.; Watanabe, T.; Kohara, M.; Wakita, T.; Naganuma, A.; Kuge, S. 2016: Hepatitis C virus inhibitor synergism suggests multistep interactions between heat-shock protein 90 and hepatitis C virus replication. World Journal of Hepatology 8(5): 282-290

Mele, D.; Mantovani, S.; Oliviero, B.; Grossi, G.; Ludovisi, S.; Mondelli, M.U.; Varchetta, S. 2017: Hepatitis C virus inhibits CD4 T cell function via binding to Toll-like receptor 7. Antiviral Research 137: 108-111

Popescu, C.-I.; Riva, L.; Vlaicu, O.; Farhat, R.; Rouillé, Y.; Dubuisson, J. 2014: Hepatitis C virus life cycle and lipid metabolism. Biology 3(4): 892-921

Parodi, C.; García, G.; Monzani, M.C.; Culasso, A.; Aloisi, N.; Corti, M.; Campos, R.; de E de Bracco, M.M.; Baré, P. 2015: Hepatitis C virus long-term persistence in peripheral blood mononuclear cells in patients with haemophilia. Detection of occult genotype 1. Journal of Viral Hepatitis 22(7): 607-616

Coppola, N.; Pisaturo, M.; Zampino, R.; Macera, M.; Sagnelli, C.; Sagnelli, E. 2015: Hepatitis C virus markers in infection by hepatitis C virus: in the era of directly acting antivirals. World Journal of Gastroenterology 21(38): 10749-10759

Preciado, M.V.; Valva, P.; Escobar-Gutierrez, A.; Rahal, P.; Ruiz-Tovar, K.; Yamasaki, L.; Vazquez-Chacon, C.; Martinez-Guarneros, A.; Carpio-Pedroza, J.C.; Fonseca-Coronado, S.; Cruz-Rivera, M. 2014: Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy. World Journal of Gastroenterology 20(43): 15992-16013

Aherfi, S.; Glazunova, O.; Borentain, P.; Botta-Fridlund, D.; Chiche, L.; Bregigeon, S.; Motte, A.; Tamalet, C.; Colson, P. 2015: Hepatitis C virus of subtype 2l in Marseille, southeastern France. Intervirology 58(1): 6-13

Senatore, S.; Galli, C.; Conti, A.; Faccini, M.; Cantoni, S.; Ciconali, G.; Mainardi, G.; Lamberti, A.; Dighera, R.; Radice Trolli, F.; Oggioni, C.; Angelini Sironi, L.; Cozzolino, M.; Zanetti, A.R.; Romanò, L. 2016: Hepatitis C virus outbreak in a haemodialysis unit: learning from failures. Journal of Hospital Infection 94(3): 249-252

Lee, G.Y.; Lee, S.; Lee, H.-R.; Yoo, Y.D. 2016: Hepatitis C virus p7 mediates membrane-to-membrane adhesion. Biochimica et Biophysica Acta 1861(9 Part A): 1096-1101

Bankwitz, D.; Pietschmann, T. 2016: Hepatitis C virus plays hide and seek with neutralizing antibodies. Hepatology 64(6): 1840-1842

Ongen, B.; Aksungar, F.B.; Cicek, B.; Akyar, I.; Coskun, A.; Serteser, M.; Unsal, I. 2016: Hepatitis C virus positive patient diagnosed after detection of atypical cryoglobulin. World Journal of Clinical Cases 4(3): 81-87

Bruno, R.; Aghemo, A. 2015: Hepatitis C virus post-exposure prophylaxis: a reasonable option in the era of pangenotypic direct-acting antivirals?. Journal of Hepatology 63(5): 1294

Umer, M.; Iqbal, M. 2016: Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data. World Journal of Gastroenterology 22(4): 1684-1700

Hickman, M.; Martin, N.K.; Huxtable, R. 2017: Hepatitis C virus prevention and treatment prioritization-ethical, economic and evidential dimensions of early rather than delayed treatment for people who inject drugs. Addiction 112(2): 201-203

Wang, Y.; Jiang, Y.; Zhou, J.; Song, W.; Li, J.; Wang, M.; Chen, J.; Xu, R.; Zhang, J.; Ma, F.; Chen, Y.H.; Ma, Y. 2016: Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(11): 15265-15274

Wozniak, A.L.; Long, A.; Jones-Jamtgaard, K.N.; Weinman, S.A. 2016: Hepatitis C virus promotes virion secretion through cleavage of the Rab7 adaptor protein RILP. Proceedings of the National Academy of Sciences of the United States of America 113(44): 12484-12489

Ferns, R.B.; Tarr, A.W.; Hue, S.; Urbanowicz, R.A.; McClure, C.P.; Gilson, R.; Ball, J.K.; Nastouli, E.; Garson, J.A.; Pillay, D. 2016: Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals. Virology 492: 213-224

Gitto, S.; Belli, L.S.; Vukotic, R.; Lorenzini, S.; Airoldi, A.; Cicero, A.F.G.; Vangeli, M.; Brodosi, L.; Panno, A.M.; Di Donato, R.; Cescon, M.; Grazi, G.L.; De Carlis, L.; Pinna, A.D.; Bernardi, M.; Andreone, P. 2015: Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. World Journal of Gastroenterology 21(13): 3912-3920

Pang, X.; Song, H.; Zhang, Q.; Tu, Z.; Niu, J. 2016: Hepatitis C virus regulates the production of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells through PI3K pathway and autocrine signaling. Clinical Immunology 164: 57-64

Herzer, K.; Gerken, G. 2015: Hepatitis C virus reinfection after liver transplant: new chances and new challenges in the era of direct-acting antiviral agents. World Journal of Hepatology 7(3): 532-538

Pineda, J.A.; Núñez-Torres, R.; Téllez, F.; Mancebo, M.ía.; García, F.; Merchante, N.ás.; Pérez-Pérez, M.; Neukam, K.; Macías, J.; Real, L.M. 2015: Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C. Journal of Infection 71(5): 571-577

Grassi, G.; Di Caprio, G.; Fimia, G.M.; Ippolito, G.; Tripodi, M.; Alonzi, T. 2016: Hepatitis C virus relies on lipoproteins for its life cycle. World Journal of Gastroenterology 22(6): 1953-1965

Du, X.; Pan, T.; Xu, J.; Zhang, Y.; Song, W.; Yi, Z.; Yuan, Z. 2016: Hepatitis C virus replicative double-stranded RNA is a potent interferon inducer that triggers interferon production through MDA5. Journal of General Virology 97(11): 2868-2882

Wasilewski, L.N.; Ray, S.C.; Bailey, J.R. 2016: Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles. Journal of General Virology 97(11): 2883-2893

Esposito, I.; Trinks, J.; Soriano, V. 2016: Hepatitis C virus resistance to the new direct-acting antivirals. Expert Opinion on Drug Metabolism and Toxicology 12(10): 1197-1209

Medici, M.C.; Galli, C.; Calderaro, A. 2015: Hepatitis C virus screening to reveal a better picture of infection. Trends in Microbiology 23(6): 324-326

Burchell, A.N.; Gardner, S.L.; Mazzulli, T.; Manno, M.; Raboud, J.; Allen, V.G.; Bayoumi, A.M.; Kaul, R.; McGee, F.; Millson, P.; Remis, R.S.; Wobeser, W.; Cooper, C.; Rourke, S.B. 2015: Hepatitis C virus seroconversion among HIV-positive men who have sex with men with no history of injection drug use: Results from a clinical HIV cohort. Canadian Journal of Infectious Diseases and Medical Microbiology 26(1): 17-22

Riou, J.; Aït Ahmed, M.; Blake, A.; Vozlinsky, S.; Brichler, S.; Eholié, S.; Boëlle, P.-Y.; Fontanet, A.; Thursz, M.; Chevaliez, S.ép.; Girard, P.-M.; Akinbami, A.; Andrieux-Meyer, I.; Berkane, S.; Candotti, D.; Cohn, J.; Diarra, A.; Dirisu, J.; Siawaya, J.; Dore, G.; Erhabor, O.; Fasola, F.; Giuliano, M.; Huraux, J.; Katabira, E.; Laperche, S.; Lefrere, J.; Modupe, T.; Murphy, E.; Niyongabo, T.; Njouom, R.; Nwogoh, B.; Ocama, P.; Ogunro, P.; Opaleye, Y.; Parboosing, R.; Price, M.; Roberts, T.; Seydi, M.; Tayou-Tagny, C.; Traore, H.; Zohoun, C. 2016: Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis. Journal of Viral Hepatitis 23(4): 244-255

Cortina-Borja, M.; Williams, D.; Peckham, C.S.; Bailey, H.; Thorne, C. 2016: Hepatitis C virus seroprevalence in pregnant women delivering live-born infants in North Thames, England in 2012. Epidemiology and Infection 144(3): 627-634

Quesada, P.; Whitby, D.; Benavente, Y.; Miley, W.; Labo, N.; Chichareon, S.; Trong, N.; Shin, H.-R.; Anh, P.T.H.; Thomas, J.; Matos, E.; Herrero, R.; Muñoz, N.; Molano, M.; Franceschi, S.; de Sanjosé, S. 2015: Hepatitis C virus seroprevalence in the general female population from 8 countries. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 68: 89-93

Quarleri, J.F.án.; Oubiña, J.é R.úl. 2016: Hepatitis C virus strategies to evade the specific-T cell response: a possible mission favoring its persistence. Annals of Hepatology 15(1): 17-26

Ramachandran, A.; Lebofsky, M.; Yan, H.-M.; Weinman, S.A.; Jaeschke, H. 2015: Hepatitis C virus structural proteins can exacerbate or ameliorate acetaminophen-induced liver injury in mice. Archives of Toxicology 89(5): 773-783

Vallianou, I.; Dafou, D.; Vassilaki, N.; Mavromara, P.; Hadzopoulou-Cladaras, M. 2016: Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma. International Journal of Biochemistry and Cell Biology 78: 315-326

Ferri, C.; Sebastiani, M.; Giuggioli, D.; Colaci, M.; Fallahi, P.; Piluso, A.; Antonelli, A.; Zignego, A.L. 2015: Hepatitis C virus syndrome: a constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer. World Journal of Hepatology 7(3): 327-343

Dore, G.J.; Feld, J.J. 2015: Hepatitis C virus therapeutic development: in pursuit of "perfectovir". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 60(12): 1829-1836

Hlaing, N.K.T.; Banerjee, D.; Mitrani, R.; Arker, S.H.; Win, K.S.; Tun, N.L.; Thant, Z.; Win, K.M.; Reddy, K.R. 2016: Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: a resource-constrained country. World Journal of Gastroenterology 22(43): 9613-9622

Salazar-Vizcaya, L.; Kouyos, R.D.; Zahnd, C.; Wandeler, G.; Battegay, M.; Darling, K.E.A.; Bernasconi, E.; Calmy, A.; Vernazza, P.; Furrer, H.; Egger, M.; Keiser, O.; Rauch, A. 2016: Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions. Hepatology 64(6): 1856-1869

Calles, D.L.; Collier, M.G.; Khudyakov, Y.; Mixson-Hayden, T.; VanderBusch, L.; Weninger, S.; Miller, T.K. 2017: Hepatitis C virus transmission in a skilled nursing facility, North Dakota, 2013. American Journal of Infection Control 45(2): 126-132

Karkar, A. 2011: Hepatitis C virus transmission through sharing hemodialysis machines. Ndt Plus 4(3): 218-219

de Vos, A.S.; Prins, M.; Kretzschmar, M.E.E. 2015: Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?. Addiction 110(6): 975-983

Hickman, M.; De Angelis, D.; Vickerman, P.; Hutchinson, S.; Martin, N.Kaleta. 2015: Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence. Current Opinion in Infectious Diseases 28(6): 576-582

Deborah Friedman, N.; Green, J.H.; Weber, H.M.; Stephen, S.; Lane, S.E.; Ting, A.Y.; Watson, J.P. 2014: Hepatitis C virus treatment in the 'real-world': how well do 'real' patients respond?. Journal of Clinical and Experimental Hepatology 4(3): 214-220

Zoulim, F.; Liang, T.J.; Gerbes, A.L.; Aghemo, A.; Deuffic-Burban, S.; Dusheiko, G.; Fried, M.W.; Pol, S.; Rockstroh, J.ür.K.; Terrault, N.A.; Wiktor, S. 2015: Hepatitis C virus treatment in the real world: optimising treatment and access to therapies. Gut 64(11): 1824-1833

Ujino, S.; Nishitsuji, H.; Hishiki, T.; Sugiyama, K.; Takaku, H.; Shimotohno, K. 2016: Hepatitis C virus utilizes VLDLR as a novel entry pathway. Proceedings of the National Academy of Sciences of the United States of America 113(1): 188-193

Fauvelle, C.; Colpitts, C.C.; Keck, Z-Yong.; Pierce, B.G.; Foung, S.K.H.; Baumert, T.F. 2016: Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies. Expert Review of Vaccines 15(12): 1535-1544

Welsch, C.; Haselow, K.; Gouttenoire, J.ér.ôm.; Schneider, M.; Morikawa, K.; Martinez, Y.; Susser, S.; Sarrazin, C.; Zeuzem, S.; Antes, I.; Moradpour, D.; Lange, C.M. 2015: Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage. Journal of Hepatology 62(4): 779-784

Trémeaux, P.; Caporossi, A.; Thélu, M-Ange.; Blum, M.; Leroy, V.; Morand, P.; Larrat, S. 2016: Hepatitis C virus whole genome sequencing: Current methods/issues and future challenges. Critical Reviews in Clinical Laboratory Sciences 53(5): 341-351

Kardashian, A.A.; Price, J.C. 2015: Hepatitis C virus-HIV-coinfected patients and liver transplantation. Current Opinion in Organ Transplantation 20(3): 276-285

Vannata, B.; Zucca, E. 2014: Hepatitis C virus-associated B-cell non-Hodgkin lymphomas. HEMATOLOGY. American Society of Hematology. Education Program 1: 590-598

Russi, S.; Sansonno, L.; Sansonno, D. 2017: Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges. Current Drug Targets 18(7): 766-771

Vannata, B.; Arcaini, L.; Zucca, E. 2016: Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?. Therapeutic Advances in Hematology 7(2): 94-107

Monaco, S.; Mariotto, S.; Ferrari, S.; Calabrese, M.; Zanusso, G.; Gajofatto, A.; Sansonno, D.; Dammacco, F. 2015: Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015. World Journal of Gastroenterology 21(42): 11974-11983

Spear, T.T.; Riley, T.P.; Lyons, G.E.; Callender, G.G.; Roszkowski, J.J.; Wang, Y.; Simms, P.E.; Scurti, G.M.; Foley, K.C.; Murray, D.C.; Hellman, L.M.; McMahan, R.H.; Iwashima, M.; Garrett-Mayer, E.; Rosen, H.R.; Baker, B.M.; Nishimura, M.I. 2016: Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability. Journal of Leukocyte Biology 100(3): 545-557

Shoji, I.; Deng, L.; Matsui, C.; Hotta, H. 2015: Hepatitis C virus-induced glucose metabolic disorder. Uirusu 65(2): 263-268

Goossens, N.; Hoshida, Y. 2015: Hepatitis C virus-induced hepatocellular carcinoma. Clinical and Molecular Hepatology 21(2): 105-114

Ren, J.P.; Zhao, J.; Dai, J.; Griffin, J.W.D.; Wang, L.; Wu, X.Y.; Morrison, Z.D.; Li, G.Y.; El Gazzar, M.; Ning, S.B.; Moorman, J.P.; Yao, Z.Q. 2016: Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway. Immunology 148(4): 377-386

Li, G.Y.; Zhou, Y.; Ying, R.S.; Shi, L.; Cheng, Y.Q.; Ren, J.P.; Griffin, J.W.D.; Jia, Z.S.; Li, C.F.; Moorman, J.P.; Yao, Z.Q. 2015: Hepatitis C virus-induced reduction in miR-181a impairs CD4(+) T-cell responses through overexpression of DUSP6. Hepatology 61(4): 1163-1173

Madejón, A.; Sheldon, J.; Francisco-Recuero, I.; Perales, C.; Domínguez-Beato, M.; Lasa, M.; Sánchez-Perez, I.; Muntané, J.; Domingo, E.; García-Samaniego, J.; Sánchez-Pacheco, A. 2015: Hepatitis C virus-mediated Aurora B kinase inhibition modulates inflammatory pathway and viral infectivity. Journal of Hepatology 63(2): 312-319

Mukherjee, A.; Di Bisceglie, A.M.; Ray, R.B. 2015: Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway. Journal of Virology 89(6): 3356-3365

Wu, Z.; Huo, N.; Li, J.; Wang, Y.; Wan, H.; Lin, X.H.; Zhao, H. 2016: Hepatitis C virus-related mixed cryoglobulinemia vasculitis: a report of one case. Zhonghua Gan Zang Bing Za Zhi 24(7): 539-540

Zhao, L-J.; Chen, F.; Li, J-G.; Yin, R.; Zhang, X-H.; Huang, S-M.; Liu, F. 2015: Hepatitis C virus-related mixed cryoglobulinemic endocapillary proliferative glomerulonephritis and B-cell non-Hodgkin lymphoma: a case report and literature review. European Review for Medical and Pharmacological Sciences 19(16): 3050-3055

Larrubia, J.-R.ón.; Moreno-Cubero, E.; Miquel, J.ín.; Sanz-de-Villalobos, E. 2015: Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control. World Journal of Gastroenterology 21(12): 3480-3491

Castro, E.; Roger, E. 2016: Hepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugs. World Journal of Virology 5(2): 68-72

Mohamed, A.A.; Elbedewy, T.A.; El-Serafy, M.; El-Toukhy, N.; Ahmed, W.; Ali El Din, Z. 2015: Hepatitis C virus: a global view. World Journal of Hepatology 7(26): 2676-2680

Attar, B.M.; Van Thiel, D.H. 2016: Hepatitis C virus: a time for decisions. who should be treated and when?. World Journal of Gastrointestinal Pharmacology and Therapeutics 7(1): 33-40

Barth, H. 2015: Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade. World Journal of Hepatology 7(5): 725-737

Bastos, J.Cristina.Santiago.; Padilla, M.Aiello.; Caserta, L.Cardia.; Miotto, N.; Vigani, A.Gonzalez.; Arns, C.Weis. 2016: Hepatitis C virus: Promising discoveries and new treatments. World Journal of Gastroenterology 22(28): 6393-6401

Li, H.-C.; Lo, S.-Y. 2015: Hepatitis C virus: Virology, diagnosis and treatment. World Journal of Hepatology 7(10): 1377-1389

Nelson, D.R.; Peter, J. 2016: Hepatitis C virus: how to provide the best treatment with what i have. Liver International: Official Journal of the International Association for the Study of the Liver 36(Suppl 1): 58-61

Barać, I.; Prlić, N.; Lovrić, R.; Kanisek, S.; Nemet, L.D.; Plužarić, J. 2018: Development and Psychometric Testing of the Croatian Version of the Job Satisfaction Scale in Hospital Nurses. Journal of Nursing Measurement 26(1): 121-133

Walker, C.M.; Grakoui, A. 2015: Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?. Current Opinion in Immunology 35: 137-143

Plissonnier, M.-L.; Lahlali, T.; Mehlen, P.; Parent, R. 2016: Hepatitis C, EGFR, cirrhosis and netrin-1: potential implications for HCC onset. Medecine Sciences: M/S 32(6-7): 566-568

Arnold, C. 2015: Hepatitis C, birth cohort screening. Revue Medicale Suisse 11(479): 1364-1365

Arshad, M.; Wei, F.; Nelsen, D.A. 2015: Hepatitis C, disease and its management: a cost-effectiveness analysis of the new generation oral protease inhibitors. Antiviral Therapy 20(8): 827-833

Osna, N.A.; Ganesan, M.; Kharbanda, K.K. 2015: Hepatitis C, innate immunity and alcohol: friends or foes?. Biomolecules 5(1): 76-94

Wang, L.S.; D'Souza, L.S.; Jacobson, I.M. 2016: Hepatitis C-A clinical review. Journal of Medical Virology 88(11): 1844-1855

Krajewska, M.; Rukasz, D.; Jakuszko, K.; Augustyniak-Bartosik, H.; Penar, J.; Bednarz, Z.; Klinger, M. 2015: Hepatitis C-associated glomerulonephritis mimicking systemic lupus erythematosus. Scandinavian Journal of Rheumatology 44(4): 343-344

Serraino, C.; Melchio, R.; Silvestri, A.; Borretta, V.; Pomero, F.; Fenoglio, L. 2015: Hepatitis C-associated osteosclerosis: a new case with long-term follow-up and a review of the literature. Internal Medicine 54(7): 777-783

Lim, E.J.; Chin, R.; Nachbur, U.; Silke, J.; Jia, Z.; Angus, P.W.; Torresi, J. 2016: Hepatitis C-induced hepatocyte apoptosis following liver transplantation is enhanced by immunosuppressive agents. Journal of Viral Hepatitis 23(9): 730-743

Conde, I.; Vinaixa, C.; Berenguer, M. 2017: Hepatitis C-related cirrhosis. Current status. Medicina Clinica 148(2): 78-85

Keoshkerian, E.; Hunter, M.; Cameron, B.; Nguyen, N.; Sugden, P.; Bull, R.; Zekry, A.; Maher, L.; Seddiki, N.; Zaunders, J.; Kelleher, A.; Lloyd, A.R.; Dolan, K.; Haber, P.; Rawlinson, W.; Treloar, C.; Dore, G.; Luciani, F. 2016: Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection. Journal of Viral Hepatitis 23(12): 985-993

Moradpour, D.; Frossard, J-L. 2015: Hepatitis C: 25 years of progress with still major challenges. Revue medicale suisse 11(484): 1579-1580

Dan, Y.Y.; Lim, S.G. 2015: Hepatitis C: An Eastern Perspective. Gastroenterology Clinics of North America 44(4): 793-805

Wangensteen, L.; Wangensteen, K.J.; Evans, S.G.; Everts, L.E.; Trooskin, S.B. 2015: Hepatitis C: how to fine-tune your approach. Journal of Family Practice 64(9): 535-540

Lee, C.K.; Jonas, M.M. 2015: Hepatitis C: Issues in Children. Gastroenterology Clinics of North America 44(4): 901-909

Filipec Kanizaj, T.; Kunac, N. 2015: Hepatitis C: new challenges in liver transplantation. World Journal of Gastroenterology 21(19): 5768-5777

Mendes-Oliveira, F.; Bolina-Santos, E.; Salomon, T.; Miranda, C.; Cioffi, Júnia.; Sabino, E.; Barbosa-Stancioli, E.; Moreno, E.; Carneiro-Proietti, A.Bárbara. 2015: Hepatitis C: Prevalence of serologic markers and risk factors in blood donors at a large blood centre in South-eastern Brazil (2007-2010). Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis 53(2): 238-241

Hilgenfeldt, E.G.; Schlachterman, A.; Firpi, R.J. 2015: Hepatitis C: Treatment of difficult to treat patients. World Journal of Hepatology 7(15): 1953-1963

Reddy, K.Rajender. 2015: Hepatitis C: Unfolding the Challenges. Gastroenterology Clinics of North America 44(4): xv-xvi

Wandeler, G.; Dufour, J.-F.ço.; Bruggmann, P.; Rauch, A. 2015: Hepatitis C: a changing epidemic. Swiss Medical Weekly 145: W14093

Vijayan, T.; Klausner, J.D. 2016: Hepatitis C: challenges and opportunities in the laboratory diagnosis of infection. Mlo: Medical Laboratory Observer 48(3): 16; 18

The Lancet 2015: Hepatitis C: cost of lost opportunities. Lancet 386(10007): 1917

Moradpour, D.; Müllhaupt, B. 2015: Hepatitis C: current therapy. Revue Medicale Suisse 11(471): 902-906

Hunyady, Béla.; Gerlei, Z.; Gervain, J.; Horváth, Gábor.; Lengyel, G.; Pár, A.; Rókusz, László.; Szalay, F.; Telegdy, László.; Tornai, Ián.; Werling, Kára.; Makara, Mály. 2015: Hepatitis C: diagnosis, anti-viral therapy, after-care. Hungarian consensus guideline. Orvosi Hetilap 156(9): 343-351

Nau, J.-Y. 2016: Hepatitis C: epidemiology and vaccination perspectives (1). Revue Medicale Suisse 12(502): 156-157

Moradpour, D.; Müllhaupt, B. 2015: Hepatitis C: epidemiology natural course and diagnosis. Revue Medicale Suisse 11(471): 896-901

Fan, Y.; Zhang, S.; Li, Y.; Li, Y.; Zhang, T.; Liu, W.; Jiang, H. 2018: Development and psychometric testing of the Knowledge, Attitudes and Practices (KAP) questionnaire among student Tuberculosis (TB) Patients (STBP-KAPQ) in China. Bmc Infectious Diseases 18(1): 213

Anonymous 2016: Hepatitis C: global ambition, national realities. Lancet 387(10032): 1970

Lanini, S.; Easterbrook, P.J.; Zumla, A.; Ippolito, G. 2016: Hepatitis C: global epidemiology and strategies for control. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 22(10): 833-838

Mouterde, A-Laure.; Bocquet, Fçois.; Fusier, I.; Paubel, P. 2016: Hepatitis C: how has France limited the expenses related to new treatments?. Expert Review of Pharmacoeconomics and Outcomes Research 16(6): 655-657

Shahnazarian, V.; Karu, E.; Mehta, P. 2015: Hepatitis C: improving the quality of screening in a community hospital by implementing an electronic medical record intervention. Bmj Quality Improvement Reports 4(1)

Nau, J.-Y. 2015: Hepatitis C: in 2015, who should be screened first?. Revue Medicale Suisse 11(470): 888-889

Morad, M.; Merrick, J. 2016: Hepatitis C: is it still around?. International Journal of Adolescent Medicine and Health 28(2): 125-126

Major, M.E. 2016: Hepatitis C: new clues to better vaccines?. Gut 65(1): 4-5

Coleman, M.P.; Allemani, C. 2015: Cancer: the elephant in the room. Lancet 385(9973): 1047-1048

Müllhaupt, B.; Moradpour, D. 2015: Hepatitis C: patient information. Revue Medicale Suisse 11(471): 907-908

Zuercher, C. 2015: Hepatitis C: reimbursement extension. Revue Medicale Suisse 11(482): 1510

Piroth, L.; Rabaud, C.; Rey, D.; Schmit, J.-L.; Chirouze, C.; Beck-Wirth, G.èv.; Robineau, O.; Bani-Sadr, F. 2016: Hepatitis C: the path towards effective universal therapy. Lancet 388(10049): 1051-1052

Mhalla, S.; Kadri, Y.; Alibi, S.; Letaief, A.; Boukadida, J.; Hannachi, N. 2016: Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Carriers and in "Isolated anti-HBc" Antibodies Profile in Central Tunisia. Hepatitis Monthly 16(1): E32354

He, W.; Ren, B.; Mao, F.; Jing, Z.; Li, Y.; Liu, Y.; Peng, B.; Yan, H.; Qi, Y.; Sun, Y.; Guo, J.-T.; Sui, J.; Wang, F.; Li, W. 2015: Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide. Plos Pathogens 11(4): E1004840

Taylor, J.M. 2015: Hepatitis D Virus Replication. Cold Spring Harbor Perspectives in Medicine 5(11)

Ahn, J.; Gish, R.G. 2014: Hepatitis D Virus: a Call to Screening. Gastroenterology and Hepatology 10(10): 647-686

Rizzetto, M. 2015: Hepatitis D Virus: Introduction and Epidemiology. Cold Spring Harbor perspectives in medicine 5(7): a021576

Abbas, Z.; Abbas, M.; Abbas, S.; Shazi, L. 2015: Hepatitis D and hepatocellular carcinoma. World Journal of Hepatology 7(5): 777-786

Xue, M.M.; Glenn, J.S.; Leung, D.H. 2015: Hepatitis D in Children. Journal of Pediatric Gastroenterology and Nutrition 61(3): 271-281

Imazeki, F. 2015: Hepatitis D in the past, present and future. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 604-608

Di Filippo Villa, D.; Cortes-Mancera, F.; Payares, E.; Montes, N.; de la Hoz, F.; Arbelaez, M.P.; Correa, G.; Navas, M.-C. 2015: Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia. Virology Journal 12: 172

Jelen, M.M.; Hošnjak, L.; Štunf, Špela.; Zagožen, A.; Fujs Komloš, K.; Markočič, P.; Poljak, M.; Seme, K. 2016: Hepatitis D virus infection in Slovenian patients with chronic hepatitis B virus infection: a national prevalence study and literature review. Acta Dermatovenerologica Alpina Pannonica et Adriatica 25(3): 49-53

Hsieh, M.-H.; Wang, S.-C.; Hsieh, M.-Y.; Huang, C.-F.; Yeh, M.-L.; Yang, J.-F.; Chang, K.; Lin, W.-R.; Lin, C.-Y.; Chen, T.-C.; Huang, J.-F.; Dai, C.-Y.; Tsai, J.-J.; Chuang, W.-L.; Yu, M.-L. 2016: Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan. Kaohsiung Journal of Medical Sciences 32(10): 526-530

Weller, M.L.; Gardener, M.R.; Bogus, Z.C.; Smith, M.A.; Astorri, E.; Michael, D.G.; Michael, D.A.; Zheng, C.; Burbelo, P.D.; Lai, Z.; Wilson, P.A.; Swaim, W.; Handelman, B.; Afione, S.A.; Bombardieri, M.; Chiorini, J.A. 2016: Hepatitis Delta Virus Detected in Salivary Glands of Sjögren's Syndrome Patients and Recapitulates a Sjögren's Syndrome-Like Phenotype in Vivo. Pathogens and Immunity 1(1): 12-40

Gheorghe, L.; Csiki, I.E.; Iacob, S.; Gheorghe, C.; Trifan, A.; Grigorescu, M.; Motoc, A.; Suceveanu, A.; Curescu, M.; Caruntu, F.; Sporea, I.; Brisc, C.; Rogoveanu, I.; Cerban, R.; Tugui, L.; Alexandrescu, A. 2015: Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors. Journal of Gastrointestinal and Liver Diseases: Jgld 24(4): 413-421

Giersch, K.; Allweiss, L.; Volz, T.; Helbig, M.; Bierwolf, J.; Lohse, A.W.; Pollok, J.M.; Petersen, J.; Dandri, M.; Lütgehetmann, M. 2015: Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. Journal of Hepatology 63(2): 346-353

Petrik, J.; Lozano, M.; Seed, C.R.; Faddy, H.M.; Keller, A.J.; Prado Scuracchio, P.S.; Wendel, S.; Andonov, A.; Fearon, M.; Delage, G.; Zhang, J.; Shih, J.W.K.; Gallian, P.; Djoudi, R.; Tiberghien, P.; Izopet, J.; Dreier, J.; Vollmer, T.; Knabbe, C.; Aggarwal, R.; Goel, A.; Ciccaglione, A.R.; Matsubayashi, K.; Satake, M.; Tadokoro, K.; Jeong, S.-H.; Zaaijer, H.L.; Zhiburt, E.; Chay, J.; Teo, D.; Chua, S.S.; Piron, M.; Sauleda, S.; Echevarría, J.é-M.; Dalton, H.; Stramer, S.L. 2016: Hepatitis e. Vox Sanguinis 110(1): 93-130

Brantsæter, A.B. 2016: Hepatitis e - a neglected disease in Norway. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 136(19): 1604

Khaskheli, M.Nissa.; Baloch, S.; Sheeba, A.; Baloch, S. 2015: Hepatitis E -- A preventable health issue -- endangering pregnant women's life and foetal outcomes. Jpma. Journal of the Pakistan Medical Association 65(6): 655-659

Pischke, S.; Wedemeyer, H. 2015: Hepatitis e in Transplant Recipients: Why Is this not a Problem in Japan?. Ebiomedicine 2(11): 1564-1565

Lhomme, Sébastien.; Marion, O.; Abravanel, F.; Chapuy-Regaud, S.; Kamar, N.; Izopet, J. 2016: Hepatitis E Pathogenesis. Viruses 8(8)

Hartl, J.; Otto, B.; Madden, R.G.; Webb, G.; Woolson, K.L.; Kriston, L.; Vettorazzi, E.; Lohse, A.W.; Dalton, H.R.; Pischke, S. 2016: Hepatitis e Seroprevalence in Europe: a Meta-Analysis. Viruses 8(8)

Pauli, G.; Aepfelbacher, M.; Bauerfeind, U.; Blümel, J.; Burger, R.; Gärtner, B.; Gröner, A.; Gürtler, L.; Heiden, M.; Hildebrandt, M.; Jansen, B.; Offergeld, R.; Schlenkrich, U.; Schottstedt, V.; Seitz, R.; Strobel, J.; Willkommen, H.; Baylis, S.A. 2015: Hepatitis E Virus. Transfusion Medicine and Hemotherapy: Offizielles Organ der Deutschen Gesellschaft für Transfusionsmedizin und Immunhamatologie 42(4): 247-265

Wang, Y.; Zhao, C.; Qi, Y.; Geng, Y. 2016: Hepatitis E Virus. Advances in Experimental Medicine and Biology 948: 1-16

La Rosa, G.; Della Libera, S.; Brambilla, M.; Bisaglia, C.; Pisani, G.; Ciccaglione, A.R.; Bruni, R.; Taffon, S.; Equestre, M.; Iaconelli, M. 2017: Hepatitis e Virus (Genotype 3) in Slurry Samples from Swine Farming Activities in Italy. Food and Environmental Virology 9(2): 219-229

Van de Garde, M.D.B.; Pas, S.D.; van der Net, G.; de Man, R.A.; Osterhaus, A.D.M.E.; Haagmans, B.L.; Boonstra, A.; Vanwolleghem, T. 2016: Hepatitis e Virus (HEV) Genotype 3 Infection of Human Liver Chimeric Mice as a Model for Chronic HEV Infection. Journal of Virology 90(9): 4394-4401

Behrendt, P.; Bremer, B.; Todt, D.; Brown, R.J.P.; Heim, A.; Manns, M.P.; Steinmann, E.; Wedemeyer, H. 2016: Hepatitis e Virus (HEV) ORF2 Antigen Levels Differentiate Between Acute and Chronic HEV Infection. Journal of Infectious Diseases 214(3): 361-368

Kantala, T.; Kinnunen, P.M.; Oristo, S.; Jokelainen, P.; Vapalahti, O.; Maunula, L. 2017: Hepatitis e Virus Antibodies in Finnish Veterinarians. Zoonoses and Public Health 64(3): 232-238

Montesano, C.; Giovanetti, M.; Ciotti, M.; Cella, E.; Lo Presti, A.; Grifoni, A.; Zehender, G.; Angeletti, S.; Ciccozzi, M. 2016: Hepatitis e Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis. Hepatitis Monthly 16(3): E31951

Samala, N.; Wright, E.C.; Buckler, A.Gretchen.; Vargas, V.; Shetty, K.; Reddy, K.Rajender.; Lucey, M.R.; Alter, H.J.; Hoofnagle, J.H.; Ghany, M.G. 2016: Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis C. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 14(6): 896-902

Traoré, K.A.; Ouoba, J.B.; Huot, N.; Rogée, S.; Dumarest, M.; Traoré, A.S.; Pavio, N.; Barro, N.; Roques, P. 2015: Hepatitis e Virus Exposure is Increased in Pork Butchers from Burkina Faso. American Journal of Tropical Medicine and Hygiene 93(6): 1356-1359

Rendon, J.; Hoyos, M.C.; di Filippo, D.; Cortes-Mancera, F.; Mantilla, C.; Velasquez, M.M.; Sepulveda, M.E.; Restrepo, J.C.; Jaramillo, S.; Arbelaez, M.P.; Correa, G.; Navas, M.-C. 2016: Hepatitis e Virus Genotype 3 in Colombia: Survey in Patients with Clinical Diagnosis of Viral Hepatitis. Plos one 11(2): E0148417

Ram, D.; Manor, Y.; Gozlan, Y.; Schwartz, E.; Ben-Ari, Z.; Mendelson, E.; Mor, O. 2016: Hepatitis e Virus Genotype 3 in Sewage and Genotype 1 in Acute Hepatitis Cases, Israel. American Journal of Tropical Medicine and Hygiene 95(1): 216-220

Shayanpour, S.; Hayati, F. 2016: Hepatitis e Virus Infection Among Chronic Hemodialysis. Jundishapur Journal of Microbiology 9(3): E26645

Sue, P.K.; Pisanic, N.; Heaney, C.D.; Forman, M.; Valsamakis, A.; Jackson, A.M.; Ticehurst, J.R.; Montgomery, R.A.; Schwarz, K.B.; Nelson, K.E.; Karnsakul, W. 2016: Hepatitis E Virus Infection Among Solid Organ Transplant Recipients at a North American Transplant Center. Open forum infectious diseases 3(1): ofw 006

Péron, J.-M. 2016: Hepatitis e Virus Infection and Cirrhosis of the Liver. Gastroenterology and Hepatology 12(9): 565-567

Manka, P.; Bechmann, L.P.; Coombes, J.D.; Thodou, V.; Schlattjan, M.; Kahraman, A.; Syn, W.-K.; Saner, F.; Gerken, G.; Baba, H.; Verheyen, J.; Timm, J.ör.; Canbay, A. 2015: Hepatitis e Virus Infection as a Possible Cause of Acute Liver Failure in Europe. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 13(10): 1836-1842.E2; Quiz E157-158

Rasche, A.; Saqib, M.; Liljander, A.M.; Bornstein, S.; Zohaib, A.; Renneker, S.; Steinhagen, K.; Wernery, R.; Younan, M.; Gluecks, I.; Hilali, M.; Musa, B.E.; Jores, J.; Wernery, U.; Drexler, J.Felix.; Drosten, C.; Corman, V.Max. 2016: Hepatitis E Virus Infection in Dromedaries, North and East Africa, United Arab Emirates, and Pakistan, 1983-2015. Emerging infectious diseases 22(7): 1249-1252

Van Tong, H.; Hoan, N.X.; Wang, B.; Wedemeyer, H.; Bock, C.-T.; Velavan, T.P. 2016: Hepatitis e Virus Mutations: Functional and Clinical Relevance. Ebiomedicine 11: 31-42

Traoré, K.A.; Ouoba, J.B.; Rouamba, H.; Nébié, Y.K.; Dahourou, H.; Rossetto, F.éd.ér.; Traoré, A.S.; Barro, N.; Roques, P. 2016: Hepatitis e Virus Prevalence among Blood Donors, Ouagadougou, Burkina Faso. Emerging Infectious Diseases 22(4): 755-757

Qi, Y.; Zhang, F.; Zhang, L.; Harrison, T.J.; Huang, W.; Zhao, C.; Kong, W.; Jiang, C.; Wang, Y. 2015: Hepatitis e Virus Produced from Cell Culture Has a Lipid Envelope. Plos one 10(7): E0132503

Naeimi, B.; Mazloom Kalimani, F.; Pourfatolah, A.A.; Azimzadeh, M.; Mankhian, A.; Akbarzadeh, S.; Hajiani, G.; Kooshesh, F.; Khamisipour, G. 2015: Hepatitis e Virus Seroprevalence Among Blood Donors in Bushehr, South of Iran. Hepatitis Monthly 15(11): E29219

Pischke, S.; Schwarze-Zander, C.; Bremer, B.; Lehmann, P.; Wiegand, S.B.; Gisa, A.; Behrendt, P.; Strassburg, C.P.; Manns, M.P.; Wedemeyer, H.; Rockstroh, J.ür.K. 2015: Hepatitis e Virus Seroprevalence Rate in HIV-Infected Patients in Germany: a Comparison of two Commercial Assays. Intervirology 58(5): 283-287

Weger, S.; Elkin, B.; Lindsay, R.; Bollinger, T.; Crichton, V.; Andonov, A. 2017: Hepatitis e Virus Seroprevalence in Free-Ranging Deer in Canada. Transboundary and Emerging Diseases 64(3): 1008-1011

Hoan, N.X.; Tong, H.V.; Hecht, N.; Sy, B.T.; Marcinek, P.; Meyer, C.G.; Song, L.H.; Toan, N.L.; Kurreck, J.; Kremsner, P.G.; Bock, C.-T.; Velavan, T.P. 2015: Hepatitis e Virus Superinfection and Clinical Progression in Hepatitis B Patients. Ebiomedicine 2(12): 2080-2086

Tyler, K.L.; Pastula, D.M. 2017: Hepatitis e Virus and Guillain-Barré Syndrome. JAMA Neurology 74(1): 13-15

Thiry, D.; Mauroy, A.; Pavio, N.; Purdy, M.A.; Rose, N.; Thiry, E.; de Oliveira-Filho, E.F. 2017: Hepatitis e Virus and Related Viruses in Animals. Transboundary and Emerging Diseases 64(1): 37-52

Wang, L.; Zhang, Y.; Gong, W.; Song, W.Tianshi.; Wang, L. 2016: Hepatitis E Virus in 3 Types of Laboratory Animals, China, 2012-2015. Emerging infectious diseases 22(12): 2157-2159

Yamada, H.; Takahashi, K.; Lim, O.; Svay, S.; Chuon, C.; Hok, S.; Do, S.H.; Fujimoto, M.; Akita, T.; Goto, N.; Katayama, K.; Arai, M.; Tanaka, J. 2015: Hepatitis e Virus in Cambodia: Prevalence among the General Population and Complete Genome Sequence of Genotype 4. Plos one 10(8): E0136903

Ivanova, A.; Tefanova, V.; Reshetnjak, I.; Kuznetsova, T.; Geller, J.; Lundkvist, Åk.; Janson, M.; Neare, K.äd.; Velström, K.; Jokelainen, P.; Lassen, B.; Hütt, P.; Saar, T.; Viltrop, A.; Golovljova, I. 2015: Hepatitis e Virus in Domestic Pigs, Wild Boars, Pig Farm Workers, and Hunters in Estonia. Food and Environmental Virology 7(4): 403-412

Burt, S.A.; Veltman, J.; Hakze-van der Honing, R.; Schmitt, H.; van der Poel, W.H.M. 2016: Hepatitis e Virus in Farmed Rabbits, Wild Rabbits and Petting Farm Rabbits in the Netherlands. Food and Environmental Virology 8(3): 227-229

Intharasongkroh, D.; Sa-Nguanmoo, P.; Tuanthap, S.; Thongmee, T.; Duang-In, A.; Klinfueng, S.; Chansaenroj, J.; Vongpunsawad, S.; Theamboonlers, A.; Payungporn, S.; Chirathaworn, C.; Poovorawan, Y. 2017: Hepatitis e Virus in Pork and Variety Meats Sold in Fresh Markets. Food and Environmental Virology 9(1): 45-53

Heldt, F.H.; Staggmeier, R.; Gularte, J.S.; Demoliner, M.; Henzel, A.; Spilki, F.R. 2016: Hepatitis e Virus in Surface Water, Sediments, and Pork Products Marketed in Southern Brazil. Food and Environmental Virology 8(3): 200-205

Dorn-In, S.; Schwaiger, K.; Twarużek, M.; Grajewski, J.; Gottschalk, C.; Gareis, M. 2017: Hepatitis e Virus in Wild Boar in Northwest Poland: Sensitivity of Methods of Detection. Foodborne Pathogens and Disease 14(2): 103-108

Yan, B.; Zhang, L.; Gong, L.; Lv, J.; Feng, Y.; Liu, J.; Song, L.; Xu, Q.; Jiang, M.; Xu, A. 2016: Hepatitis e Virus in Yellow Cattle, Shandong, Eastern China. Emerging Infectious Diseases 22(12): 2211-2212

Colson, P.; Saint-Jacques, P.; Ferretti, A.; Davoust, B. 2015: Hepatitis e Virus of Subtype 3a in a Pig Farm, South-Eastern France. Zoonoses and Public Health 62(8): 593-598

Guinault, D.; Ribes, D.; Delas, A.; Milongo, D.; Abravanel, F.; Puissant-Lubrano, B.én.éd.; Izopet, J.; Kamar, N. 2016: Hepatitis e Virus-Induced Cryoglobulinemic Glomerulonephritis in a Nonimmunocompromised Person. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 67(4): 660-663

Caruso, C.; Peletto, S.; Rosamilia, A.; Modesto, P.; Chiavacci, L.; Sona, B.; Balsamelli, F.; Ghisetti, V.; Acutis, P.L.; Pezzoni, G.; Brocchi, E.; Vitale, N.; Masoero, L. 2017: Hepatitis E Virus: A Cross-Sectional Serological and Virological Study in Pigs and Humans at Zoonotic Risk within a High-Density Pig Farming Area. Transboundary and Emerging Diseases 64(5): 1443-1453

Caruso, C.; Modesto, P.; Prato, R.; Scaglione, F.E.; De Marco, L.; Bollo, E.; Acutis, P.L.; Masoero, L.; Peletto, S. 2015: Hepatitis e Virus: first Description in a Pet House Rabbit. a new Transmission Route for Human?. Transboundary and Emerging Diseases 62(3): 229-232

Dalton, H.R.; Webb, G.W.; Norton, B.C.; Woolson, K.L. 2016: Hepatitis E Virus: Time to Change the Textbooks. Digestive Diseases 34(4): 308-316

Kumar, A.; Saraswat, V.A. 2013: Hepatitis e and Acute-on-Chronic Liver Failure. Journal of Clinical and Experimental Hepatology 3(3): 225-230

Dartevel, Aïs.; Colombe, B.; Bosseray, A.; Larrat, S.; Sarrot-Reynauld, Fçoise.; Belbezier, A.; Lagrange, E.; Bouillet, L. 2015: Hepatitis E and neuralgic amyotrophy: Five cases and review of literature. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 69: 156-164

Widén, F. 2016: Hepatitis e as a Zoonosis. Advances in Experimental Medicine and Biology 948: 61-71

Gerbi, G.B.; Williams, R.; Bakamutumaho, B.; Liu, S.; Downing, R.; Drobeniuc, J.; Kamili, S.; Xu, F.; Holmberg, S.D.; Teshale, E.H. 2015: Hepatitis E as a cause of acute jaundice syndrome in northern Uganda, 2010-2012. American journal of tropical medicine and hygiene 92(2): 411-414

Shrestha, A.; Lama, T.K.; Karki, S.; Sigdel, D.R.; Rai, U.; Rauniyar, S.K.; Al-Mahtab, M.; Takahashi, K.; Arai, M.; Akbar, S.M.F.; Mishiro, S. 2015: Hepatitis e epidemic, Biratnagar, Nepal, 2014. Emerging Infectious Diseases 21(4): 711-713

Fischler, Börn.; Baumann, U.; Dezsofi, A.; Hadzic, N.; Hierro, L.; Jahnel, Jörg.; McLin, Vérie.; Nobili, V.; Smets, F.; Verkade, H.; Debray, D. 2016: Hepatitis E in Children: A Position Paper by the ESPGHAN Hepatology Committee. Journal of pediatric gastroenterology and nutrition 63(2): 288-294

Le Guern, A.; Eftekhari-Hassanlouie, S.; Lastere, S.; Beaugendre, E.; Oehler, E. 2015: Hepatitis e in French Polynesia. Medecine et Maladies Infectieuses 45(7): 301-302

Erez-Granat, O.; Lachish, T.; Daudi, N.; Shouval, D.; Schwartz, E. 2016: Hepatitis E in Israel: A nation-wide retrospective study. World Journal of Gastroenterology 22(24): 5568-5577

Lange, H.; Øverbø, J.; Borgen, K.; Dudman, S.; Hoddevik, G.; Urdahl, A.M.; Vold, L.; Sjurseth, S.K. 2017: Hepatitis e in Norway: seroprevalence in humans and swine. Epidemiology and Infection 145(1): 181-186

Araújo, F.; Koch, M.C.; Monteiro, F.; Araújo, A.R.; Cunha-Ribeiro, L.M. 1997: Hepatitis e in Portuguese haemophiliacs and blood donors. Haemophilia: the Official Journal of the World Federation of Hemophilia 3(3): 219-220

Bradley-Stewart, A.J.; Jesudason, N.; Michie, K.; Winter, A.J.; Gunson, R.N. 2015: Hepatitis e in Scotland: assessment of HEV infection in two high-risk patient groups with elevated liver enzymes. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 63: 36-37

Marion, O.; Abravanel, F.; Lhomme, S.; Izopet, J.; Kamar, N. 2016: Hepatitis e in Transplantation. Current Infectious Disease Reports 18(3): 8

Appuhamy, R.; Moffatt, C.; Davis, S.; Kelly, P.; Kennedy, K. 2014: Hepatitis E in a food handler--a rapid risk assessment to guide the public health response. Western Pacific Surveillance and Response Journal: Wpsar 5(4): 1-4

Tarantino, G.; Bagnarelli, P.; Marzioni, M.; Marinelli, K.; Surace, G.; Traini, S.; Baroni, G.S.; Menzo, S.; Benedetti, A. 2016: Hepatitis e in a region of Italy: An emerging autochthonous infection?. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 48(11): 1340-1345

Vollmer, T.; Diekmann, J.; Eberhardt, M.; Knabbe, C.; Dreier, J. 2016: Hepatitis e in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 21(35)

Renou, C.; Lesgourgues, B.; Macaigne, G.; Pauwels, A.; Le Bricquir, Y.; Henrion, J.; Khemissa, F.; Clair, E.; Paupard, T.; Pelaquier, A.; Agostini, H.él.èn.; Roque-Afonso, A.-M. 2017: Hepatitis e in decompensated alcoholic cirrhosis. Hepatology 65(1): 388-389

Dalton, H.R.; Kamar, N.; Izopet, J. 2014: Hepatitis e in developed countries: current status and future perspectives. Future Microbiology 9(12): 1361-1372

Scotto, G.; Aucella, F.; Grandaliano, G.; Martinelli, D.; Querques, M.; Gesuete, A.; Infante, B.; Carri, P.D.; Massa, S.; Salatino, G.; Bulla, F.; Fazio, V. 2015: Hepatitis e in hemodialysis and kidney transplant patients in south-east Italy. World Journal of Gastroenterology 21(11): 3266-3273

Borg, B.B.; Feng, Z.; Earl, T.M.; Anderson, C.D. 2016: Hepatitis e in post-liver transplantation: is it time to routinely consider it?. Clinical Transplantation 30(9): 975-979

Chaudhry, S.A.; Verma, N.; Koren, G. 2015: Hepatitis e infection during pregnancy. Canadian Family Physician Medecin de Famille Canadien 61(7): 607-608

Rudler, M.; Thibault, V.; Mouri, S.; Akhavan, S.; Mallet, M.; Charlotte, F.éd.ér.; Poynard, T.; Thabut, D. 2015: Hepatitis e infection in patients with severe alcoholic hepatitis: is there a place for systematic screening?. European Journal of Gastroenterology and Hepatology 27(12): 1367-1371

Benito, R.; Bueno, J.; Cebollada, Río.; Algarate, S. 2016: Hepatitis E infections in Zaragoza, Spain (2011-2015). Medicina clinica 146(11): 513-514

Pischke, S.; Iking-Konert, C. 2015: Hepatitis e infections in rheumatology. a previously underestimated infectious disease?. Zeitschrift für Rheumatologie 74(8): 731-736

Cui, W.; Sun, Y.; Xu, A.; Gao, R.; Gong, L.; Zhang, L.; Jiang, M. 2016: Hepatitis E seroprevalence and related risk factors among seafood processing workers: a cross-sectional survey in Shandong Province, China. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 49: 62-66

Senosiain, C.; González-Tallón A, A.; López-Sanromán, A.; Mateos, M.L.; Pérez-Gracia, M.T.; García-Sánchez, M.C.ón.; Maroto, M.; Garrido, E. 2016: Hepatitis e seroprevalence in inflammatory bowel disease. Gastroenterologia y Hepatologia 39(3): 185-190

Zhang, Y.; Zeng, H.; Liu, P.; Liu, L.; Xia, J.; Wang, L.; Zou, Q.; Wang, L.; Zhuang, H. 2015: Hepatitis E vaccine immunization for rabbits to prevent animal HEV infection and zoonotic transmission. Vaccine 33(38): 4922-4928

Koppolu, S.; Chitnis, P.V.; Mamou, J.; Allen, J.S.; Ketterling, J.A. 2015: Correlation of rupture dynamics to the nonlinear backscatter response from polymer-shelled ultrasound contrast agents. IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control 62(3): 494-501

Anonymous 2016: Hepatitis E vaccine: WHO position paper, May 2015--Recommendations. Vaccine 34(3): 304-305

Baylis, S.A.; Corman, V.M.; Ong, E.; Linnen, J.M.; Nübling, C.M.; Blümel, J. 2016: Hepatitis e viral loads in plasma pools for fractionation. Transfusion 56(10): 2532-2537

Izopet, J.; Lhomme, S.éb.; Abravanel, F.; Roque, A.-M.; Kamar, N. 2015: Hepatitis e virus. Presse Medicale 44(3): 328-332

Chen, D.; Chen, S.; Hao, S.; Ling, Y.; Wu, T.; Wang, X.; Yao, H.; Niu, J. 2016: Hepatitis e virus (HEV) infection analysis of patients with maintenance haemodialysis. Zhonghua Yu Fang Yi Xue Za Zhi 50(3): 277-279

Chatterjee, S.N.; Devhare, P.B.; Pingle, S.Y.; Paingankar, M.S.; Arankalle, V.A.; Lole, K.S. 2016: Hepatitis e virus (HEV)-1 harbouring HEV-4 non-structural protein (ORF1) replicates in transfected porcine kidney cells. Journal of General Virology 97(8): 1829-1840

Ojha, N.K.; Lole, K.S. 2016: Hepatitis e virus ORF1 encoded macro domain protein interacts with light chain subunit of human ferritin and inhibits its secretion. Molecular and Cellular Biochemistry 417(1-2): 75-85

Ojha, N.K.; Lole, K.S. 2016: Hepatitis e virus ORF1 encoded non structural protein-host protein interaction network. Virus Research 213: 195-204

Shrestha, A.C.; Flower, R.L.P.; Seed, C.R.; Keller, A.J.; Harley, R.; Chan, H.-T.; Hoad, V.; Warrilow, D.; Northill, J.; Holmberg, J.A.; Faddy, H.M. 2016: Hepatitis e virus RNA in Australian blood donations. Transfusion 56(12): 3086-3093

Mahilkar, S.; Paingankar, M.S.; Lole, K.S. 2016: Hepatitis e virus RNA-dependent RNA polymerase: RNA template specificities, recruitment and synthesis. Journal of General Virology 97(9): 2231-2242

Gentry-Shields, J.; Myers, K.; Pisanic, N.; Heaney, C.; Stewart, J. 2015: Hepatitis e virus and coliphages in waters proximal to swine concentrated animal feeding operations. Science of the Total Environment 505: 487-493

Sotoodeh Jahromi, A.; Pourahmad, M. 2013: Hepatitis e virus and serum level aminotransferases in blood donors. Reports of Biochemistry and Molecular Biology 2(1): 48-51

Farcet, M.R.; Lackner, C.; Antoine, G.; Rabel, P.O.; Wieser, A.; Flicker, A.; Unger, U.; Modrof, J.; Kreil, T.R. 2016: Hepatitis e virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processes. Transfusion 56(2): 383-391

Schielke, A.; Ibrahim, V.; Czogiel, I.; Faber, M.; Schrader, C.; Dremsek, P.; Ulrich, R.G.; Johne, R. 2015: Hepatitis E virus antibody prevalence in hunters from a district in Central Germany, 2013: a cross-sectional study providing evidence for the benefit of protective gloves during disembowelling of wild boars. Bmc Infectious Diseases 15: 440

Nouhin, J.; Prak, S.; Madec, Y.; Barennes, H.; Weissel, R.; Hok, K.; Pavio, N.; Rouet, F.ço. 2016: Hepatitis e virus antibody prevalence, RNA frequency, and genotype among blood donors in Cambodia (Southeast Asia). Transfusion 56(10): 2597-2601

Tholen, A.T.R.; Schinkel, J.; Molenkamp, R.; Ang, C.W. 2016: Hepatitis e virus as a Cause of Acute Hepatitis in the Netherlands. Plos one 11(2): E0146906

Park, W.-J.; Park, B.-J.; Ahn, H.-S.; Lee, J.-B.; Park, S.-Y.; Song, C.-S.; Lee, S.-W.; Yoo, H.-S.; Choi, I.-S. 2016: Hepatitis e virus as an emerging zoonotic pathogen. Journal of Veterinary Science 17(1): 1-11

Salines, M.; Barnaud, E.; Andraud, M.; Eono, F.; Renson, P.; Bourry, O.; Pavio, N.; Rose, N. 2015: Hepatitis e virus chronic infection of swine co-infected with Porcine Reproductive and Respiratory Syndrome Virus. Veterinary Research 46: 55

Scotto, G.; Grisorio, B.; Filippini, P.; Ferrara, S.; Massa, S.; Bulla, F.; Martini, S.; Filippini, A.; Tartaglia, A.; Lo Muzio, L.; Fazio, V. 2015: Hepatitis e virus co-infection in HIV-infected patients in Foggia and Naples in southern Italy. Infectious Diseases 47(10): 707-713

Yunoki, M.; Tanaka, H.; Takahashi, K.; Urayama, T.; Hattori, S.; Ideno, S.; Furuki, R.; Sakai, K.; Hagiwara, K.; Ikuta, K. 2016: Hepatitis e virus derived from different sources exhibits different behaviour in virus inactivation and/or removal studies with plasma derivatives. Biologicals: Journal of the International Association of Biological Standardization 44(5): 403-411

Holla, P.; Ahmad, I.; Ahmed, Z.; Jameel, S. 2015: Hepatitis e virus enters liver cells through a dynamin-2, clathrin and membrane cholesterol-dependent pathway. Traffic 16(4): 398-416

Vina-Rodriguez, A.; Schlosser, J.; Becher, D.; Kaden, V.; Groschup, M.H.; Eiden, M. 2015: Hepatitis e virus genotype 3 diversity: phylogenetic analysis and presence of subtype 3b in wild boar in Europe. Viruses 7(5): 2704-2726

Mesquita, J.ão.R.; Oliveira, D.; Rivadulla, E.; Abreu-Silva, J.; Varela, M.F.; Romalde, J.ús.L.; Nascimento, M.S.J. 2016: Hepatitis e virus genotype 3 in mussels (Mytilus galloprovinciallis), Spain. Food Microbiology 58: 13-15

Nijskens, C.M.; Pas, S.D.; Cornelissen, J.; Caliskan, K.; Hoek, R.A.S.; Hesselink, D.A.; van der Eijk, A.A.; de Man, R.A. 2016: Hepatitis e virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 74: 82-87

Colson, P.; Brunet, P.; Lano, G.; Moal, V.ér. 2016: Hepatitis e virus genotype 4 in Southeastern France: still around. Liver International: Official Journal of the International Association for the Study of the Liver 36(5): 765-767

Sayed, I.M.; Vercouter, A.-S.; Meuleman, P. 2016: Hepatitis e virus in acute liver failure: An unusual suspect?. Hepatology 64(6): 1837-1839

Dalton, H.R.; Saunders, M.; Woolson, K.L. 2015: Hepatitis e virus in developed countries: one of the most successful zoonotic viral diseases in human history?. Journal of Virus Eradication 1(1): 23-29

Minagi, T.; Okamoto, H.; Ikegawa, M.; Ideno, S.; Takahashi, K.; Sakai, K.; Hagiwara, K.; Yunoki, M.; Wakisaka, A. 2016: Hepatitis e virus in donor plasma collected in Japan. Vox Sanguinis 111(3): 242-246

Frange, P.; Roque-Afonso, A.-M.; Neven, B.én.éd.; Moshous, D.; Touzot, F.; Cavazzana, M.; Fischer, A.; Leruez-Ville, M.; Blanche, S.ép. 2015: Hepatitis e virus in hematopoietic stem cell donors: Towards a systematic HEV screening of donors?. Journal of Infection 71(1): 141-144

Blasco-Perrin, H.; Madden, R.G.; Stanley, A.; Crossan, C.; Hunter, J.G.; Vine, L.; Lane, K.; Devooght-Johnson, N.; Mclaughlin, C.; Petrik, J.; Stableforth, B.; Hussaini, H.; Phillips, M.; Mansuy, J.M.; Forrest, E.; Izopet, J.; Blatchford, O.; Scobie, L.; Peron, J.M.; Dalton, H.R. 2015: Hepatitis e virus in patients with decompensated chronic liver disease: a prospective UK/French study. Alimentary Pharmacology and Therapeutics 42(5): 574-581

Yazbek, S.; Kreidieh, K.; Ramia, S. 2016: Hepatitis e virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety. Infection 44(1): 11-22

Kantala, T.; Heinonen, M.; Oristo, S.; von Bonsdorff, C.-H.; Maunula, L. 2015: Hepatitis e virus in young pigs in Finland and characterization of the isolated partial genomic sequences of genotype 3 HEV. Foodborne Pathogens and Disease 12(3): 253-260

Huang, F.; Yang, C.; Yu, W.; Bi, Y.; Long, F.; Wang, J.; Li, Y.; Jing, S. 2016: Hepatitis e virus infection activates signal regulator protein α to down-regulate type i interferon. Immunologic Research 64(1): 115-122

Schreuder, I.; Limper, M.; Gerstenbluth, I.; Osterhaus, A.D.M.E.; van Veen, M.G.; Scherbeijn, S.M.J.; van Gorp, E.C.M.; Duits, A.J. 2016: Hepatitis e virus infection among blood donors in the South Caribbean: is screening warranted?. Netherlands Journal of Medicine 74(1): 51-53

Shimakawa, Y.; Njai, H.F.; Takahashi, K.; Berg, L.; Ndow, G.; Jeng-Barry, A.; Ceesay, A.; Tamba, S.; Opoku, E.; Taal, M.; Akbar, S.M.F.; Arai, M.; D'Alessandro, U.; Taylor-Robinson, S.D.; Njie, R.; Mishiro, S.; Thursz, M.R.; Lemoine, M. 2016: Hepatitis e virus infection and acute-on-chronic liver failure in West Africa: a case-control study from the Gambia. Alimentary Pharmacology and Therapeutics 43(3): 375-384

Silva, M.; Wicki, B.ît.; Tsouni, P.; Cunningham, S.; Doerig, C.; Zanetti, G.; Aubert, V.; Sahli, R.; Moradpour, D.; Kuntzer, T. 2016: Hepatitis e virus infection as a direct cause of neuralgic amyotrophy. Muscle and Nerve 54(2): 325-327

Pischke, S.; Hartl, J.; Pas, S.D.; Lohse, A.W.; Jacobs, B.C.; Van der Eijk, A.A. 2017: Hepatitis e virus: Infection beyond the liver?. Journal of Hepatology 66(5): 1082-1095

Passos-Castilho, A.M.; de Sena, A.; Reinaldo, M.ôn.R.; Granato, C.F.H. 2015: Hepatitis e virus infection in Brazil: results of laboratory-based surveillance from 1998 to 2013. Revista da Sociedade Brasileira de Medicina Tropical 48(4): 468-470

Pisano, M.ía.B.én.; Balderramo, D.; Wassaf, M.M.ín.; Lotto, M.ín.; Carlino, Y.; Ré, V.E.; Debes, J.é D. 2017: Hepatitis e virus infection in patients on dialysis and in solid organ transplant recipients in Argentina: exploring associated risk factors. Archives of Virology 162(3): 787-792

Freitas, N.R.d.; Santana, E.B.R.d.; Silva, Ág.M.d.C.E.; Silva, S.M.d.; Teles, S.A.új.; Gardinali, N.R.; Pinto, M.A.; Martins, R.M.B. 2016: Hepatitis e virus infection in patients with acute non-A, non-B, non-C hepatitis in Central Brazil. Memorias do Instituto Oswaldo Cruz 111(11): 692-696

Peláez, D.; Hoyos, M.ía.C.; Rendón, J.C.és.; Mantilla, C.; Ospina, M.C.; Cortés-Mancera, F.án.; Pérez, O.L.ía.; Contreras, L.; Estepa, Y.; Arbeláez, M.ía.P.; Navas, M.ía.C. 2014: Hepatitis e virus infection in patients with clinical diagnosis of viral hepatitis in Colombia. Biomedica: Revista del Instituto Nacional de Salud 34(3): 354-365

Debes, J.D.; Pisano, M.B.; Lotto, M.; Re, V. 2016: Hepatitis e virus infection in the HIV-positive patient. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 80: 102-106

O'Riordan, J.; Boland, F.; Williams, P.; Donnellan, J.; Hogema, B.M.; Ijaz, S.; Murphy, W.G. 2016: Hepatitis e virus infection in the Irish blood donor population. Transfusion 56(11): 2868-2876

Aggarwal, A.; Perumpail, R.B.; Tummala, S.; Ahmed, A. 2016: Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management. World Journal of Hepatology 8(2): 117-122

Bennett, S.; Li, K.; Gunson, R.N. 2015: Hepatitis e virus infection presenting with paraesthesia. Scottish Medical Journal 60(2): E27-E29

Łapiński, T.W.; Jaroszewicz, J. 2016: Hepatitis e virus infection--a new threat for Europe. Przeglad Epidemiologiczny 70(1): 11-14; 103-106

Andersson, M.I.; Stead, P.A.; Maponga, T.; van der Plas, H.; Preiser, W. 2015: Hepatitis e virus infection: An underdiagnosed infection in transplant patients in Southern Africa?. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 70: 23-25

Lee, G.Y.; Poovorawan, K.; Intharasongkroh, D.; Sa-Nguanmoo, P.; Vongpunsawad, S.; Chirathaworn, C.; Poovorawan, Y. 2015: Hepatitis e virus infection: Epidemiology and treatment implications. World Journal of Virology 4(4): 343-355

De Schryver, A.; De Schrijver, K.; François, G.; Hambach, R.; van Sprundel, M.; Tabibi, R.; Colosio, C. 2015: Hepatitis e virus infection: an emerging occupational risk?. Occupational Medicine 65(8): 667-672

Patel, R.C.; Kamili, S.; Teshale, E. 2015: Hepatitis e virus infections in children age 0-15, Uganda outbreak, 2007. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 73: 112-114

Shrestha, A.C.; Flower, R.L.P.; Seed, C.R.; Keller, A.J.; Hoad, V.; Harley, R.; Leader, R.; Polkinghorne, B.; Furlong, C.; Faddy, H.M. 2017: Hepatitis e virus infections in travellers: assessing the threat to the Australian blood supply. Blood Transfusion 15(3): 191-198

Kokki, I.; Smith, D.; Simmonds, P.; Ramalingam, S.; Wellington, L.; Willocks, L.; Johannessen, I.; Harvala, H. 2016: Hepatitis e virus is the leading cause of acute viral hepatitis in Lothian, Scotland. New Microbes and new Infections 10: 6-12

Debing, Y.; Ramière, C.; Dallmeier, K.; Piorkowski, G.ér.; Trabaud, M.-A.; Lebossé, F.; Scholtès, C.; Roche, M.; Legras-Lachuer, C.; de Lamballerie, X.; André, P.; Neyts, J. 2016: Hepatitis e virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity. Journal of Hepatology 65(3): 499-508

Shrestha, A.; Lama, T.K.; Gupta, B.P.; Sapkota, B.; Adhikari, A.; Khadka, S.; Shrestha, S.M.; Maharjan, K.G.; Karmacharya, P.; Akbar, S.M.F. 2016: Hepatitis e virus outbreak in postearthquake Nepal: is a vaccine really needed?. Journal of Viral Hepatitis 23(6): 492

Shrestha, A.C.; Flower, R.L.P.; Seed, C.R.; Rajkarnikar, M.; Shrestha, S.K.; Thapa, U.; Hoad, V.C.; Faddy, H.M. 2016: Hepatitis e virus seroepidemiology: a post-earthquake study among blood donors in Nepal. Bmc Infectious Diseases 16(1): 707

Kang, Y.-H.; Cong, W.; Zhang, X.-Y.; Wang, C.-F.; Shan, X.-F.; Qian, A.-D. 2017: Hepatitis e virus seroprevalence among farmers, veterinarians and control subjects in Jilin province, Shandong province and Inner Mongolia Autonomous Region, China. Journal of Medical Virology 89(5): 872-877

Passos-Castilho, A.M.; de Sena, A.; Domingues, A.L.C.; Lopes-Neto, E.P.; Medeiros, T.ér.B.; Granato, C.F.H.; Ferraz, M.L.úc. 2016: Hepatitis e virus seroprevalence among schistosomiasis patients in Northeastern Brazil. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 20(3): 262-266

Joulaei, H.; Rudgari, O.; Motazedian, N.; Gorji-Makhsous, S. 2015: Hepatitis e virus seroprevalence in HIV positive individuals in Shiraz, Southern Iran. Iranian Journal of Microbiology 7(2): 103-108

Gu, G.; Huang, H.; Zhang, L.; Bi, Y.; Hu, Y.; Zhou, Y.-H. 2015: Hepatitis e virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years. Bmc Infectious Diseases 15: 560

Izopet, J.; Labrique, A.B.; Basnyat, B.; Dalton, H.R.; Kmush, B.; Heaney, C.D.; Nelson, K.E.; Ahmed, Z.B.; Zaman, K.; Mansuy, J.-M.; Bendall, R.; Sauné, K.; Kamar, N.; Arjyal, A.; Karkey, A.; Dongol, S.; Prajapati, K.G.; Adhikary, D. 2015: Hepatitis e virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 70: 39-42

Covarrubías, N.; Hurtado, C.; Díaz, A.; Mezzano, G.; Brahm, J.; Venegas, M. 2015: Hepatitis e virus seroprevalence: a reappraisal. Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de Infectologia 32(4): 482-484

Unzueta, A.; Valdez, R.; Chang, Y.-H.H.; Desmarteau, Y.M.; Heilman, R.L.; Scott, R.L.; Douglas, D.D.; Rakela, J. 2016: Hepatitis e virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation. Annals of Hepatology 15(1): 33-40

Zylberman, M.; Turdó, K.; Odzak, A.; Arcondo, F.; Altabert, N.; Munné, S. 2015: Hepatitis E virus-associated aplastic anemia. Report of a case. Medicina 75(3): 175-177

Fierro, N.A.; Realpe, M.; Meraz-Medina, T.; Roman, S.; Panduro, A. 2016: Hepatitis E virus: An ancient hidden enemy in Latin America. World Journal of Gastroenterology 22(7): 2271-2283

Adlhoch, C.; Avellon, A.; Baylis, S.A.; Ciccaglione, A.R.; Couturier, E.; de Sousa, R.; Epštein, J.; Ethelberg, S.; Faber, M.; Fehér, Ág.; Ijaz, S.; Lange, H.; Manďáková, Z.; Mellou, K.; Mozalevskis, A.; Rimhanen-Finne, R.; Rizzi, V.; Said, B.ü; Sundqvist, L.; Thornton, L.; Tosti, M.E.; van Pelt, W.; Aspinall, E.; Domanovic, D.; Severi, E.; Takkinen, J.; Dalton, H.R. 2016: Hepatitis e virus: Assessment of the epidemiological situation in humans in Europe, 2014/15. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 82: 9-16

Wu, X.; Chen, P.; Lin, H.; Hao, X.; Liang, Z. 2016: Hepatitis E virus: Current epidemiology and vaccine. Human Vaccines and Immunotherapeutics 12(10): 2603-2610

Dalton, H.R.; Seghatchian, J. 2016: Hepatitis e virus: Emerging from the shadows in developed countries. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 55(3): 271-274

Madden, R.G.; Wallace, S.; Sonderup, M.; Korsman, S.; Chivese, T.; Gavine, B.; Edem, A.; Govender, R.; English, N.; Kaiyamo, C.; Lutchman, O.; van der Eijk, A.A.; Pas, S.D.; Webb, G.W.; Palmer, J.; Goddard, E.; Wasserman, S.; Dalton, H.R.; Spearman, C.W. 2016: Hepatitis e virus: Western Cape, South Africa. World Journal of Gastroenterology 22(44): 9853-9859

Shrestha, A.C.; Faddy, H.M.; Flower, R.L.P.; Seed, C.R.; Keller, A.J. 2015: Hepatitis e virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history?. Pathology 47(2): 97-100

Anonymous 2015: Hepatitis E virus: opinions of the Working Group of the Federal Ministry of Health Blood. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 58(2): 198-218

Stramer, S.L.; Moritz, E.D.; Foster, G.A.; Ong, E.; Linnen, J.M.; Hogema, B.M.; Mak, M.; Chia, C.P.; Dodd, R.Y. 2016: Hepatitis e virus: seroprevalence and frequency of viral RNA detection among US blood donors. Transfusion 56(2): 481-488

Blasco-Perrin, H.él.èn.; Abravanel, F.; Blasco-Baque, V.; Péron, J.M. 2016: Hepatitis E, the neglected one. Liver International: Official Journal of the International Association for the Study of the Liver 36(Suppl 1): 130-134

Mihalčin, M.; Polák, P.; Husa, P. 2015: Hepatitis E--overview of the latest knowledge. Epidemiologie Mikrobiologie Imunologie: Casopis Spolecnosti Pro Epidemiologii a Mikrobiologii Ceske Lekarske Spolecnosti J.E. Purkyne 64(2): 72-78

Mengel, A.M.; Stenzel, W.; Meisel, A.; Büning, C. 2016: Hepatitis E-induced severe myositis. Muscle and Nerve 53(2): 317-320

Sridhar, S.; Lau, S.K.P.; Woo, P.C.Y. 2015: Hepatitis E: a disease of reemerging importance. Journal of the Formosan Medical Association 114(8): 681-690

De Keukeleire, S.; Reynders, M. 2015: Hepatitis E: An Underdiagnosed, Emerging Infection in Nonendemic Regions. Journal of Clinical and Translational Hepatology 3(4): 288-291

Khuroo, M.S.; Khuroo, M.S.; Khuroo, N.S. 2016: Hepatitis E: Discovery, global impact, control and cure. World Journal of Gastroenterology 22(31): 7030-7045

Spengler, E.K.; Fontana, R.J. 2015: Hepatitis E: Emerging Pathogen or Domestic Bystander?. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 13(10): 1843-1845

Shrivastava, P.Saurabh.; Shrivastava, S.Ram.Bihari.Lal.; Ramasamy, J.; Zaidi, S.Hasan.Nawaz. 2014: Hepatitis E: Risk and Prevention. International Journal of Preventive Medicine 5(Suppl. 3): S231-S232

Khuroo, M.S.; Khuroo, M.S. 2016: Hepatitis E: an emerging global disease - from discovery towards control and cure. Journal of Viral Hepatitis 23(2): 68-79

Pérez-Gracia, M.T.; Suay-García, B.; García, M.; Mateos-Lindemann, M.L. 2016: Hepatitis E: latest developments in knowledge. Future Microbiology 11: 789-808

Nelson, K.E.; Heaney, C.D.; Labrique, A.B.; Kmush, B.L.; Krain, L.J. 2016: Hepatitis E: prevention and treatment. Current Opinion in Infectious Diseases 29(5): 478-485

Mueller, N.J.; Tini, G.M.; Weber, A.; Gaspert, A.; Husmann, L.; Bloemberg, G.; Boehler, A.; Benden, C. 2015: Hepatitis from Spiroplasma sp. in an Immunocompromised Patient. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15(9): 2511-2516

Praharaj, A.K.; Kalghatgi, A.T.; Nagendra, A. 2006: Hepatitis G Virus Infection in Healthy Individuals, Acute Viral Hepatitis and Persons at Risk for Parenteral Transmission. Medical Journal Armed Forces India 62(4): 321-324

Praharaj, A.K.; Tripathy, S.; Kalghatgi, A.K.; Nagendra, A. 2005: Hepatitis G Virus: Prevalence in Blood Donors in Armed Forces. Medical Journal Armed Forces India 61(4): 333-335

Salehi, M.; Kalbasi, N.; Salehi, H.; Kassaian, N.; Salehi, M.; Khorvash, F.; Salehi, M.M. 2014: Hepatitis G virus exposure in dialysis patients and blood donors in Isfahan-Iran. International Journal of Preventive Medicine 5(Suppl 3): S219-S222

Takayama, S.; Miura, T.; Taki, M. 1997: Hepatitis G virus infection in Japanese haemophiliacs. Haemophilia: the Official Journal of the World Federation of Hemophilia 3(4): 283-287

Chang, J.H.; Wei, L.; Du, S.C.; Wang, H.; Sun, Y.; Tao, Q.M. 1997: Hepatitis G virus infection in patients with chronic non-A-E hepatitis. World Journal of Gastroenterology 3(3): 143-146

Rezaee-Zavareh, M.Saeid.; Sa'adat, S.Hassan.; Alavian, S.Moayed. 2016: Hepatitis Monthly, an International Journal in the Field of Hepatology. Hepatitis Monthly 16(3): E37015

Ogholikhan, S.; Schwarz, K.B. 2016: Hepatitis Vaccines. Vaccines 4(1)

Anonymous 2016: Hepatitis Viral. Journal of Gastroenterology and Hepatology 31 Suppl. 2: 65-88

Yugo, D.M.; Hauck, R.; Shivaprasad, H.L.; Meng, X.-J. 2016: Hepatitis Virus Infections in Poultry. Avian Diseases 60(3): 576-588

Bahri, F.; Kargar Kheirabad, A.; Ghasemzadeh, I.; Shoja, S.; Gouklani, H. 2016: Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes. Hepatitis Monthly 16(1): E32971

Gajurel, K.; Stapleton, J.T. 2016: Hepatitis Viruses in Kidney Transplantation. Seminars in Nephrology 36(5): 386-396

Teisen, E.; Vainer, B.; Ytting, H. 2016: Hepatitis after chewing of khat leaves. Ugeskrift for Laeger 178(20)

Danis, K.; Doherty, L.; McCartney, M.; McCarrol, J.; Kennedy, H. 2007: Hepatitis and HIV in Northern Ireland prisons: a cross-sectional study. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 12(1)

Chan, K.; Al-Roubaie, J.; El Sheikh, S.; Mumtaz, F. 2016: Hepatitis and Solitary Left Renal Mass: Renal Hepatocellular Carcinoma. Urology 96: 114-115

Beeson, P.B. 1995: Hepatitis as a complication of blood transfusion. Haemophilia: the Official Journal of the World Federation of Hemophilia 1(1): 70-73

Kim, K.W.; Sung, J.J.; Tchah, H.; Ryoo, E.; Cho, H.K.; Sun, Y.H.; Cho, K.H.; Son, D.W.; Jeon, I.S.; Kim, Y.M. 2015: Hepatitis associated with Mycoplasma pneumoniae infection in Korean children: a prospective study. Korean Journal of Pediatrics 58(6): 211-217

Kong, Y.; Ye, F.; Jin, Y.; Shi, J.; Qiu, H.; Lin, S. 2016: Hepatitis b virus expression and replication in ovum and the influencing factors. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 22(3): 215-219

Abdo, A.A. 2016: Hepatitis c eradication: It's now or never…let's get to work. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 22(4): 249-250

Shier, M.K.; El-Wetidy, M.S.; Ali, H.H.; Al-Qattan, M.M. 2016: Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 22(3): 240-248

Stroffolini, T.; Sagnelli, E.; Sagnelli, C.; Russello, M.; De Luca, M.; Rosina, F.; Cacopardo, B.; Brancaccio, G.; Furlan, C.; Gaeta, G.B.; Licata, A.; Almasio, P.L. 2017: Hepatitis delta infection in Italian patients: towards the end of the story?. Infection 45(3): 277-281

Shirvani-Dastgerdi, E.; Pourkarim, M.R.; Herbers, U.; Amini-Bavil-Olyaee, S.; Yagmur, E.; Alavian, S.M.; Trautwein, C.; Tacke, F. 2016: Hepatitis delta virus facilitates the selection of hepatitis B virus mutants in vivo and functionally impacts on their replicative capacity in vitro. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 22(1): 98.e1-98.e6

El Bouzidi, K.; Elamin, W.; Kranzer, K.; Irish, D.N.; Ferns, B.; Kennedy, P.; Rosenberg, W.; Dusheiko, G.; Sabin, C.A.; Smith, B.C.; Nastouli, E. 2015: Hepatitis delta virus testing, epidemiology and management: a multicentre cross-sectional study of patients in London. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 66: 33-37

Cunha, C.; Tavanez, J.ão.P.; Gudima, S. 2015: Hepatitis delta virus: a fascinating and neglected pathogen. World Journal of Virology 4(4): 313-322

Alfaiate, D.; Dény, P.; Durantel, D. 2015: Hepatitis delta virus: from biological and medical aspects to current and investigational therapeutic options. Antiviral Research 122: 112-129

Romeo, R.; Perbellini, R. 2015: Hepatitis delta virus: Making the point from virus isolation up to 2014. World Journal of Hepatology 7(22): 2389-2395

Béguelin, C.; Moradpour, D.; Sahli, R.; Suter-Riniker, F.; Lüthi, A.; Cavassini, M.; Günthard, H.F.; Battegay, M.; Bernasconi, E.; Schmid, P.; Calmy, A.; Braun, D.L.; Furrer, H.; Rauch, A.; Wandeler, G. 2017: Hepatitis delta-associated mortality in HIV/HBV-coinfected patients. Journal of Hepatology 66(2): 297-303

Wang, C.; Ji, D.; Chen, J.; Shao, Q.; Li, B.; Liu, J.; Wu, V.; Wong, A.; Wang, Y.; Zhang, X.; Lu, L.; Wong, C.; Tsang, S.; Zhang, Z.; Sun, J.; Hou, J.; Chen, G.; Lau, G. 2017: Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients with Hepatitis C Treated with Direct-acting Antiviral Agents. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 15(1): 132-136

Shalimar; Acharya, S.K. 2013: Hepatitis e and acute liver failure in pregnancy. Journal of Clinical and Experimental Hepatology 3(3): 213-224

Nelson, K.E.; Shih, J.W.K.; Zhang, J.; Zhao, Q.; Xia, N.; Ticehurst, J.R.; Labrique, A.B. 2014: Hepatitis e vaccine to prevent morbidity and mortality during epidemics. Open Forum Infectious Diseases 1(3): Ofu098

Chijioke, O.; Bawohl, M.; Springer, E.; Weber, A. 2015: Hepatitis e virus detection in liver tissue from patients with suspected drug-induced liver injury. Frontiers in Medicine 2: 20

Anonymous 1998: Hepatitis fear. Nursing Standard 1987) 13(15): 36-36

Cramp, M.E.; Williams, R. 1997: Hepatitis in alcohol and drug misusers: practical issues. Addiction Biology 2(4): 411-420

Kresina, T.F.; Sylvestre, D.; Seeff, L.; Litwin, A.H.; Hoffman, K.; Lubran, R.; Clark, H.W. 2008: Hepatitis infection in the treatment of opioid dependence and abuse. Substance Abuse: Research and Treatment 1: 15-61

Hasan, S.S.; Ma, J.; Kang, F.; Song, J.; Fang-Hollingsworth, Y.; Sears, D. 2015: Hepatitis prevention project in the Korean American community in Killeen, Texas. Proceedings 28(4): 435-437

Negash, A.A.; Gale, M. 2015: Hepatitis regulation by the inflammasome signaling pathway. Immunological Reviews 265(1): 143-155

Kassem, A.Meguid. 2014: Hepatitis research in Arab countries: questions needing answers. Arab Journal of Gastroenterology: the Official Publication of the Pan-Arab Association of Gastroenterology 15(3-4): 91

Gonçalves, Pícia.Lofêgo.; Zago-Gomes, M.da.Penha.; Gonçalves, C.Sandoval.; Pereira, F.Edmundo.Lima. 2014: Hepatitis virus and hepatocellular carcinoma in Brazil: a report from the State of Espírito Santo. Revista da Sociedade Brasileira de Medicina Tropical 47(5): 559-563

Wakita, T. 2015: Hepatitis virus culture and anti-viral development. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 63-68

Fukuhara, T.; Matsuura, Y. 2015: Hepatitis virus related viruses. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 30-35

Pazienza, V.; Panebianco, C.; Andriulli, A. 2016: Hepatitis viruses exploitation of host DNA methyltransferases functions. Clinical and Experimental Medicine 16(3): 265-272

Tumwine, J.K. 2015: Hepatitis, HIV and Ebola: light at the end of the tunnel. African Health Sciences 15(3): I-Iv

McMahon, B.; Block, J.; Block, T.; Cohen, C.; Evans, A.A.; Hosangadi, A.; London, W.T.; Sherman, M.; El-Serag, H.; Gordon, S.; Greten, T.; Hoshida, Y.; Mehta, A.; Mitchell, E.; Rinaudo, J.A.; Shetty, K.; Soulen, M.; Su, Y.-H.; Wang, X.W. 2016: Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care. Journal of the National Cancer Institute 108(4)

Hossain, K.J.; Nandi, A.K. 2015: Hepatitis-B Infections among the Injection Drug Abusers: An Emerging Risk in Public Health, Bangladesh. Mymensingh Medical Journal: Mmj 24(4): 813-824

Quddus, M.; Jehan, M.; Ali, N.Hassan. 2015: Hepatitis-B Vaccination Status and Knowledge, Attitude and Practice of High Risk Health Care Worker about Body Substance Isolation. Journal of Ayub Medical College Abbottabad: Jamc 27(3): 664-668

Akhtar, A.Majeed.; Majeed, S.; Jamil, M.; Rehman, A.; Majeed, S. 2016: Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study. Pakistan Journal of Medical Sciences 32(2): 373-378

Décard, B.F.; Grimm, A.; Andelova, M.; Deman, A.; Banderet, B.; Garcia, M.; Fuhr, P. 2015: Hepatitis-E virus associated neuralgic amyotrophy with sustained plexus brachialis swelling visualized by high-resolution ultrasound. Journal of the Neurological Sciences 351(1-2): 208-210

Yang, W.R.; Jing, L.P.; Zhou, K.; Peng, G.X.; Li, Y.; Ye, L.; Li, Y.; Li, J.P.; Fan, H.H.; Song, L.; Zhao, X.; Yang, Y.; Zhang, F.K.; Zhang, L. 2016: Hepatitis-associated aplastic anaemia: clinical characteristics and immunosuppressive therapy outcomes. Zhonghua Xue Ye Xue Za Zhi 37(5): 399-404

Dondeti, M.F.; El-Maadawy, E.A.; Talaat, R.M. 2016: Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms. World Journal of Gastroenterology 22(30): 6800-6816

HassanpourDehkordi, A.; Mohammadi, N.; NikbakhatNasrabadi, A. 2016: Hepatitis-related stigma in chronic patients: a qualitative study. Applied Nursing Research: Anr 29: 206-210

Menhas, R.; Umer, S. 2015: Hepatitis: a Rapidly Spreading Viral Infection in Pakistan. Iranian Journal of Public Health 44(6): 879-880

Jablonka, A.; Solbach, P.; Happle, C.; Hampel, A.; Schmidt, R.E.; Behrens, G.M.N. 2017: Hepatitis A immunity in refugees in Germany during the current exodus. Medizinische Klinik Intensivmedizin und Notfallmedizin 112(4): 347-351

Yang, S.-L.; Ren, Q.-G.; Zhang, T.; Pan, X.; Wen, L.; Hu, J.-L.; Yu, C.; He, Q.-J. 2017: Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells. Oncology Reports 37(1): 348-356

Gao, W.-Y.; Li, D.; Cai, D.-E.; Huang, X.-Y.; Zheng, B.-Y.; Huang, Y.-H.; Chen, Z.-X.; Wang, X.-Z. 2017: Hepatitis B virus X protein sensitizes HL-7702 cells to oxidative stress-induced apoptosis through modulation of the mitochondrial permeability transition pore. Oncology Reports 37(1): 48-56

Weill-Barillet, L.; Pillonel, J.; Semaille, C.; Léon, L.; Le Strat, Y.; Pascal, X.; Barin, F.; Jauffret-Roustide, M. 2016: Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey. Revue d'Epidemiologie et de Sante Publique 64(4): 301-312

Zhou, J.-J.; Meng, Z.; He, X.-Y.; Cheng, D.; Ye, H.-L.; Deng, X.-G.; Chen, R.-F. 2017: Hepatitis C virus core protein increases Snail expression and induces epithelial-mesenchymal transition through the signal transducer and activator of transcription 3 pathway in hepatoma cells. Hepatology Research: the Official Journal of the Japan Society of Hepatology 47(6): 574-583

Dacaj, R.; Izetbegovic, S.; Stojkanovic, G.; Gjocaj, C. 2016: Hepato - Cephalic Index as a Predictor of Intrauterine Growth Restriction. Acta Informatica Medica: Aim: Journal of the Society for Medical Informatics of Bosnia and Herzegovina: Casopis Drustva Za Medicinsku Informatiku Bih 24(1): 12-15

Tesan, F.Carla.; Portillo, M.Gaston.; Martinel-Lamas, D.; Medina, V.Araceli.; Salgueiro, M.Jimena.; Zubillaga, M.Beatriz. 2017: Hepato and Cardiotoxicity of Chemotherapeutic Treatment Evaluated by Means of Small Animal Imaging. Anti-Cancer Agents in Medicinal Chemistry 17(3): 359-364

Suchecka, D.; Harasym, J.; Wilczak, J.; Gromadzka-Ostrowska, J. 2016: Hepato- and gastro- protective activity of purified oat 1-3, 1-4-β-d-glucans of different molecular weight. International Journal of Biological Macromolecules 91: 1177-1185

Zidan, N.E.-H.A. 2015: Hepato- and nephrotoxicity in male albino rats exposed to malathion and spinosad in stored wheat grains. Acta Biologica Hungarica 66(2): 133-148

Abdalla, F.áb.C.; Domingues, C.E.d.C. 2015: Hepato-Nephrocitic System: a Novel Model of Biomarkers for Analysis of the Ecology of Stress in Environmental Biomonitoring. Plos one 10(7): E0132349

Anand, S.S.; Handa, R.K.; Singh, J.; Sinha, I. 2006: Hepato-biliary Scintigraphy in diagnosis of Biliary Atresia. Medical Journal Armed Forces India 62(1): 20-21

Nanchal, R.S.; Subramanian, R.M. 2016: Hepato-centric Musings of Two Intensivists-Back to the Future. Critical Care Clinics 32(3): Xiii-Xxiv

Ahrén, B. 2015: Hepato-incretin function of GLP-1: novel concept and target in type 1 diabetes. Diabetes 64(3): 715-717

Tran, T.B.; Dua, M.M.; Spain, D.A.; Visser, B.C.; Norton, J.A.; Poultsides, G.A. 2015: Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 17(9): 763-769

Butte, J.M.; Hameed, M.; Ball, C.G. 2015: Hepato-pancreato-biliary emergencies for the acute care surgeon: etiology, diagnosis and treatment. World Journal of Emergency Surgery: Wjes 10: 13

Edwards, J.P.; Bressan, A.; Dharampal, N.; Grondin, S.C.; Datta, I.; Dixon, E.; Cleary, S.P.; Barkun, J.S.; Butte, J.M.; Ball, C.G. 2015: Hepato-pancreato-biliary surgery workforce in Canada. Canadian Journal of Surgery. Journal Canadien de Chirurgie 58(3): 212-215

Mogensen, M.F.; Edling, P.; Raade, T.B.; Pedersen, T.I.; Pilegaard, H.K. 2015: Hepato-pericardial fistula caused by radiofrequency ablation of colorectal liver metastases. Ugeskrift for Laeger 177(14): V09140481

Bourgain, G.; Sbai, W.; Luciano, L.; Massoure, M.P.; Brardjanian, S.; Goin, G.; De Biasi, C.; Wolf, A.; Al Shukry, A.; Coton, T. 2016: Hepato-peritoneal tuberculosis with negative interferon gamma assay (Quantiferon™) in an immunocompetent patient: A case report. Clinics and Research in Hepatology and Gastroenterology 40(4): e44-e45

Russell-Jones, D.L. 2016: Hepato-preferential insulins: Is this the end, or the end of the beginning?. Diabetes Obesity and Metabolism 18(11): 1053-1054

Wang, Y.; Jiang, Y.; Fan, X.; Tan, H.; Zeng, H.; Wang, Y.; Chen, P.; Huang, M.; Bi, H. 2015: Hepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1-p53 signaling pathways. Toxicology Letters 236(2): 82-89

Hafez, M.M.; Al-Harbi, N.O.; Al-Hoshani, A.R.; Al-Hosaini, K.A.; Al Shrari, S.D.; Al Rejaie, S.S.; Sayed-Ahmed, M.M.; Al-Shabanah, O.A. 2015: Hepato-protective effect of rutin via IL-6/STAT3 pathway in CCl4-induced hepatotoxicity in rats. Biological Research 48: 30

Xu, H.; Ma, Q.; Ma, J.; Wu, Z.; Wang, Y.; Ma, C. 2016: Hepato-protective effects and chemical constituents of a bioactive fraction of the traditional compound medicine-Gurigumu-7. Bmc Complementary and Alternative Medicine 16: 179

Jiang, Y.; Fan, X.; Wang, Y.; Tan, H.; Chen, P.; Zeng, H.; Huang, M.; Bi, H. 2015: Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation. Chemico-Biological Interactions 231: 83-89

Foguet, C.; Marin, S.; Selivanov, V.A.; Fanchon, E.; Lee, W.-N.P.; Guinovart, J.J.; de Atauri, P.; Cascante, M. 2016: HepatoDyn: a Dynamic Model of Hepatocyte Metabolism that Integrates 13C Isotopomer Data. Plos Computational Biology 12(4): E1004899

Baruah, S.D.; Mishra, S.; Marwah, A.; Sharma, R. 2016: Hepatoazygos venous shunt for Fontan completion after Kawashima operation. Annals of Pediatric Cardiology 9(3): 254-257

Azhar, M.; Sheikh, A.S.F.; Khan, A.; Mustafa, S.; Shah, I.A.; Hameed, B. 2015: Hepatobiliary Ascariasis Complicated by Pancreatitis. Journal of Ayub Medical College Abbottabad: Jamc 27(2): 479-481

Basile, J.; Branch, M.S.; Desai, S.V.; Arnold, C.; Smith, A.; Lee, T.-H. 2014: Hepatobiliary Fascioliasis: An Uncommon Cause of Biliary Obstruction in the United States. Acg Case Reports Journal 1(3): 124-125

Rastogi, A.; Bihari, C.; Grover, S.; Rajbongshi, A.; Arora, A.; Nikhil, N.; Pamecha, V.; Sarin, S.Kumar. 2015: Hepatobiliary IgG4 Cholangiopathy: Case Series and Literature Review. International Journal of Surgical Pathology 23(7): 531-536

Al-Katib, S.; Al-Faham, Z.; Sokhandon, F. 2015: Hepatobiliary Iminodiacetic Acid Scanning Detects High-Grade Biliary Obstruction Secondary to IgG4-Related Sclerosing Cholangitis. Journal of Nuclear Medicine Technology 43(4): 297-298

Issa, H.; Al-Salem, A.H. 2010: Hepatobiliary Manifestations of Sickle Cell Anemia. Gastroenterology Research 3(1): 1-8

Tuomikoski, A-Maria.; Ruotsalainen, H.; Mikkonen, K.; Miettunen, J.; Kääriäinen, M. 2018: Development and psychometric testing of the nursing student mentors' competence instrument (MCI): A cross-sectional study. Nurse Education Today 68: 93-99

Seitovirta, J.; Lehtimäki, A.-V.; Vehviläinen-Julkunen, K.; Mitronen, L.; Kvist, T. 2019: Development and Psychometric Testing of the Registered Nurses' Perceptions of Rewarding Scale. Journal of Nursing Research: Jnr 27(2): E13

Sun, F-Ko.; Lu, C-Yun.; Huang, H-Man.; Yu, P-Jane.; Chiang, C-Ying. 2018: Development and Psychometric Testing of the Suicidal Recovery Ability Scale (SRAS) for Assessing Individuals Who Have Attempted Suicide. Issues in Mental Health Nursing 39(11): 954-961

Sellmaier, C.; Jivanjee, P.; Brennan, E.M.; Grover, L. 2019: Development and Psychometric Testing of the Transition Service Provider Competency Scale. Journal of Behavioral Health Services and Research 46(2): 353-362

Shaker, Y.; Samy, N.; Ashour, E. 2014: Hepatobiliary Schistosomiasis. Journal of Clinical and Translational Hepatology 2(3): 212-216

Truant, Séphanie.; Baillet, C.; Deshorgue, A.Claire.; Leteurtre, E.; Hebbar, M.; Ernst, O.; Huglo, D.; Pruvot, Fçois-René. 2017: Hepatobiliary Scintigraphy in ALPPS: A Response. Annals of Surgery 266(6): E112-E113

De Santibañes, M.; Alvarez, F.A.; de Santibañes, E. 2017: Hepatobiliary Scintigraphy in Associating Liver Partition and Portal vein ligation for Staged hepatectomy: all that Glitters Is not Gold. Annals of Surgery 266(6): E111-E112

Flynt, L.; Grant, P.; Seitz, J.P.; Qing, F. 2015: Hepatobiliary Scintigraphy of Evolving Spontaneous Biliary Leak. Clinical Nuclear Medicine 40(7): 592-595

Sørensen, M.; Munk, O.L.; Ørntoft, N.W.; Frisch, K.; Andersen, K.J.; Mortensen, F.V.; Alstrup, A.K.O.; Ott, P.; Hofmann, A.F.; Keiding, S. 2016: Hepatobiliary Secretion Kinetics of Conjugated Bile Acids Measured in Pigs by 11C-Cholylsarcosine PET. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 57(6): 961-966

Smirnova, S.V.; Barilo, A.A.; Smolnikova, M.V. 2016: Hepatobiliary System Diseases as the Predictors of Psoriasis Progression. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2: 102-108

Karaosmanoglu, A.D.; Onur, M.R.; Sahani, D.V.; Tabari, A.; Karcaaltincaba, M. 2016: Hepatobiliary Tuberculosis: Imaging Findings. AJR. American Journal of Roentgenology 207(4): 694-704

Kabbach, G.; Assi, H.A.; Bolotin, G.; Schuster, M.; Lee, H.Jeong.; Tadros, M. 2015: Hepatobiliary Tumors: Update on Diagnosis and Management. Journal of Clinical and Translational Hepatology 3(3): 169-181

Godbole, C.B.; Mangukiya, D.O.; Kakkar-Kashikar, R.; Doctor, N.H. 2014: Hepatobiliary actinomycosis masquerading as malignancy. Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 35(4): 253-256

Hu, H.-J.; Jing, Q.-Y.; Cheng, N.-S.; Li, F.-Y. 2016: Hepatobiliary and Pancreatic: a hepatic mass involving diaphragm: a real malignancy?. Journal of Gastroenterology and Hepatology 31(11): 1801

Xu, X.; Li, B.; Zheng, C. 2016: Hepatobiliary and Pancreatic: Acute acalculous cholecystitis in systemic lupus erythematosus, successfully treated with corticosteroid. Journal of Gastroenterology and Hepatology 31(10): 1673

Gassiep, I.; Clark, P.J.; McManus, D.P.; Looke, D.L. 2016: Hepatobiliary and Pancreatic: Acute hepatitis in the setting of chronic Schistosoma mansoni infection and post-praziquantel therapy. Journal of Gastroenterology and Hepatology 31(5): 910

Takeda, K.; Yamazaki, H.; Oda, M.; Yokomori, H. 2016: Hepatobiliary and Pancreatic: Acute liver injury induced by Vigna angularis (adzuki bean) pastry. Journal of Gastroenterology and Hepatology 31(6): 1072

Chetcuti Zammit, S.; Chircop, A.; Cortis, K.; Pullicino, E.; Gerada, J. 2016: Hepatobiliary and Pancreatic: Congenital intrahepatic portosystemic venous shunting: a great mimicker of liver cirrhosis. Journal of Gastroenterology and Hepatology 31(12): 1917

Kaida, T.; Higashi, T.; Kitano, Y.; Yamamura, K.; Arima, K.; Taki, K.; Imai, K.; Nitta, H.; Hashimoto, D.; Chikamoto, A.; Namimoto, T.; Nakahara, O.; Beppu, T.; Baba, H. 2016: Hepatobiliary and Pancreatic: Degenerative hepatic hemangioma mimicking biliary cystadenocarcinoma. Journal of Gastroenterology and Hepatology 31(8): 1385

Chua, T.C.; Roseverne, L.O.; Goh, A.C.; Maher, R.; Samra, J.S. 2016: Hepatobiliary and Pancreatic: Dual system stenting of the biliary and porto-venous systems to palliate locoregional recurrence of hilar cholangiocarcinoma. Journal of Gastroenterology and Hepatology 31(7): 1239

Guo, B.; Li, D. 2016: Hepatobiliary and Pancreatic: Ectopic pregnancy in the liver: another rare cause of space occupying lesion. Journal of Gastroenterology and Hepatology 31(9): 1514

Lai, W.J.; Chiu, N.C.; Chau, G.Y. 2016: Hepatobiliary and Pancreatic: Focal peliosis hepatis mimicking hepatocellular carcinoma in a hepatitis B carrier. Journal of Gastroenterology and Hepatology 31(6): 1073

Fung, A.; Chok, K.; Lo, A.; Lo, C.M. 2016: Hepatobiliary and Pancreatic: Hepatic splenosis: a rare differential of a liver mass in an HBV endemic area. Journal of Gastroenterology and Hepatology 31(7): 1238

Lai, Y.-C.; Wu, P.; Huang, C.-C.; Wu, C.-H.; Wang, C.-J.; Wong, Y.-C. 2016: Hepatobiliary and Pancreatic: Intra-hepatic arterio-biliary fistula caused by blunt abdomen trauma. Journal of Gastroenterology and Hepatology 31(10): 1672

Liu, L.; Li, X.; Zhang, Y. 2016: Hepatobiliary and Pancreatic: Leiomyosarcoma: unusual cause of inferior vena cava obstruction. Journal of Gastroenterology and Hepatology 31(8): 1384

Luangsukrerk, T.; Aumpansub, P.; Chaiteerakij, R. 2016: Hepatobiliary and Pancreatic: Liver abscesso-colonic fistula: a rare complication of transarterial chemoembolization for treatment of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 31(11): 1800

Han, M.; Rehman, R.B.; Kleiner, D.; Cohen, J.; Heller, T. 2016: Hepatobiliary and Pancreatic: not all that "Glisson's" is fat. Journal of Gastroenterology and Hepatology 31(9): 1515

Lakananurak, N. 2016: Hepatobiliary and Pancreatic: Plate-like atelectasis mimics pneumoperitoneum in patient with acute gangrenous cholecystitis. Journal of Gastroenterology and Hepatology 31(5): 911

García-Alonso, F.J.; Hernández Tejero, M.; Castanon-Deprit, A. 2015: Hepatobiliary and Pancreatic: Pseudoachalasia from pancreatic cancer. Journal of Gastroenterology and Hepatology 30(9): 1336

Okabe, H.; Hashimoto, D.; Chikamoto, A.; Hayashi, H.; Nitta, H.; Taki, K.; Higashi, T.; Arima, K.; Ishiko, T.; Beppu, T.; Baba, H. 2015: Hepatobiliary and Pancreatic: Skin metastases from cholangiocarcinoma mimicking herpes zoster. Journal of Gastroenterology and Hepatology 30(9): 1337

Rana, S.S.; Sharma, R.; Sharma, V.; Dhalaria, L.; Gupta, R.; Basher, R.K.; Mittal, B.R.; Das, A.; Bhasin, D.K. 2016: Hepatobiliary and Pancreatic: Unusual space occupying lesion of liver. Journal of Gastroenterology and Hepatology 31(12): 1916

Khuroo, M.S.; Rather, A.A.; Khuroo, N.S.; Khuroo, M.S. 2016: Hepatobiliary and pancreatic ascariasis. World Journal of Gastroenterology 22(33): 7507-7517

Lynser, D.; Marbaniang, E. 2016: Hepatobiliary and pancreatic ascariasis-sonographic pictorial essay on four pediatric cases with acute biliary colic. Emergency Radiology 23(2): 197-200

Zhu, Y.; Niu, M.; Chen, J.; Zou, Z.-S.; Ma, Z.-J.; Liu, S.-H.; Wang, R.-L.; He, T.-T.; Song, H.-B.; Wang, Z.-X.; Pu, S.-B.; Ma, X.; Wang, L.-F.; Bai, Z.-F.; Zhao, Y.-L.; Li, Y.-G.; Wang, J.-B.; Xiao, X.-H. 2016: Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. Journal of Gastroenterology and Hepatology 31(8): 1476-1482

Su, C. 2016: Hepatobiliary cancer: all efforts for one goal. Cancer Letters 379(2): 164-165

Graeter, T.; Ehing, F.; Oeztuerk, S.; Mason, R.A.; Haenle, M.M.; Kratzer, W.; Seufferlein, T.; Gruener, B. 2015: Hepatobiliary complications of alveolar echinococcosis: a long-term follow-up study. World Journal of Gastroenterology 21(16): 4925-4932

Francisco, F.áv.A.él.F.; de Araújo, A.L.E.; Oliveira Neto, J.A.új.; Parente, D.B. 2014: Hepatobiliary contrast agents: differential diagnosis of focal hepatic lesions, pitfalls and other indications. Radiologia Brasileira 47(5): 301-309

Terada, T. 2015: Hepatobiliary cystadenocarcinoma of the liver with features of ductal plate malformations. Journal of Gastrointestinal Cancer 46(2): 197-200

Kudo, Y.; Kikuchi, T.; Sato, Y.; Hirau, K.; Sugawara, K.; Sato, T.; Yamada, N.; Saito, Y.; Sugita, A.; Ishida, H. 2008: Hepatobiliary cystadenocarcinoma with rapid growth: report of a case. Journal of Medical Ultrasonics 35(3): 133-138

Hance, J.M.; Harris, J.W.; Neltner, J.; Vilchez, V.; Tzeng, C.-W.; Maynard, E.; Gedaly, R.; Shah, M.B. 2015: Hepatobiliary mucinous cystadenoma resulting in biliary obstruction. American Surgeon 81(6): E238-E239

Takatsu, Y.; Kobayashi, S.; Miyati, T.; Shiozaki, T. 2016: Hepatobiliary phase images using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRi as an imaging surrogate for the albumin-bilirubin grading system. European Journal of Radiology 85(12): 2206-2210

Lee, J.K.; Kim, Y.; Lee, S.; Park, J.E. 2015: Hepatobiliary phase of gadoxetic acid-enhanced MR in patients suspected of having gallbladder dyskinesia: comparison with hepatobiliary scintigraphy. Clinical Imaging 39(1): 66-71

Clark, C.M.; Sattler, V.P.; Barbosa-Leiker, C. 2018: Development and Psychometric Testing of the Workplace Civility Index: a Reliable Tool for Measuring Civility in the Workplace. Journal of Continuing Education in Nursing 49(9): 400-406

Shaikh, K.T.; Tatham, E.L.; Parikh, P.K.; McCreath, G.A.; Rich, J.B.; Troyer, A.K. 2019: Development and Psychometric Validation of a Questionnaire Assessing the Impact of Memory Changes in Older Adults. Gerontologist 59(4): E248-E257

Hennigs, A.é; Heil, J.ör.; Wagner, A.; Rath, M.; Moosbrugger, H.; Kelava, A.; Golatta, M.; Hug, S.; Riedel, F.; Rauch, G.; Feißt, M. 2018: Development and psychometric validation of a shorter version of the Breast Cancer Treatment Outcome Scale (BCTOS-12). Breast 38: 58-65

Kearns, N.T.; Peterson, J.K.; Smurr Walters, L.; Jackson, W.T.; Miguelez, J.M.; Ryan, T. 2018: Development and Psychometric Validation of Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL). Archives of Physical Medicine and Rehabilitation 99(9): 1789-1797

Santos, R.Z.D.; Bonin, C.D.B.; Martins, E.T.C.; Pereira Junior, M.; Ghisi, G.L.d.M.; Macedo, K.R.P.d.; Benetti, M. 2018: Development and Psychometric Validation of HIPER-Q to Assess Knowledge of Hypertensive Patients in Cardiac Rehabilitation. Arquivos Brasileiros de Cardiologia 110(1): 60-67

Shin, H.; Park, Y-Joo.; Cho, I. 2018: Development and psychometric validation of the Menstrual Health Instrument (MHI) for adolescents in Korea. Health Care for Women International 39(10): 1090-1109

Brittain, J.M.; Kvist, N.; Johansen, L.S.øn.; Borgwardt, L. 2016: Hepatobiliary scintigraphy for early diagnosis of biliary atresia. Danish Medical Journal 63(8)

Seyyedmajidi, M.; Kiani, M.; Javadi, H.; Raeisi, A.; Assadi, M. 2015: Hepatobiliary scintigraphy with SPET in the diagnosis of bronchobiliary fistula due to a hydatid cyst. Hellenic Journal of Nuclear Medicine 18(2): 160-162

Louie, C.Y.; Concepcion, W.; Park, J.K.; Rangaswami, A.; Finegold, M.J.; Hazard, F.K. 2016: Hepatoblastoma Arising in a Pigmented β-catenin-activated Hepatocellular Adenoma: Case Report and Review of the Literature. American Journal of Surgical Pathology 40(7): 998-1003